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ABSTRACT OF THE DISSERTATION 
A MULTI-FACETED DIAGNOSTIC APPROACH TO LUNG INFECTIONS IN 
PATIENTS WITH CYSTIC FIBROSIS  
by 
 
Melissa S. Doud 
Florida International University, 2010 
Miami, Florida 
Professor Kalai Mathee, Major Professor 
One in 3,000 people in the US are born with cystic fibrosis (CF), a genetic disorder 
affecting the reproductive system, pancreas, and lungs.  Lung disease caused by chronic 
bacterial and fungal infections is the leading cause of morbidity and mortality in CF. 
Identities of the microbes are traditionally determined by culturing followed by 
phenotypic and biochemical assays.  It was first thought that the bacterial infections were 
caused by a select handful of bacteria such as S. aureus, H. influenzae, B. cenocepacia, 
and P. aeruginosa. With the advent of PCR and molecular techniques, the polymicrobial 
nature of the CF lung became evident.  The CF lung contains numerous bacteria and the 
communities are diverse and unique to each patient.  The total complexity of the bacterial 
infections is still being determined.  In addition, only a few members of the fungal 
communities have been identified.  Much of the fungal community composition is still a 
mystery.  This dissertation addresses this gap in knowledge.  A snap shot of CF sputa 
bacterial community was obtained using the length heterogeneity-PCR community 
profiling technique.  The profiles show that south Florida CF patients have a unique, 
diverse, and dynamic bacterial community which changes over time.  The identities of 
 vi 
 
the bacteria and fungi present were determined using the state-of-the-art 454 sequencing.  
Sequencing results show that the CF lung microbiome contains commonly cultured 
pathogenic bacteria, organisms considered a part of the healthy core biome, and novel 
organisms. Understanding the dynamic changes of these identified microbes will 
ultimately lead to better therapeutical interventions.  Early detection is key in reducing 
the lung damage caused by chronic infections.  Thus, there is a need for accurate and 
sensitive diagnostic tests.  This issue was addressed by designing a bacterial diagnostic 
tool targeted towards CF pathogens using SPR.  By identifying the organisms associated 
with the CF lung and understanding their community interactions, patients can receive 
better treatment and live longer. 
 vii 
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1.1  Preface 
 Cystic fibrosis (CF) is a genetic disorder that affects the exocrine glands of the 
human body (Davis, 1987).  Sweat glands, lungs, and pancreas are the most affected but 
problems can arise in other systems such as the reproductive system (Davis, 1987).  The 
mucus found in the lungs, pancreas, and reproductive system is thicker and stickier in 
people who have CF and this leads to chronic lung infection, digestion problems and 
infertility, respectively (Andersen, 1938; Johansen et al., 1968; Oppenheimer & Esterly, 
1969; Oppenheimer et al., 1970).  The leading cause of morbidity and mortality in CF 
patients is due to lung deterioration as the result of the chronic infections (Buzzetti et 
al., 2009; Patient-registry, 2008).  Diagnosis and treatment of the pulmonary infections 
is key to the overall health and age of survival for the CF individual.  The following 
introduction discusses the microbial community found in the lungs of CF patients and 
the techniques that identify these microbes. 
 
1.2 Cystic fibrosis 
Cystic fibrosis (CF) is a fatal inherited disease primarily affecting Caucasians. In 
the United States (US), 3500 children are born with the disease each year (Patient-
registry, 2008). The gene responsible for CF encodes a protein called the CF 
transmembrane conductance regulator (CFTR) (Kerem et al., 1989; Riordan et al., 
1989; Rommens et al., 1989). The CFTR is a secretory epithelial cyclic-AMP-activated 
chloride channel; mutations in the cftr gene lead to decreased fluid secretion and 
dehydration of epithelial surfaces (Figure 1.1) (Anderson et al., 1991). The change in 
 3 
 
mucus production and consistency affects various systems of the human body.  The 
thick mucus can plug the pancreatic ducts which lead to pancreatic enzyme 
insufficiency and thus vitamin deficiency and malnutrition (Andersen, 1938; Johansen 
et al., 1968; Oppenheimer & Esterly, 1969). The thick mucus also causes reproductive 
complications (Kaplan et al., 1968; Kotloff et al., 1992; Oppenheimer & Esterly, 1969; 
Oppenheimer & Esterly, 1970).  Although the anatomy of the female reproductive tract 
is normal, pregnancy can be difficult as a result of the presence of the viscous mucus 
preventing the sperm from fertilizing the egg (Kopito et al., 1973; Oppenheimer et al., 
1970).  Over 90 % of males are born with congenital bilateral absence of the vas 
deferens, meaning that a man can produce sperm but due to the lack of vas deferens the 
sperm cannot leave the testicles (Landing et al., 1969; Mercier et al., 1995; 
Oppenheimer & Esterly, 1969).   
The airways in a CF individual are also negatively affected by the defective 
CFTR protein.  Oversecretion of thick mucus in the airway leads to congestion of the 
respiratory tract and increased susceptibility to chronic broncho-pulmonary infection, 
which is the major cause of morbidity and mortality among patients with CF (Buzzetti et 
al., 2009).  To retard the rate of decreasing lung function, bacterial infections are treated 
with antibiotics, however these must be tailored to the particular infection, which is 
often polymicrobial. For example, anti-pseudomonal drugs are often ineffective against 
Burkholderia cenocepacia infections due to the bacteria’s resistance to the drug 
(McGowan Jr, 2006).  Thus, it is important to correctly identify the infecting pathogens, 
bacteria and fungi, in order to prescribe an appropriate treatment and prolong the life of 
the individual.  
 4 
 
  
Figure 1.1: Cystic fibrosis transmembrane conductance regulator (CFTR) 
channel.  Schematic representation of proposed CFTR structure. CFTR is made 
up of five domains: two nucleotide-binding domains that bind and hydrolyze 
ATP and a regulatory domain comprised of two membrane-spanning domains 
which form the chloride ion channel, http://www.cfgenetherapy.org.uk/). 
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1.2.1 CF sputum bacterial flora.  Initially because of culturing techniques, it 
was thought that only a few bacterial species were present in the CF lungs.  
Staphylococcus aureus, Haemophilus influenzae and Pseudomonas aeruginosa are the 
primary pathogens cultured from CF patients (Whittier, 2001).  Staphylococcus aureus, 
the predominant pathogen in children, is succeeded by H. influenzae during early 
childhood and P. aeruginosa becomes the predominant pathogen during adolescence, 
reaching a prevalence rate of 80% in adults (Beringer & Appleman, 2000; Patient-
registry, 2008) (Figure 1.2).   
 
 
 
 
 
Figure 1.2: Respiratory infections at a given age.  Patients throughout their life are 
affected with numerous bacteria.  Each line represents a specific bacterial infection over 
the lifespan of the patient.  The height of the line indicates the percentage of patients 
that have a particular bacterial infection at that specific age (Patient-registry, 2008). 
 6 
 
However, there has been the emergence of other opportunistic pathogens such as 
Burkholderia cenocepacia, Alcaligenes xylosoxidans, Ralstonia pickettii, Burkholderia 
gladioli, Stenotrophomonas maltophilia, and Mycobacterium species (Pierre-Audigier et 
al., 2005; Whittier, 2001).  The occurrence of the more recent emerging organisms 
increases with advancing age and severity of lung disease (Beringer & Appleman, 2000; 
Lewin et al., 1990; Patient-registry, 2008; Pierre-Audigier et al., 2005).  The 
identification of these emerging pathogens suggests the presence of a complex bacterial 
community present in the CF lung.  The true polymicrobial nature of the lung was 
revealed with the development of DNA based diagnostic tools.  These methods have 
identified Streptococcus mitis, Streptococcus pneumoniae, Prevotella melaninogenica, 
Veionella sp., Granulicatella para-adiacens and Exiguobacterium in CF samples (Bittar 
et al., 2008; Harris et al., 2007).  Potential novel pathogens Lysobacter, Coxiellaceae, and 
Rickettsiales have also been found (Harris et al., 2007).  The diversity of the CF lung 
community continues to increase and change as more samples from CF lungs are 
analyzed. 
 
1.2.2  CF sputum fungal flora.  Invasive mold infections are very common in 
patients suffering from chronic bronchitis. Thus, it was not surprising when the fungal 
infections in CF patients were recognized as early as 1967 by the presence of 
precipitating antibody to Aspergillus fumigatus (Mearns et al., 1967). In fact, A. 
fumigatus is one of the most common fungal pathogens found in the CF lung.  In one 
study, 65 patients underwent a lung transplant and it was noted that 52% of these 
patients were determined to being infected with A. fumigatus before surgery 
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(Paradowski, 1997).  Candida albicans is the other common fungal pathogens (Bakare 
et al., 2003; Cimon et al., 2001). Recently, Candida dubliniensis, a close relative of C. 
albicans, has been detected in these patients as well (Kim et al., 2003).  Occasionally, 
other fungi such as Scedosporium apiospermum, Scedosporium prolificans, Aspergillus 
terreus, Acrophialophora fusispora, Exophiala dermatitidis and Penicillium emersonii 
have been shown to infect CF patients (Bakare et al., 2003; Cimon et al., 1999; Cimon 
et al., 2003; Cimon et al., 2005; Defontaine et al., 2002; Hennequin et al., 1997; Horré 
et al., 2004).   
Recent statistics have shown that there is an increase in the prevalence of fungi 
being detected in the CF patient which may be a consequence from aggressive 
antibacterial therapy (Nagano et al., 2007).  Yet, the prevalence of fungi present in the 
CF lung is still unknown.  For instance, the prevalence of Aspergillus infection ranges 
from nine to 57 % of CF individuals (Bakare et al., 2003). In addition, the fungal 
community may be more diverse than culturing results have shown. Depending on the 
organism present, fungal infections can lead to health problems ranging from allergic 
bronchopulmonary aspergillosis (ABPA) to post-transplant fungaemia (Fahy et al., 
1991; Kubak, 2002; Mastella et al., 2000; Nagano et al., 2007)  It is also possible for a 
fungal infection to become chronic and lead to bronchitis (Nagano et al., 2007).  
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1.3 Common assays used for clinical identification of bacteria and their 
limitations 
Cystic fibrosis patients that are experiencing an exacerbation typically produce a 
sputum sample that can be analyzed for the presence of pathogenic bacteria and fungi.  
Most often diagnostic clinics use culturing and commercial kits to identify common 
pathogenic organisms that may be present in the sample (Figure 1.3).  A few of these 
assays and their limitations are discussed in further detail below.   
 
1.3.1  Culturing and commercial phenotypic identification assays.  Culturing 
for microbial identification is commonly used in laboratories handling CF sputum.  Using 
various media, sputum is swabbed onto plates and then the organism is allowed to grow 
for a period of time.  Based on the phenotype of the organism and the media it is growing 
on, an identification of the bacteria or fungi is made.  Bacteria can be cultured using 
various media including: Luria Bertani (LB), blood agar, chocolate agar, Pseudomonas 
Isolation Agar (PIA), Burkholderia cenocepacia Selective Agar (BCSA) and MacConkey 
agar (Murray & Baron, 2007).  The phenotype of the bacteria can be examined using 
microscopy.  In addition, a sample of the bacteria can undergo Gram Staining to 
determine if the bacteria is Gram-positive or Gram-negative (Gram, 1884).  This 
information in conjunction with phenotypic results is used to identify organisms present 
in the sample.  
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CHROMagar, a specialized media can identify some bacteria based on the colony 
color; thus, circumventing any need for microscopy (Figure 1.4).  CHROMagar plates 
contain a specific substrate that is hydrolyzed by a specific organism which results in the 
bacterial colony being colored or surrounded by a diffusible color (Merlino et al., 1996).   
There are plates can identify various species of Salmonella, Staphylococcus aureus 
including methicillin resistant strains, Group B Streptococcus, Enterococcus, various 
strains of Escherchia coli, Listeria monocytogenes, and various species of Vibrio (Alonso 
et al., 1996; Gaillot et al., 1999; Hegde et al., 2007; Merlino et al., 1996; Pape et al., 
2006; Su et al., 2005). 
 
 
Besides visual phenotypes, the biochemical tests are performed.  Currently, 
multiple biochemical tests can be performed at the same time.  For example, the API 20 
NE system (BioMérieux, Marcy l'Etoile, France) is a strip that contain up to 20 
biochemical tests.  There are 16 identification products with comprised of different 
Figure 1.4:  CHROMagar plates.  Seven bacteria were grown on a plate.  The color 
of the colonies indicates the organism plated (www.chromagar.com). 
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biochemical tests that should identify up to 550 different species.  These products identify 
bacteria in two to 24 hours.  Another advanced product that identifies bacteria is the 
VITEK 2 by BioMérieux.  The fully automated BioMérieux system uses different cards 
containing biochemical assays.  Fluorescence is used to detect the outcome of the assay 
and then based on the results of the assays bacteria are identified.  The VITEK2 ID-GNB 
card can identify bacteria based on 41 biochemical tests and 20 preformed enzymes 
(O'Hara & Miller, 2003).   
Fungal identification tools are similar to the methods used in bacterial detection.  
Culturing, phenotypic determination using microscopy and Gram staining can all be used 
in the identification process.  Fungi can be cultured on blood agar, chocolate agar, eosine 
methylene blue agar, Sabouraud glucose agar, and potato dextrose agar (Murray & 
Baron, 2007).  Often the CF sputum sample contains Pseudomonas aeruginosa which is a 
bacterium that can grow on the media listed above and thus impede the growth and 
identification of the fungi.  Therefore, antibiotics can be added to the medium to stop 
bacterial contamination (Bakare et al., 2003).  Culturing fungi can take as little as three 
days but many species need weeks to grow.  After the organism has been isolated, 
microscopy is used to examine the fungi’s hyphae.  The phenotype can be used to provide 
an identification (Bakare et al., 2003).  
Gram staining can also be used for yeast such as Candida (Gram negative) to 
make the organism more readily observed microscopically (Subhash, 2004).  Aspergillus 
and other molds only retain a small amount of color and thus are poorly stained.  Many 
other fungi can be visualized and differentiated using other stains such as Fontana-
Masson stain, Grocott’s modification of Gomori’s methenamine silver method, Gridley’s 
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stain, hematoxylin and eosin stains (Dixon & Polak-Wyss, 1991; Huppert et al., 1978; 
Saeed & Hay, 1981; Schwarz, 1982; Wood & Russel-Bell, 1983).   
Biochemical assays can also aid in identification.  These methods may include 
CHROMagar plates which contain a substrate that is hydrolyzed by a specific fungus.  
The product from the reaction stains the fungus and based on the color the Candida 
species can be identified (Figure 1.5) (Odds & Bernaerts, 1994).  For example, 
CHROMagar Candida plates uses a chromogenic β-glucosaminidase substrate, which 
when metabolized results in green colonies of C. albicans, steel blue colonies of C. 
tropicalis, and fuzzy rose-colored colonies of C. krusei (Baumgartner et al., 1996; Cooke 
et al., 2002) (CHROMagar, Paris, France).  Currently, no other CHROMagar plates have 
been developed for other species of fungi. 
 
 
 
 
Figure 1.5: CHROMagar Candida plate.  Plate shows the growth of four different 
Candida species on CHROMagar Candida media (www.mycology.adelaide.edu.au). 
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Multiple phenotypic commercial assays exist for fungal identification.  For 
example, BioMérieux (Marcy l'Etoile, France) makes strips such as the API 20C AUX 
that contain 18 biochemimal tests which aid in fungal identification (Gundes et al., 2001).  
In this assay, a liquid suspension is made from a fungal isolate that has been growing for 
48-72 hours.  The suspension is placed onto the strip and based on the results of the 
individual chemical tests, an identification is made (Gundes et al., 2001).  The automatic 
identification system VITEK 2 (BioMérieux) also works with fungi by using the ID-YST 
card which consists of 47 biochemical tests and is capable of identifying 51 taxa in 15 
hours (Graf et al., 2000). 
 
1.3.2  Accuracy of commercial identification systems.  Multiple studies have 
been performed to determine the accuracy and specificity of the commercially available 
identification system for both bacteria and fungi (Bosshard et al., 2006; Brisse et al., 
2002; O'Hara & Miller, 2003; van Pelt et al., 1999).   
 
1.3.2.1 Bacterial identification.  Three studies have examined the 
accuracy of the VITEK2 ID-GNB card (BioMérieux, Marcy l'Etoile, France).  In one 
study, the commercial system accurately identified 93.0 % of 414 clinically relevant 
enteric bacteria strains (O'Hara & Miller, 2003).  This study also correctly identified 
95.1 % of the 103 glucose-fermenting and nonfermenting nonenteric strains (O'Hara & 
Miller, 2003).   
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Another study compared the bacterial identification systems, API 20 NE 
(BioMérieux) and the VITEK2 ID-GNB card (BioMérieux), with sequencing data from 
the same 107 isolates (Bosshard et al., 2006).  The API system was only able to identify 
54 % of the isolates to species level and 7 % to the genus level.  Thirty-nine percent or 
42 isolates were not identified at all and of 26 % (11 isolates) belonged to a species that 
was not in the API database (Bosshard et al., 2006).  The VITEK 2 system had similar 
results where as 53 % of the isolates were identified to species level, one percent to 
genus level, and 46 % (49 isolates) were unidentifiable.  Of the 49 isolates, 39 belonged 
to a species not represented in the VITEK 2 database (Bosshard et al., 2006).  A third 
study compared the VITEK with the BD Phoenix (BD Diagnostic System, Sparks, MD) 
to determine the accuracy in identifying isolates of the B. cenocepacia complex, a 
known CF pathogen (Brisse et al., 2002).  The study determines an overall correct ID 
rate of 50 % for both systems.  The authors conclude by strongly recommending the use 
of molecular techniques to identify members of the B. cenocepacia complex (Brisse et 
al., 2002).   
 
1.3.2.2 Fungal identification.  Commercial fungal identification systems 
have also been evaluated.  The API 20C AUX strip (BioMérieux, Marcy l'Etoile, 
France) was determined to be 87 % accurate in a study that used 116 strains representing 
11 species of Candida and one species of Trichosporon (Gundes et al., 2001).  This 
increased by 12 % when the strains not equivocally identified were analyzed with an 
additional step.  Only one strain was misidentified.  In a separate study, the VITEK 2 
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ID-YST card (BioMérieux) was tested with 241 strains representing 21 species (Graf et 
al., 2000).  Of these strains, 211 were identified to the species level.  Eleven other 
strains were identified conclusively after an additional assay was performed.  Of the 
remaining 19 strains, 10 strains were not conclusively identified even with additional 
tests, four fungi were misidentified, and five were unidentifiable (Graf et al., 2000).  
The most common Candida species isolated in clinic laboratories were correctly 
identified 93.8 % of the time.  With the addition of a second assay, 97.5 % of Candida 
species were identified correctly.  These two studies concluded that both BioMérieux 
systems can identify high percentage of clinically relevant fungi that have been isolated 
from a patient sample. 
 
1.3.3  Misidentification through culturing.  Commercial phenotypic tests are 
indeed a rapid cost efficient way of identifying pathogens but there are potential issues 
that lead to a misdiagnosis (Bosshard et al., 2006).  These systems rely on a reference 
database which can be limiting because the sample may contain organisms that are not 
in the database (Bosshard et al., 2006; Ramani et al., 1998).  Error may also occur 
because of strain variation, that is, not all strains within a species possess the same 
phenotypes (Brisse et al., 2002; Wigley & Burton, 1999).    Patients have been 
diagnosed with Burkholderia cenocepacia on the basis of results obtained from 
culturing techniques but with more stringent molecular techniques, it was shown to be 
Burkholderia gladioli or Stenotrophomonas maltophilia (McDowell et al., 2001; 
McMenamin et al., 2000).  Identification of common CF pathogen, Pseudomonas 
 16 
 
aeruginosa, can be difficult.  The CF-derived isolates of this bacterium acquire many 
mutations resulting in a huge phenotypic diversity from loss of pigment production, 
mucoidy, and change in lipopolysaccharide (Spilker et al., 2004).  Occasionally, P. 
aeruginosa is identified as another bacterium.  In one study, 770 strains of B. 
cenocepacia were reanalyzed using a polyphasic approach that included selective media 
and biochemical tests.  Only 682 strains were confirmed to be B. cenocepacia.  The 
remaining 88 samples were misidentified of which 11 of them were P. aeruginosa 
(Shelly et al., 2000).  The misidentified strains were inaccurately identified using a 
variety of commercial assays including the VITEK and API 20NE (BioMérieux, Marcy 
l'Etoile, France).    
Multiple studies have shown that fungal misidentification is also a problem 
(Balajee et al., 2006; Rowen et al., 1999).  For example, a common CF fungus, 
Aspergillus fumigatus is identified based on macroscopic and microscopic features.  
Through the use of molecular techniques, A. fumigatus identified isolates were shown to 
be Aspergillus lentulus and Aspergillus udagawae (Balajee et al., 2006).  These 
organisms vary greatly in their resistance to certain drugs and thus misidentification 
may contribute to failure in treatment certain patients (Balajee et al., 2006).  Strains of 
Candida are often confused with one another because of similar phenotypes (Coleman 
et al., 1997).  Some strains also possess similar biochemical activities which can cause 
inaccurate results when using commercial systems like the API 20C thus leading to 
misidentification   (Elie et al., 1998; Rowen et al., 1999).   
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All of the above bacterial and fungal identification systems rely on culturing 
which therein is a problem.  It has been estimated that less than 1 % of eubacteria in the 
environment can be cultured (Roszak & Colwell, 1987; Ward et al., 1990a; Ward et al., 
1990b).  Therefore, the bacteria present in a sample may not grow in a laboratory 
setting and thus can never be identified using culture based phenotypic assays.  Fungal 
organisms can also be difficult to grow and some species can take up to 5 weeks to 
culture (Elie et al., 1998; Murray & Baron, 2007).  Misidentification problems can be 
reduced or completely eliminated by using non-phenotypic methods like mass 
spectrometry and genotype-based molecular identification methods (Elie et al., 1998; 
Spilker et al., 2004). 
 
1.4 Identification through mass spectrometry 
 There are many ways to identify bacteria and fungi that do not rely on phenotypic 
assays.  Some of these techniques originated from the chemistry field and were later 
adapted to study microorganisms.  One of the most widely studied techniques relies on 
mass spectrometry.    
 
 1.4.1  Mass spectrometry (MS).  Since the 1970’s mass spectrometry has been 
used to identify bacteria (Abel et al., 1963; Fox, 2006).  Mass spectrometry determines 
the elemental composition of a sample by identifying the mass to charge ratio of the 
compound (Aston, 1919; Dempster, 1918; Gross, 2004). The first mass spectrometry 
based bacterial identification technique used MS coupled with gas chromatography (GC) 
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to study the fatty acid composition of a bacterium (Abel et al., 1963; Fox, 2006).  In this 
technique, the polymers such as phospholipids are first broken into monomers by 
hydrolysis or saponification.  The monomers are then chemically converted through 
derivatization by methylation in order to inhibit ionic or hydrogen-bonding interactions 
which allow the compounds to be volatile and separated through the column in the gas 
chromatograph. The isolated monomer which is in the gas phase then enters the mass 
spectrometer and is ionized (Gross, 2004).  The mass to charge ratio for the monomer is 
calculated and with the generated retention time from the gas chromatograph, a fatty acid 
mixture profile is determined for the bacteria being analyzed.  The profile is characteristic 
to each bacterium and thus provides identification of a sample (Fox, 2006).   
In the 1980s and 1990s, MS technology evolved and soft ionization MS was 
developed (Fenn et al., 1989; Fox, 2006; Karas & Hillenkamp, 1988).  In soft ionization 
MS, compounds do not have to be separated into individual components before 
undergoing MS or if separation is needed then it is done using a liquid phase (Gross, 
2004).  Soft ionization MS has been coupled to numerous instruments and continues to be 
used in bacterial identification (Fox, 2006).  The roles and limitations of matrix-assisted 
laser desorption/ionization – time of flight mass spectrometry (MALDI-TOF MS) and 
electrospray ioinization (ESI-MS) in bacterial identification will be discussed in more 
detail.   
  
1.4.2  MALDI-TOF MS.  In this technique, the sample being analyzed is spotted, 
with a matrix, on a metal plate and allowed to air dry. The matrix is typically a solution 
containing 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid), α-cyano-4-
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hydroxycinnamic acid (alpha-cyano or alpha-matrix) or 2,5-dihydroxybenzoic acid 
(DHB) and water, ethanol, or acetonitrile (Gross, 2004).  Once the solvent has 
evaporated, a crystallized matrix with the sample is left on the plate.  The MALDI plate is 
placed in the TOF MS.  The matrix spot is struck with a laser beam which absorbs the 
light and transfers some of the charge to the sample of interest. The ions from the sample 
drift through a tube to the MS detector.  The smaller the ion, the faster it will traverse the 
tube and be detected.  The TOF MS spectrum produced indicates the mass to charge ratio 
for the sample and the time in which the ions took to reach to the detector (Gross, 2004). 
  The MALDI-TOF MS spectra has been used to look at the DNA, proteins, 
bacterial toxins, bacteria DNA/RNA and bacterial metabolites (Jackson, 2001).  Most 
notably here is the use of proteins and whole cells to differentiate between bacteria 
species.  Bacteria were identified first by using MALDI-TOF MS to generate a total 
protein profile from a total protein fraction from lysed bacteria (Cain et al., 1994; 
Jackson, 2001).  Another group, Holland et al. took bacteria colonies from an agar plate 
and dried them on the MALDI plate with a solvent.  The protein profile did not contain 
all proteins that would be seen on the whole protein fraction spectra yet enough ions were 
present to still ascertain and identification (Holland et al., 1996; Jackson, 2001).  
Reproducibility of these spectra from whole cells, both from colonies and from liquid 
culture, plagues this analysis (Jackson, 2001).  However, the technique was refined and 
eventually identification of whole cell bacteria became a more reliable tool.   
To make MALDI-TOF MS more applicable as a tool for clinical diagnosis, a 
database of protein profiles for individual bacteria was generated (Keys et al., 2004).  
Over 3500 spectra with multiple spectra for a species were produced.  The ability to 
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identify an unknown profile using the database ranges from 33 to 100 % (Hsieh et al., 
2008; Keys et al., 2004).  As a result of the strain variation in protein profiles, some 
species were not correctly identified.  This error decreased as more strains were added to 
the database (Keys et al., 2004).   
The database software may have also caused low identification rates (Hsieh et al., 
2008).  This problem was addressed using bioinformatics programs like Support Vector 
Machines and other algorithms (Hsieh et al., 2008).  By using clustering methods, 
identification based on the protein profile of a bacterial colony greatly increased.  In 
addition, the programs were able to identify components of bacteria mixtures from six 
human pathogenic bacteria (Staphylococcus aureus, Streptococcus serogroup B, 
Escherichia coli, Klebsiella pneumoniae, Salmonella enterica serogroup B, and 
Pseudomonas aeruginosa) (Figure 1.6) (Hsieh et al., 2008).  The MALDI-TOF MS 
spectra has been determined for many CF pathogens including members of the B. 
cenocepacia complex (Degand et al., 2008; Keys et al., 2004).   
The MALDI-TOF MS technique has also been used to identify fungi.  In one 
study, 92.5 % of 247 clinical fungal isolates were correctly identified using this technique 
(Marklein et al., 2009).  The strains in this study included Candida, Cryptococcus, 
Saccharomyces, Trichosporon, Geotrichum, Pichia, and Blastoschizomyces spp.  Some 
fungi were not identified because of the lack of a reference strain in the current database.  
Updating the database ensured that the remaining fungi were identified based on the 
protein profile (Marklein et al., 2009).   
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Figure 1.6:  MALDI-TOF MS spectra for six different bacterial species.  The 
representative MALDI-TOF MS spectra of each of the six bacterial species (Panels A–F) 
representing Escherichia coli (Panel A, blue), Klebsiella pneumoniae (Panel B, yellow), 
Salmonella enterica (Panel C, purple), Staphylococcus aureus (Panel D, red), 
Pseudomonas aeruginosa (Panel E, light blue), and Streptococcus serogroup B (Panel F, 
green), respectively are displayed. The enlarged region with the m/z ranging from 3800 
to 5600 is shown. Species-specific m/z values across spectra are indicated by different 
colors as noted above in arbitrary units.  Image adapted from (Hsieh et al., 2008). 
 22 
 
Though MALDI-TOF MS can only use cultured organisms, it has its own merit in 
that it is rapid and involves minimal sample preparation (Degand et al., 2008).  In 
addition, the technique may have the potential to be cost efficient when used in a clinical  
setting (Carbonnelle et al., 2007; Tang & Stratton, 2006).  Recently, a routine clinical 
laboratory identified 1600 strains using MALDI-TOF MS (Seng et al., 2009).  
Identification was attained in two to two and half hours.  The cost of identification was 
estimated to be between 22 and 32 % of the cost of traditional phenotypic assays (Seng et 
al., 2009).  Once the equipment is purchased, it is only a few cents to process a sample 
because of the minimal consumables that are needed and the lack of a special operator 
(Carbonnelle et al., 2007).  These studies highlight the role MALDI-TOF MS may play 
in future diagnostic laboratories.   
 
1.4.3  Electrospray ionization (ESI).  ESI-MS is another technique that can 
identify bacteria but unlike MALDI-TOF MS, the sample being analyzed can be in liquid 
form (Fenn et al., 1989; Vaidyanathan et al., 2002).  In ESI-MS, the analyte that is either 
liquid or dissolved in a liquid solvent is dispersed by an electrospray, an instrument that 
uses electricity to disperse the liquid into fine aerosol.   The aerosol enters the vacuum 
stage of the MS where it is further heated evaporating any residual solvent and the 
remaining ions are detected by the MS which determines the mass to charge ratio 
(Griffiths et al., 2001).  The technique has been used to characterize bacteria by 
analyzing specific cell fractions of the bacteria or by studying phospholipids, 
lipopolysaccharides, lipooligosaccharides, muramic acids, and proteins (Vaidyanathan et 
al., 2002).   In 1999, Goodacrea et al. was the first to use ESI-MS to study intact whole 
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bacteria.  In this study, three strains of Bacillus cereus and three strains of Escherichia 
coli were subjected to ESI-MS and produced mass spectra (Figure 1.7, Panel A) 
(Goodacre et al., 1999).  Each spectra contained fragments that correlated to fragments 
produced from bacterial phospholipids.  In addition, spectra were also specific for the 
organism analyzed (Goodacre et al., 1999).  In a related study, E. coli, Bacillus 
sphaericus, Bacillus licheniformis, and Brevibacillus laterosporus were analyzed with 
flow injection ESI-MS.  Again, the mass spectra were produced for each bacterium and 
the results were reproducible (Vaidyanathan et al., 2001).   
In recent years, ESI-MS technology has been modified so that the analyte can be 
in a solid form (Dole et al., 1968; Fenn et al., 1989).  This technique, desorption ESI-MS 
(DESI-MS), ionizes an analyte that is placed on a solid surface using an electrospray 
(Figure 1.7, Panel B).  The sample flows into the MS as it is ionized.  Some analyte will 
stay on the surface longer and thus the ions are more separated before entering the MS.  
This method can also produce bacteria mass spectra and aid in bacterial identification and 
detection (Mohammed et al., 2007).  Both ESI-MS and DESI-MS have been used to 
analyze bioactivity of fungi but at this time it appears that specific detection of fungi 
using these techniques is limited (Pankiewicz et al., 2006).     
Many instruments have been coupled to MS and used to study various biomarkers 
of bacteria and fungi, enzyme pathways, and overall mass spectra of organisms.  Mass 
spectrometry techniques can be rapid, efficient, and reproducible but they are rarely used 
in a clinical setting (Fox, 2006; Seng et al., 2009).  These techniques may begin to cross 
over to the clinical laboratory when there are cost-efficient instrumentation and reagents, 
developed reference databases, and validated standard operation protocols (Nassif, 2009).   
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Figure 1.7:  Electrospray ionization.  Panel A shows the ESI spectra for Bacillus 
sphaericus, Bacillus licheniformis, Brevibaacillus laterosporus, and two strains of 
Escherichia coli (Goodacre et al., 1999).  Panel B depicts the desorption electrospray 
ionization method in which bacteria in an ambient environment can be identified using 
mass spectrometry. Water is sprayed into an electric field making hydronium ions which 
will transfer the extra proton to the bacterial sample causing the bacteria to be ionized.  
The ions are then vacuumed into the mass spectrometer where the mass to charge (m/z) 
ratio is determined for the ions (Song et al., 2007).   
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1.5 Detection through antibody-antigen interactions 
 Detection of microorganisms through antibody-antigen interaction is a main stay 
in most clinical microbiology laboratories.  Bacteria and fungi detection systems have 
been developed based on the natural human immune response to these organisms.  The 
next session gives a brief introduction to antibody response followed by two techniques, 
enzyme-linked immunosorbent assay (ELISA) and surface plasmon resonance (SPR) that 
heavily depend on the host immune response.   
 
1.5.1  The antibody response.  Antibodies are glycoproteins that are produced in 
response to the presence of foreign molecules (like bacteria and fungi) in the body 
(Edelman et al., 1961; Edelman & Poulik, 1961; Edelman & Benacerraf, 1962; Nisonoff 
et al., 1960; Porter, 1959).  In general, antibodies are in the shape of a Y (Figure 1.8) and 
are composed of two identical copies of a polypeptide chain (heavy chain) and two 
identical copies of another polypeptide (light chain) (Berggard & Edelman, 1963; 
Nisonoff et al., 1960).  Humans have five classes of antibodies, IgG, IgM, IgA, IgE, and 
IgD which vary in the number of Y units and the types of heavy-chain polypeptide they 
contain (Ceppellini et al., 1964).  For example, IgG antibodies have one Y unit 
(monomer) which has three protein domains; the Fc domain is the stalk of the Y and the 
two Fab domains are the branches of the Y (Ceppellini et al., 1964).  At the top of the 
branch or the Fab domain is the antigen binding site (Figure 1.8).  This site is composed 
of the variable regions of the heavy and the light chains and will interact with the foreign 
body (Ceppellini et al., 1964).  The hinge region can vary in structure giving rise to  
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subtypes or isotypes within IgG molecules (Figure 1.8).  IgG has four isotypes and they 
provide the majority of the antibody-based immunity against pathogens in the human 
(Jefferis et al., 1985; Klein et al., 1977).  Like IgG, IgD, and IgE exist as monomers.  IgD 
has one isotype and it functions as an antigen receptor on B cells (Pernis et al., 1966; 
Figure 1.8:  IgG antibody.  Two identical L chains are joined with two identical H 
chains. Each light (L) chain is held to a heavy (H) chain via an interchain disulfide 
bond. The variable regions of the four polypeptides lie at the ends of the arms of the Y-
shaped molecule. These regions are responsible for the antigen recognition function of 
the antibody molecules.  The hinge region varies based on the isotype of IgG present 
(Garrett & Grisham, 2010). 
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Takahashi et al., 1982).  The only isotype of IgE is involved in the immune response to 
allergies (Stanworth, 1969).  The two isotypes of IgA exists as dimers and are found in 
mucosal areas such as the respiratory tract to help prevent colonization by pathogens 
(Heremans et al., 1959).  The last antibody, IgM, is a pentamer (Tomasi, 1973).  The only 
isotype of IgM is expressed on the surface of B cells and is the primary antibody 
produced at the first encounter to an antigen (Sanders et al., 1987).   
All immunoglobulins have a site that interacts with antigens.  Interactions can 
only occur if the antigen is close enough to the antibody Fab domain.  This domain of 
110-130 amino acids gives specificity to antibody binding (Novotný et al., 1983).  If the 
proper antigen is present it will form an antibody-antigen complex held together by many 
weak interactions including hydrogen bonds and van der Waals forces.  Once the 
antibody has bound the antigen, other immune cells will help remove the antigen from 
the human (Gowans, 1971; Nossal & Ada, 1971).        
 
1.5.2  Enzyme-linked immunosorbant assay (ELISA).  The presence of an 
antigen such bacteria or fungi or an antibody in a human sample can be detected using the 
same theory as the immune response mechanism described above.  Antibody-antigen 
interactions can be specific.  By detecting this interaction, the causative agent of an 
infection can be determined.  To detect an antigen using ELISA, the sample being 
analyzed will first be fixed to a polystyrene microtiter plate.  The antibody, for the 
organism that is being detected, is linked to an enzyme and then added to the plate.  If the 
proper antigen is present, the enzyme-linked antibody will bind.  Unbound antibodies are 
washed away with a mild detergent.  Then, an enzymatic substrate is added to the plate.  
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Any enzyme present will react with the substrate producing a visible signal; thus 
indicating the presence of a certain bacteria or fungi in the sample.  This reaction can be 
chromogenic or fluorogenic (Engvall & Perlmann, 1971; van Weemen & Schuurs, 1971; 
Voller et al., 1978). 
The ELISA technique can also be performed by immobilizing antibodies to the 
plate.  A variation of this method is the sandwich ELISA (Figure 1.9) (Engvall & 
Perlmann, 1972; Miles & Hales, 1968; Voller et al., 1978).  In this assay, two antibodies  
  
Figure 1.9:  Sandwich ELISA.  An antigen is detected using an assay in which 
horseradish peroxidase (HRP) (linked to the antibody that binds the antigen) oxidizes 
tetramethylbenzidine (TMB) to produce a blue color (www.newenglandbiolabs.de). 
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are used.  The first antibody called capture antibodies are attached to a plate.  The sample 
is added and if the specific antigen is present it will bind.  After the remaining sample is 
washed away, a primary antibody is added which will also bind to the antigen present.  
Next, an enzyme-linked antibody is added which will bind to the primary antibody.  
During the last step, an enzyme is added which is converted to a detectable form (color or 
fluorescence).  This signal tells the user if a bacteria or fungi are present in the sample 
and the intensity of the signal can indicate the quantity (Voller et al., 1978).   
Indirect ELISA is similar to the sandwich method except that first capture 
antibody is serum that contains an unknown concentration of the antibody (Engvall & 
Perlmann, 1972).  The secondary antibody affixed to an enzyme is added and the 
sandwich ELISA method is followed (Engvall & Perlmann, 1972).  A major disadvantage 
of the indirect ELISA is that the method of antigen immobilization is non-specific.  Any 
amount of analyte present in the serum can stick to the plate.  Thus indirect ELISA can 
only give determine if an antigen is present but not the abundance (Engvall & Perlmann, 
1972). 
 Competitive ELISA uses the theory of competitive binding.  In this method, 
unlabeled antibody is incubated with the antigen (Engvall & Perlmann, 1971).  The 
complexes that form are added to an antigen coated well.  The plate is washed and 
unbound antibody is removed.  The antibody competes with the free antigen to bind to 
the plate fixed antigen.  Then, the secondary antibody with the attached fluorophore is 
added and the signal is measured (Engvall & Perlmann, 1971).  For competitive ELISA, 
the higher the original antigen concentration, the weaker the eventual signal. This type of 
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ELISA is well suited in situations in which the antigen is a low concentration or when 
using crude or impure samples (Jordan, 2005). 
 Reverse ELISA uses a solid phase made up of an immunosorbent polystyrene rod 
with 4-12 protruding fingerlike objects (ogives).  The entire device is immersed in a test 
tube containing the collected sample.  Then, the ogives are dipped into wells of a 
standard microplate.  These wells have been pre-filled with ELISA reagents.  The ogives 
are washed by a buffer in one well.  The rods are then moved and the ogives are 
immersed in the next well which contains enzyme labeled antibodies.  After conjugation, 
the ogives are incubated in a chromogenous sample.  The develop color is read by 
spectrophotometer (Sakaguchi et al., 1989).  The ogives can be sensitized to the reagents 
and thus be able to detect more than one antigen at a time (Emmerich et al., 2006).  In 
addition, sample sizes can be optimized to achieve high levels of antigen detection 
(Emmerich et al., 2006) 
The ELISA technique has been performed on numerous types of samples for 
numerous organisms including P. aeruginosa and A. fumigates in CF sera (Brett et al., 
1988; Knutsen et al., 1994).  An ELISA test has been developed to diagnose chronic P. 
aeruginosa infections by fixing antigens from 17 serotypes of the bacteria to a plate 
(Pedersen et al., 1987).  The presence of serum IgG to the bacteria was then detected 
indicating the patient had P. aeruginosa infection (Pedersen et al., 1987).  Serum IgG 
antibodies to Candida albicans and Aspergillus fumigatus have also been detected using 
indirect ELISA (Przyklenk et al., 1987).  The ELISA method is not used to detect 
organisms directly from CF sputum but bacterial isolates and CF sera can be used with 
ELISA detection systems. 
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1.5.3  Surface plasmon resonance (SPR).  Interactions between two surfaces, 
such as antibodies and antigens, can also be identified using SPR.  This technique relies 
on the phenomenon of surface plasmons which are electron oscillations that exist at the 
interface between any two materials (Figure 1.10) (Otto, 1968; Wood, 1902, 1912).  The 
interaction between two molecules can be measured by exciting the surface plasmons 
with light and then measuring the degree of light refraction (Kretschmann & Raether, 
1968; Otto, 1968).  SPR was originally developed for chemical sensing.  In 1983, SPR 
began to be utilized for biosensing (Kretschmann & Raether, 1968). 
One specific type of SPR biosensors is an immunosensor which detects 
interactions between antibodies fixed on a gold sensor and antigens (Geddes et al., 1994; 
Mayo & Hallock, 1989).  The interactions cause charge-density oscillations that occur at 
the interface of the two media; a SPR sensor measures the angle, wavelength, and the 
intensity of each oscillation.  These factors vary when the oscillations at the interface 
between the two media change.  For example, an antibody attached to the gold surface 
will affect the oscillations (Dudak & Boyaci, 2009; Geddes et al., 1994).  Most often the 
angular modulation (the change in degree of light refraction from the gold sensor) is 
measured.  This measurement change when antigens bind to the antibody that is fixed to 
the gold (Dudak & Boyaci, 2009).   
Immunosensors have been used to identify E. coli O157:H7 (Fratamico et al., 1998; 
Meeusen et al., 2005; Oh et al., 2003; Su & Li, 2005; Subramanian et al., 2006a; Taylor 
et al., 2005), Vibrio cholera (Jyoung et al., 2006), Salmonella enteritis (Bokken et al., 
2003),  Salmonella typhimurium (Oh et al., 2004a), Salmonella paratyphi (Oh et al., 
2004b), Listeria monocytogenes (Hearty et al., 2006; Koubova et al., 2001; Leonard et 
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al., 2005), Yersinia enterocolitica (Oh et al., 2005), Campylobacter jejuni (Taylor et al., 
2006), and Staphylococcus aureus (Subramanian et al., 2006b).   
 The sensitivity is not as good as many other detection systems that are marketed; 
depending on the specific design of the SPR sensor, the detecting limits were between 
102 to 107 cfu/ml (Dudak & Boyaci, 2009).  The sensitivity of the assay can be changed 
by modifying the mechanism in which the antibodies bind to the gold and the antigens 
bind to the gold as well as specific instrument parameters (Dudak & Boyaci, 2009).  
Surface plasmon resonance has been used to detect some isolated CF pathogens such as 
S. aureus but has not been used to detect bacteria directly from sputum or bronchiolavage 
fluid (Subramanian et al., 2006b).   
 
 
1.6 Molecular analysis of isolates 
Technologies based on DNA are increasingly used as diagnostic tools.  Most 
often bacteria and fungi are identified using ribosomal RNA.  Specifically, molecular 
markers such as 16S ribosomal RNA (16S rRNA) and fungal internal transcribed spacer 
regions (ITS) contain information that can lead to the identification of pure isolates of 
many types of bacteria and fungi, respectively.   
 
1.6.1  Molecular markers.  Not all regions of DNA can be used to identify an 
organism.  The regions that are used for speciation can be referred to as molecular 
markers and these regions share a few characteristics.  First, markers are molecular 
chronometers meaning the region contains a DNA sequences that changes randomly in 
time but overall have a constant rate of evolution.  This clocklike behavior can be seen in 
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genes that have a high degree of functionally constancy (Woese, 1987).  Molecular 
chronometers should also have a large phylogenetic range and therefore be present in 
most to all organisms (Olsen & Woese, 1993).  Lastly, the molecular marker needs to 
have a large size with regions that are evolutionarily independent (Woese, 1987).  One 
family of genes fills all of these requirements to become the “ultimate molecular 
chronometers”, the rRNA genes (Olsen & Woese, 1993).   The rRNAs have a constant 
function, are found in all organisms, and the sequences change at different positions and 
at different rates (Olsen & Woese, 1993). 
 
1.6.2 Ribosomal RNA (rRNA). Ribosomal RNA is directly associated with 
ribosomes (ribonucleoproteins) that play a role in protein synthesis (Lewin, 2002; 
Nomura & Erdmann, 1970; Nomura et al., 1977).  The basic form of the ribosome is 
conserved throughout organisms although changes in overall proportions and size of 
RNA and protein can be seen (Nomura & Erdmann, 1970; Nomura et al., 1977).  All 
ribosomes in a cell are identical and in prokaryotes they consist of a small (30S) subunit 
that is composed of 16S rRNA and 21 proteins and the large (50S) subunit (Figure 1.11).  
The larger unit contains 23S rRNA, 5S rRNA, and 31 proteins (Lewin, 2002; Nomura & 
Erdmann, 1970; Nomura et al., 1977).  In eukaryotes, ribosomes consist of a small (40S) 
subunit that is composed of 18S rRNA.  The large subunit (60S) consists of the 5S, 5.8S, 
and the 28S subunits  (Hillis & Dixon, 1991).    
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Figure 1.11: Ribosome subunits.  The purple 30S subunit joins the gray 50S subunit to 
form the 70S ribosome (Yarris, 2003). 
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1.6.3  16S ribosomal RNA (rRNA).  The 16S ribosomal subunit is most 
commonly used in studies of prokaryotic phylogeny (Klappenbach et al., 2001).  This 
gene is composed of alternating evolutionary conserved and variable regions (Figure 1.12 
and 1.13) (van de Peer et al., 1996). The conserved regions are involved in functions that 
are shared across the species, as such any mutation in this region would affect its ability 
to translate (Klappenbach et al., 2001).   
 
 
 
  
Figure 1.12: 16S rRNA secondary structure map.  Purple indicates absolutely conserved 
regions, blue represents regions with a high amount of conservation.  Red areas are the 
most variable (van de Peer et al., 1996). 
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Figure 1.13: Schematic representation of the variable and conserved regions of the 16S 
rRNA genes, using Escherichia coli genome as a reference. The diagram illustrates the 
approximate positions of some of the variable regions of the gene via base number. The 
variable regions are interspersed with conserved regions. LH-PCR primer sequences are 
included (Doud et al., 2009).  
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1.6.4  Fungal internal transcribed spacer (ITS) regions.  Similarly, molecular 
diagnosis of the 18S rRNA (the fungal equivalent of 16S rRNA) can be used to identify 
fungi (Atkins & Clark, 2004; Melchers et al., 1994).  However, very often closely 
related species in a genus are not easily differentiated. To resolve closely related 
species, the ITS regions between the 18S and the 5.8S rRNA genes and between the 
5.8S and 28S rRNA genes, referred to as ITS1 and ITS2, respectively, can be used 
(Figure 1.14) (Leaw et al., 2006). The contiguous ITS regions have also been 
successfully used to differentiate between the Aspergillus species, such as Aspergillus 
flavus, Aspergillus fumigatus, and Aspergillus terreus, (Henry et al., 2000) and other 
medically important yeasts (Chen et al., 2000; Chen et al., 2001).   
 
Figure 1.14: Fungal rRNA genes.  ITS1 region is located between the 18S and 5.8S 
rRNA genes and can be amplified using the ITSF1 and the ITS2R primers.  The ITS2 
region is between the 5.8S and the 28S rRNA genes and can be amplified using the 
ITSF3 and ITSR4 primers.  All primers bind to conserved regions within the rRNA 
genes and the reverse primers can be labeled with fluorophores for downstream 
applications.   
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1.6.5  Polymerase chain reaction (PCR).  The PCR technique is often used to 
isolate and amplify the bacterial and fungal molecular markers for use in downstream 
applications (Erlich, 1991; Mullis et al., 1986).  This method heralded a new era for the 
detection and identification of various microorganisms in any sample. Thus, many 
techniques that study microorganisms are molecular-based using both universal and 
species-specific primers to select molecular markers (Liesack & Stackebrandt, 1992).  
Polymerase chain reaction can be used to identify the presence of one specific organism 
using one pair of specific primers.  There have been numerous PCR assays developed to 
identify the common CF pathogens P. aeruginosa (da Silva Filho et al., 1999), H. 
influenzae (Falla et al., 1994), Staphylococcus aureus (Stepán et al., 2001), and 
Aspergillus fumigatus (Reddy et al., 1993).   
 
1.6.6  Multiplex PCR.  By combining pairs of primers and optimizing the PCR 
reaction, multiple organisms can be detected in the same reaction.  Multiple PCR assays 
have been developed for many different combinations of CF pathogen including but not 
limited to: P. aeruginosa, Burkholderia cenocepacia, and Stenotrophomonas maltophilia 
(da Silva Filho et al., 2004); Streptococcus pneumoniae, H. influenzae, Mycoplasma 
pneumonia, and Chlamydophila pneumonia (Stralin et al., 2005); and Aspergillus 
fumigatus, Aspergillus flavus, Aspergillus niger, and Aspergillus terreus (Logotheti et al., 
2009).  By using multiplex PCR, multiple organisms can be identified in a small time 
frame (Henegariu et al., 1997).  Establishing a multiplex PCR assay can be difficult due 
to uneven or lack of amplification for certain targets and difficulties reproducing the 
 39 
 
results.  Thus, optimization of PCR protocols and carefully planned PCR primers are 
crucial in the successfulness of a multiplex reaction (Henegariu et al., 1997).  
 
1.7  Molecular tools for community studies 
 The aforementioned techniques more readily identify an organism if it is has been 
isolated from a sample through culturing.  Though some techniques such as multiplex 
PCR can identify multiple organisms in a sample, the entire diversity of microbial 
communities in complex samples such as water, soil, and CF sputa cannot be determined.  
Community profiling techniques such as terminal restriction fragment length 
polymorphism – polymerase chain reaction (T-RFLP) and amplicon length heterogeneity 
– PCR (LH-PCR) are molecular tools that identify organisms in mixed samples without 
the need to culture or isolate from the sample.   
Community profiling techniques use variation within the molecular marker as 
described earlier to determine the composition of the community within a sample.  For 
bacteria, the lengths and sequences of one or more of the nine variable regions of 16S 
rRNA can lead to the identification of bacteria present in a complex community.  
Similarly, the 18S or the ITS regions can be used to identify members in a fungal 
community.  The two techniques, T-RFLP and LH-PCR generate PCR products of 
different lengths which can provide a community profile and can putatively identify 
individual organisms at the strain, species or genus level (Klappenbach et al., 2001). 
(Klappenbach et al., 2001; Suzuki et al., 1998).  In addition, the sequence of the 
fragments can be determined using high throughput sequencing which enables rapid 
sequencing of the amplicons (bacterial and fungal, with the use of appropriate primers) 
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which would lead to the rapid understanding of the community structure of any complex 
niche.  
 
1.7.1  Terminal restriction fragment analysis (T-RFLP) analysis.  This PCR 
based technique relies on the inherent variation of the sequence of a molecular marker 
(Dunbar et al., 2001) and is the most widely used method in identifying phylogenetic 
specificity in bacterial communities (Hiraishi et al., 2000).  The amplicons are generated 
using one primer that is fluorescently end-labeled, followed by  restriction enzyme 
digestion, and detection of the terminal restriction fragment by an automated DNA 
sequencer or capillary electrophoresis (Figure 1.15, Panel A) (Hiraishi et al., 2000). The 
resulting output consists of a microbial profile where each detected length is that of 
specific fragments from the digested PCR product.  Each length represents one or more 
bacteria that have the same terminal restriction fragment length (Figure 1.15, Panel B).  
The profiles can be used for community differentiation, identification of specific 
organisms in populations, and comparison of the relative phylotype richness and 
community structure (Dunbar et al., 2001).   
This method has been successful in differentiation of bacterial and fungal 
communities present in many environments including marine samples, soil samples, and 
sputum samples from CF patients (Dickie & FitzJohn, 2007; Hiraishi et al., 2000; Mills 
et al., 2003; Rogers et al., 2003).  Rogers et al. analyzed T-RFLP amplicons of CF 
patient sputa and bronchoscopy samples using a computer program called MapSort  
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A 
B 
Figure 1.15: Terminal restriction fragment length polymorphism (T-RFLP).   Panel A 
illustrates the T-RFLP process starting with PCR, followed by restriction digest and 
ending with product separation (http://nodens.ceab.csic.es/t-rfpred/).  Panel B is a T-
RFLP of a mixed DNA sample.  Each peak represents at least one bacteria (Gonzalez et 
al., 2000). 
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(Wisconsin Package version 10.3; Accelrys) that has a database which contains restriction 
patterns and lengths of fragments generated for known 16S rRNA bacterial sequences 
(Rogers et al., 2003).  The analysis inferred the presence of P. aeruginosa, Burkholderia 
cenocepacia, Staphylococcus aureus, and H. influenzae in the CF samples (Rogers et al., 
2003).  T-RFLP analysis of the fungal community in the CF lung does not appear to have 
been performed yet.   
The T-RFLP method is fast and data can be easily replicated for statistical 
analysis. The major disadvantage of T-RFLP is that many bacteria produce similar 
fragment sizes and thus not all peaks in the profiles are species-specific.  Some peaks 
may even represent more than one genus (Dunbar et al., 2001; Rogers et al., 2003).  
There are also inherent problems using restriction enzymes, such as incomplete digestion, 
which can produce DNA fragments that do not correlate to the correct bacterium (Mills et 
al., 2003). Therefore to achieve better identification of the organism, further analysis like 
sequencing of the 16S rRNA gene must be performed.   
 
1.7.2  Amplicon length heterogeneity (LH).  The LH technique analyzes 
microbial populations based on the lengths of generated PCR products produced from the 
hypervariable regions of the 16S rRNA or the fungal ITS regions (Bernhard et al., 2005; 
Martin & Rygiewicz, 2005; Moreno et al., 2006; Ritchie et al., 2000; Suzuki et al., 1997; 
Yang et al., 2006).  Profiles from each region can be produced and used to understand the 
community. These profiles represent the minimum diversity of bacteria present within the 
eubacterial or fungal community.  The profiles contain peaks at specific amplicon 
lengths, which is representative of the number of nucleotides in the hypervariable region 
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between the conserved regions. The peak heights are representative of the relative 
abundance of amplicons for that particular length present in the community.   
The organisms present in a community are determined by using a database which 
contains the expected amplicon sizes for bacteria and fungi for given a certain set of 
primers (Doud et al., 2009).  The fragment lengths in the sample profile are compared 
against the database to identity the putative organisms. A profile resulting from this 
analysis infers the presence of certain organisms and the definitive absence of others.  In 
cases where the amplicon length is not species-specific, it is often genus-specific (Doud 
et al., 2009).   
The LH profiles can also be used to compare community profiles from multiple 
samples.  Previous research using LH profiles has shown that the compositions of 
bacterial communities are highly specific to the environment in which they are found 
(Mills et al., 2003; Moreno et al., 2006).  Changes in the community’s niche can 
drastically influence bacteria and thus add specificity to the profile of a bacterial 
community showing that the overall bacterial community has many unique features from 
sample to sample (Mills et al., 2003; Moreno et al., 2006).  
The main advantages of LH-PCR are that it rapidly surveys relative gene 
frequencies within complex mixtures of DNA, is reproducible, requires small sample 
sizes, and can be performed simultaneously with many samples (Suzuki et al., 1998).  
The LH profiles provide information about the members of the entire bacterial/fungal 
community (not just specific isolates) and their relative abundance.  This data allows one 
to make taxonomic inferences and sample comparisons (Suzuki et al., 1998).  A major 
disadvantage of this technique is that one amplicon in the profile can represent more than 
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one bacterium or fungus (Manter & Vivanco, 2007).  Therefore, identification at the 
species level cannot be guaranteed.  This is also true with many length-based molecular 
techniques such as T-RFLP.  However, the fragments are discrete ‘units’ of information 
that can be used for comparative analyses (Dunbar et al., 2001).  Analysis of different 
combinations of the 16S rRNA variable regions and ITS regions can increase the power 
of microbial detection and sample discrimination and lead to more definitive 
identification (Yang et al., 2006).  
The LH-PCR method was first used in several ecological research projects to 
compare microbial communities between samples and identify members within one 
community (Mills et al., 2003; Mills et al., 2006; Moreno et al., 2006; Yang et al., 2006).  
Multiples types of soil and water samples have been profiled using LH and various 
regions of the 16S rRNA gene (Mills et al., 2003; Moreno et al., 2006; Ritchie et al., 
2000; Suzuki et al., 1998).  LH has also been used to study bacterial communities present 
in the CF lung.  Fourteen CF sputum samples were analyzed using LH-PCR for the 
presence of eubacteria (Rogers et al., 2003).  The raw data generated from the Genetic 
Analyzer was first processed with corresponding software such as GeneimageIR v.3.56 
(Scanalytics, Fairfax, Va.) (Rogers et al., 2003).  To presumptively identify the bacteria 
present in the CF samples, the fragment lengths were compared with a database of 
theoretical fragment lengths constructed using GAP (Wisconsin Package version 10.3; 
Accelrys, Inc., San Diego, CA) (Rogers et al., 2003).  For example, P. aeruginosa was 
presumptively identified in all 14 CF samples, five of which were confirmed by cloning 
and sequencing (Rogers et al., 2003).  
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To expand the use of LH-PCR in clinical settings, Bjerketorp et al. combined it 
with a lab-on-chip (LOC) system, which is used for sizing and quantifying DNA, to 
analyze samples containing mixtures of known human gut microbes (Bjerketorp et al., 
2008).  An Agilent 2100 Bioanalyzer, a bench-top instrument that uses microfluidics-
based separation, was used to detect the LH fragments.  This modified method allows 
LH-PCR to be more affordable and faster and thus more convenient and suitable for 
clinical and diagnostic situations (Bjerketorp et al., 2008).  To test this system, samples 
containing mixtures of human gut microbes and known human gut bacteria isolates were 
analyzed using both LOC and a capillary electrophoresis based genetic analyzer.  The 
latter method had a higher resolution and was thus able to resolve more peaks or 
fragments from one another.  It is important to clearly separate PCR fragments as that LH 
identification is based on the lengths of PCR products.  Single base pair length 
differences are known to occur between species and even at the genus level.  Though the 
level of resolution for the LOC LH-PCR technique is limiting, the technique is rapid, 
economical and easier to analyze than the traditional system.  Future modifications may 
improve the resolution making it more useful for clinical diagnosis (Bjerketorp et al., 
2008). 
Amplicon length heterogeneity studies of fungal communities from CF lungs have 
not been performed but the lengths of ITS 1, ITS 2 and ITS 1-4 have been determined via 
sequencing for many fungi that are known to colonize the CF lung such as various 
species of Candida and Aspergillus (Henry et al., 2000; Leaw et al., 2006).   
Community profiling techniques such as T-RFLP and LH-PCR can be used to 
study both bacterial and fungal communities.  The profiles generated provide a snapshot 
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of the microorganism community as a whole.  The identity of community members may 
be determined with the aid of reference database; but, due to shared amplicon lengths for 
certain organisms, some community members will not be identified.  Through the use of 
sequencing, these organisms can be identified.   
 
1.8 Sequencing 
Many organisms may share the amplicon length for a certain molecular marker 
but they rarely share the same sequence for the same given marker.  Sequencing of the 
entire or partial 16S rRNA gene or 18S gene and the associated ITS regions is imperative 
in identifying a bacterium or fungus with near certainty.  
 
1.8.1  Sanger sequencing. The most common method of sequencing is the Sanger 
Method developed in 1977 (Sanger et al., 1977).  This method uses a single strand of 
DNA.  The DNA is divided into four reactions, each reaction containing four standard 
deoxynucleotides (dNTPs), one dideoxynucleotide (ddNTP), and a polymerase (Figure 
1.16).  The complementary strand of DNA is made with the dNTPs and when a ddNTP is 
incorporated into the growing strand, the chain extension will terminate.  These different 
sized newly synthesized fragments are then separated by size and visualized (using 
radioactivity) to determine the sequence of the DNA (Sanger et al., 1977).  This 
technique can be modified so that all sequencing reactions occur in one tube through the 
use of fluorescently labeled dideoxynucleotides.  The fragments are separated by size and 
sequence is determined by the fluorescence.  Once the sequences are generated they are 
compared to known 16S rRNA, 18S, or ITS sequences stored in the Ribosomal Database 
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Project II (Maidak et al., 1999), Greengenes (DeSantis et al., 2006), and GenBank 
(Benson et al., 2008) to identify organisms in any sample including the CF lung 
(Bosshard et al., 2006; Harris et al., 2007).   
  Figure 1.16:  Sanger sequencing. Single stranded DNA is amplified using fluorescently 
labeled ddNTPs and unlabelled dNTPs.  Incorporation of a ddNTP causes the chain 
lengthening to stop, leaving the fragment fluorescently labeled, which are separated by 
polyacrylamide gel electrophoresis (Kae, 2009). 
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Sanger sequencing is able to identify organisms if the correct marker is being 
sequenced.  For some bacteria, partial sequencing of the 16S rRNA gene would lead to 
identification, for others the entire gene would need to be analyzed. The same could be 
said for fungi; that is, only the entire 18S rRNA gene sequence can be used to distinguish  
between some fungi.  Some bacteria or fungi can only be identified using the more 
Sequencing isolates can be performed in a timely manner and the data produced is quite 
easy to analyze especially with the use of commercial sequencing kits (Vliegen et al., 
2006).   
Sanger sequencing has been used to identify the organisms present in CF children 
bronciolavage (BAL) samples (Harris et al., 2007).  As that the total DNA extracted is a 
mixture of DNA (fungal, bacterial, and human), the bacterial DNA was isolated using 
RFLP-PCR and the resulting PCR products were separated using bacterial cloning 
methods.  The individual RFLP fragments were then sequenced and  bacteria such as P. 
aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia, and H. influenzae  
were found to be present in the BAL sample (Harris et al., 2007).  Novel pathogens from 
the genus Lysobacter, Coxiellaceae, and Rickettsiales were also sequenced (Harris et al., 
2007).  
Fungi have also been identified in CF samples through PCR and Sanger 
sequencing (Bouchara et al., 2009).  By sequencing the entire PCR product from the ITS 
region, A. fumigatus and C. albicans were identified in CF samples (Bouchara et al., 
2009).  It is more common to use specie specific PCR to detect fungi in CF samples 
because few fungal isolates have been sequenced (Williamson et al., 2001). 
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Sanger sequencing is capable of providing the identification of isolates, but the 
high cost of reagents and labor may be too expensive for wide-spread clinical use (Patel, 
2001).  This method can also been used to identify members of a complex community, 
but it requires additional protocols, reagents, and time.  With traditional sequencing 
methods, cloning must be performed to isolate individual 16S rRNA genes or fungal ITS 
regions which were amplified by PCR.  The PCR product from a complex community 
will contain multiple copies of the same gene and further screening such as restriction 
digest must be performed to ensure that the same PCR product is not repetitively 
sequenced thereby wasting time, reagents, and money.  The cloning and screening 
process also increases the likelihood that certain members of the community are never 
sequenced and the community composition is not entirely determined.  Though possible, 
traditional sequencing is a time consuming, arduous method when addressing 
microorganism community based questions.     
 
1.8.2  Pyrosequencing.  New developments in sequencing technologies are 
revolutionizing the way microbial communities are being studied (Mardis, 2008; 
Schuster, 2008).  Pyrosequencing relies on a process referred to as sequencing-by-
synthesis, a technique that allows for real-time monitoring of DNA synthesis (Ahmadian 
et al., 2006; Ronaghi et al., 1998).  Pyrosequencing is based upon the principle that 
pyrophosphate (PPi) is released when the DNA polymerase adds a nucleotide to the 
growing complementary strand (Figure 1.17).  The PPi is converted to adenosine 
triphosphate (ATP) that is used as a substrate in a chemical reaction that results in visible  
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Figure 1.17:  Pyrosequencing reaction.   Schematic representation of the automated 
pyrosequencing (sequence-by-synthesis) method.  The addition of a nucleotide to the 
growing strand releases pyrophosphate (PPi) which is converted to ATP by ATP 
sulfurylase.  The ATP then catalyzes a luciferase mediated conversion of luciferin to 
oxyluciferin that produces light and is measured by a camera (Gharizadeh et al., 2001). 
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light emission.  The detectable amount of light produced is relative to the amount of 
synthesis (Ronaghi et al., 1998). The dNTPs are added sequentially and light is only 
emitted if the dNTP added to the reaction is the next one to be incorporated to the 
growing strand.  Like the Sanger method, pyrosequencing can only sequence individual 
PCR products and thus must be used in conjunction with cloning to study microbial 
communities (Ronaghi et al., 1998).  The method can produce a large amount of 
sequencing reads in a small amount of time.  Thus, it is more efficient to sequence a large 
clone library using pyrosequencing rather than the Sanger method.    
 Pyrosequencing techniques that allow faster sequencing at a lower cost, are 
opening doors for many laboratories to use sequence data for microbial identification.  
Pyrosequencing of the first and third variable region of the 16S rRNA gene has been used 
to identify bacterial isolates of Helicobacter pylori from secretions, indwelling catheters 
and prosthetic devices, urine, blood and faecal specimens (Jonasson et al., 2002).  In 
addition, Acinetobacter and Haemophilus isolates from gastric biopsies were sequenced 
for the same regions (Monstein et al., 2001).  Most recently, clinical isolates of 
mycobacteria was identified using the V1 region (Heller et al., 2008).  A year later, 
antibiotic resistance of mycobacteria could be determined by pyrosequencing the 
resistance-determining regions of three genes and looking for specific mutations (Bravo 
et al., 2009).   
Importantly, pyrosequencing surpassed traditional methods of detection in a 
clinical setting by identifying 90 % of the isolates at least at the genus level (Luna et al., 
2007).  The remaining 10 % could not be identified due to the short sequencing reads, a 
clear drawback of pyrosequencing (Luna et al., 2007).  Pyrosequencing may help 
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bacterial identification in samples that do not lend themselves to polyphasic approaches, 
such as phenotypic assays (Heller et al., 2008; Tuohy et al., 2005).  This technique has 
also been shown to clearly distinguish between multiple species of Mycobacterium.  
Pyrosequencing can also identify fungi including different species and strains of 
Candida, a known CF pathogen (Boyanton et al., 2008). 
With the additional step of cloning, pyrosequencing can be used to identify 
organisms in a complex sample.  One study used cloning followed by pyrosequencing to 
identify bacteria present in 13 adult CF sputa samples (Kolak et al., 2003).  Sequences 
were determined by the amplification of the V3 and V6 region of the 16S rRNA gene.  
Known CF pathogens were sequenced and the results concurred with the culture 
identifications (Kolak et al., 2003).  Sanger sequencing and pyrosequencing were also 
compared in a later study.  Both techniques were used to analyze the same sputum sample 
from a 13 month old CF girl (Armougom et al., 2009).  Both techniques identified many 
of the same bacteria but pyrosequencing showed greater species richness and a more 
reliable estimate on bacteria abundance.  The authors concluded that pyrosequencing is 
reliable and with newer technologies, the short reads will no longer be an issue 
(Armougom et al., 2009).  The fungal community in CF samples has yet to be analyzed 
with pyrosequencing.   
 
1.8.3  454 sequencing.  Deep sequencing technologies are capable of sequencing 
a whole genome in a matter of days. There are multiple platforms that are capable of 
performing high throughput, parallel sequencing of a single isolate or mixed samples.  
Previously cloning was necessary to provide clean sequence reads from mixed DNA 
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samples.  To circumvent the need for cloning, Roche’s 454 sequencing, which performs 
many pyrophosphate-sequencing reactions in parallel, was developed (Figure 1.18) 
(Margulies et al., 2005). The 454 sequencing combines an emulsion-based method that 
isolates and amplifies DNA fragments in vitro with an instrument that performs 
pyrosequencing in picoliter-sized wells (Margulies et al., 2005). The reactions are 
resolved on a Genome Sequencer FLX which reads 200-300 bases and in one run can 
read up to 400,000 bases (Patrick, 2007).  This method has been used to study the 
microbial diversity of the deep sea (Sogin et al., 2006) and the metagenome found in 
honey bees, which led to the discovery of a possible causative agent of colony collapse 
disorder (Cox-Foster et al., 2007).  Members of the human oral bacterial community have 
been identified using 454 sequencing (Zaura et al., 2009).  Fungal communities have also 
been sequenced in soil and the human mouth (Ghannoum et al., 2010; Lauber et al., 
2009). 
 
1.8.4  Illumina. Another platform that is capable of high throughput, parallel 
sequencing is the Illumina Genome Analyzer (previously called Solexa).  Illumina 
sequencing technology amplifies randomly fragmented genomic DNA that are attached to 
a planar, optically transparent surface which creates an ultra-high density sequencing 
flow cell with hundreds of millions of clusters, each containing ~1,000 copies of the same 
template (Adam, 2001; Balasubramanian et al., 2002; Mardis, 2008). These templates are 
sequenced using a robust four-color DNA sequencing by synthesis technology that 
employs reversible terminators with removable fluorescent dyes (Figure 1.19) (Adam, 
2001; Balasubramanian et al., 2002; Mardis, 2008).   
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Figure 1.18:  Overview of 454 sequencing.  (a) Genomic DNA is isolated, 
fragmented, ligated to adapters and separated into single strands (ss). (b) One 
fragment per bead is placed in a PCR-reaction-mixture-in-oil emulsion and amplified. 
c) Beads carrying ssDNA templates are deposited into wells. (d) Smaller beads 
carrying immobilized enzymes required for pyrophosphate sequencing reaction are 
deposited. (e) Scanning electron micrograph of a portion of a fiber-optic slide. (f) The 
454 sequencing instrument consists of: a fluidic assembly (i), a flow cell (ii), a CCD 
camera-based imaging assembly (iii), and a computer (iii) (Rothberg & Leamon, 
2008).    
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Figure 1.19.  Illumina sequencing technology.  Schematic diagram of technique 
with a brief explanation (Hodges et al., 2007). 
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Illumina sequencing has a high degree of accuracy due to the base-by-base 
sequencing which enables sequencing through homopolymers and repetitive sequences 
and eliminates sequence-context specific errors (Balasubramanian et al., 2002; Mardis, 
2008).  This platform has been used to sequence the human oral bacterial community, 
where hundreds of millions of 50 to 100 bp reads were obtained revealing the abundance 
of bacterial species present in the mouth (Lazarevic et al., 2009; Mardis, 2008).  No 
fungal communities have been sequence using this technology. 
 
 1.8.5  SOLiD. Another next generation sequencing platform is the Applied 
Biosystem SOLiDTM (sequencing by oligonucleotide ligation and detection) system 
(McKernan et al., 2009; Valouev et al., 2008).  As with 454 sequencing, a DNA library is 
made which then undergoes emulsion PCR.  The products are render single stranded and 
fixed on a bead and deposited into a well.  A set of four fluorescently labeled di-base 
probes are added to each well where they compete for ligation to the DNA being 
sequenced (sequencing by oligonucleotide ligation).  A DNA polymerase is not used for 
sequencing but rather a DNA ligase that attaches the labeled di-base probe to the growing 
strand (Figure 1.20).  On the basis of the fluorescence produced by the molecule, the 
identity of the nucleotide at each position can be determined (McKernan et al., 2009; 
Valouev et al., 2008).  At this time SOLiDTM cannot be used for metagenomic 
sequencing but technological advances may change this in the future. 
Illumina and 454 sequencing are both capable of sequencing mixed DNA samples 
and within days the microorganisms present in a sample can be determined.  At this time 
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the bacterial and fungal community found in the CF sputum has not been analyzed with 
either methods.   
 
 
  
Figure 1.20.  SOLiDTM sequencing technology.  Schematic diagram of sequencing by 
ligation.  The single stranded template DNA is ligated to a bead via an adapter 
sequence.  The primer for sequencing hybridizes to the adapter on the templated beads.  
A set of four fluorescently labeled di-base probes compete for ligation to the 
sequencing primer. The probe with the complementary base will attach to the primer 
using a DNA ligase.  The fluorescent molecule will produce a detectable signal.  The 
fluor will be cleaved from the probe leaving a phosphate at the end of the growing 
strand that will be used in the next cycle of ligation.  Multiple cycles of ligation, 
detection and cleavage are performed (Hodges et al., 2007).  SOLiDTM sequencing 
technology description and figure was obtained from the manufacturer (Applied 
Biosystems, Foster City, CA). 
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1.9 Metagenomic statistics and bioinformatics 
Identifying members of a community through LH-PCR or 454 sequencing only 
addresses one question, “Who belongs to the community?”  The significance of these 
identities is determined using multiple statistical tests and bioinformatic programs.  
Statistical analysis using 454 data is a field that is just beginning to be developed.  
Analyzing the large amount of sequencing data obtained from 454 uses some 
mathematical analyses and bioinformatic programs which are based on previous methods 
that are used in LH, TRFLP, and other community profiling techniques, while other 
analysis methods are created anew.   
 
1.9.1  Statistical analysis based on ecological indices.   The earlier approaches 
used to study microbial diversity and community dynamics include computing measures 
derived from ecological indices such as species richness and dominance or evenness 
indices (Hill et al., 2003).  Traditional indices include the richness (S), the Shannon 
information index (H), and the evenness (E) derived from it, and are defined as follows in 
Equations (1), (2) and (3), respectively: 
#=S of peaks of in each sample,               (1) 
            ,                     (2) 
where pi is the ratio of individual peak height to the sum total of the heights of all the 
peaks in the  LH profile, and  
,            (3) 
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where Hmax = ln(S).  Note the traditional diversity indices are based on the clear 
definition of an ecological description of an individual species but these definitions have 
been modified for presumptive identification of LH/T-RFLP profiles by replacing the 
definition of an individual species with that of individual peaks in LH/T-RFLP profiles. 
 These calculations identify the richness (how many different types of organisms 
are present in a community), the evenness (how these organisms are distributed 
throughout the community), and the Shannon index (the diversity of the community 
based on number of species and their abundance in the community).  These indices 
provide the basic framework to understanding a particular niche.   
 
1.9.2  Statistical analysis based on abundance models.  Even with the 
availability of the numerous diversity indices, analyzing microbial diversity and 
communities merely using ecological indices has its shortcomings (Mills et al., 2006).  
Although each index represents an attempt to distill diversity information into a single 
quantity, each one ends up measuring specific aspects of diversity. Diversity indices vary 
in their sensitivity to different abundance classes. Species abundance models are 
considered to be more sophisticated tools to investigate diversity because they examine 
the distribution of abundances in a population.  
 Statistical models used for species abundance of microbial communities include 
log series distribution, log-normal distribution, broken stick model, and overlapping 
niche model (Curtis et al., 2002; Hill et al., 2003).  The most frequently used statistical 
model for species abundance distributions is the log-normal distribution. In log-normal 
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communities, the null model for the bacterial species abundance is a lognormal 
distribution as follows: 
 
where S(R) is the number of species that contain R individuals, ST is the total number of 
species in the community, and σ2 is the variance of the distribution. The parameters ST 
and σ2 can be estimated from a sample of measured species abundance data by using 
statistical techniques such as the method of moments or least squares analysis (Curtis et 
al., 2002).  This distribution is seen when a species is persistent within a community 
(Magurran & Henderson, 2003).  The log series distribution comes into effect when a 
species is not persistent in a community but only occasionally distributed (Magurran & 
Henderson, 2003).  Occasionally, a species can transition between the two types of 
distribution (Magurran & Henderson, 2003).  The broken stick model describes the 
relative abundance of species by random breaking of a theoretical line which represents 
the resources of the environment.  The length of each broken line or stick represents the 
abundance for a particular species (McArthur, 1957).  This definition can be rephrased to 
mean that “a group of n species of equal competitive ability simultaneously occupying 
the total niche and jostling each other to determine niche boundaries” (Tokeshi, 1993).  
McArthur also proposed the overlapping niche which refers to species that share a part of 
the same niche as another species (McArthur, 1957).  Each of these statistical models can 
be used to describe bacterial or fungal communities when species abundance is of 
interest. 
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1.9.3  Comparative metagenomics.  Ecological indices and abundance models 
can be informative when studying one population at a time or comparing between two 
species.  Comparing communities as a whole can also provide clues as to how 
communities change over time or how a community is affected by its environment or 
outside factors.  For instance, by comparing all sequencing or LH data, it can be 
determined if there are statistically differences between the bacterial or fungal 
community from a healthy sputum sample versus a CF sample.  In addition, the factors 
that cause these distinctions can be identified. 
Comparative metagenomics can be studied using statistics or bioinformatics.  
Most statistical comparisons start with a distance matrix which determines the similarity 
of one community to another community.  Jaccard’s coefficient, Hellinger distance, 
Pearson chi-square test, Euclidean distance matrices, and Bray-Curtis/Sorenson 
coefficient are often used to determine the relationship between two samples or two 
populations (Beran, 1977; Bray & Curtis, 1957; De Leuuw & Heiser, 1982; Jaccard, 
1901; Pearson, 1900).  These equations use the presence/absence and/or abundance of all 
the organisms in a sample to determine the relatedness between two samples (Beran, 
1977; Bray & Curtis, 1957; De Leuuw & Heiser, 1982; Jaccard, 1901; Pearson, 1900).  
The resulting distance/similarity matrices can then be further analyzed using multivariate 
statistics.  
Multivariate statistics can be used to identify what data links two samples (either 
members in a sample or external environmental factors).  These analyses can also be used 
to determine if samples within a population are similar to one another (Rudi et al., 2007).  
An example of multivariate statistical analysis is the clustering of microbial communities 
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in soil using the unweighted pair-group method which uses the arithmetic averages 
(UPGMA) algorithm on the data derived from the distance metric data (such as the 
Jaccards or Hellinger or Pearson distances) (Blackwood et al., 2003; Dunbar et al., 2000; 
Griffiths et al., 2000).  Such methods have been used to support claims that certain 
relationships between communities can be discerned, that the groupings are natural, and 
that outliers can be identified (Clarke et al., 2006).  Other statisitcs such as principle 
component analysis, and multi-dimensional scaling will be discussed in detail in Chapters 
2 and 3.  
 Phylogenetics can also be used to compare among samples and populations.  The 
evolution and/or relatedness of a community can be determined using the phylogenetic 
tree that is present in the sample.  The bioinformatic program, UniFrac can use 
phylogenetic trees to determine if the microbial community in a sample is similiar to 
another sample factors (Lozupone & Knight, 2005; Lozupone et al., 2006; Lozupone et 
al., 2007).  If there are differences between the communities, then the program will 
determine if a particular lineage of the tree is responsible for the difference.  The UniFrac 
program can also cluster communities based on environmental factors (Lozupone & 
Knight, 2005; Lozupone et al., 2006; Lozupone et al., 2007).  Megan 3 (metagenome 
analysis software) is another bioinformatic program that can compare communities by 
using the orginal sequencing data and identifying taxa (Huson et al., 2007).  Both of these 
programs can handle large amount of data which is key when analysis 454 sequencing 
reads.  The output for both programs can be used in colloboration with statitics to identify 
correlations between communities. 
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With rigorous statistical analysis and bioinformatics, it is possible to differentiate 
between significant differences and random events.  Thus, leading one to understand how 
a microbial community is affected by its members and environment. 
 
1.10 Hypothesis and aims 
The CF lower respiratory tract contains a complex community of fungi and 
bacteria which cause chronic lung infections. Because of the long term effects on the 
lungs by microbial infection, a better understanding of the microbes present and the 
factors that drive evolution of the microbial community will enable the development of 
improved therapies.  
This project proposes to characterize the bacterial and fungal communities found 
in the CF lungs using the molecular techniques, amplicon length heterogeneity–
polymerase chain reaction (LH-PCR) and 454 sequencing. In addition, this study 
proposes to develop a novel detection assay for CF pathogens.  The hypothesis of this 
project is that there is both bacteria and fungi present in the CF lung and the dynamics of 
the community is dependent on the host and antimicrobial treatment.  The hypothesis will 
be tested by accomplishing the following three aims: 
 
Aim I: Analyze the metagenomic DNA from the CF sputa samples using the V1 and 
V1_V2 regions of the bacterial 16S rRNA gene using LH-PCR community profiling.  
Community dynamics will be studied using these profiles.  The working hypothesis is the 
CF lung contains numerous bacteria and selective pressures from the host and antibiotic 
therapy cause the community to change over time. 
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Aim II:  Analyze the metagenomic DNA from the CF sputa samples using the V1_V2 
region of the bacteria 16S rRNA gene and the fungal ITS1 region using 454 sequencing.  
The CF microbiomes will be compared with healthy oral rinse microbiomes.  The 
working hypothesis is the CF microbiome will contain organisms that are associated 
with healthy individuals as well as pathogens unique to the CF lung infection. 
Aim III:  Detect bacteria from CF sputa samples using SPR technology.  The working 
hypothesis is CF pathogens can be detected based on antibody-antigen reactions 
measured by SPR. 
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2.1  Abstract 
Chronic bronchopulmonary bacterial infections remain the most common cause of 
morbidity and mortality among patients with cystic fibrosis (CF). Recent community 
sequencing work has now shown that the bacterial community in the CF lung is 
polymicrobial.  Identifying bacteria in the CF lung through sequencing can be costly and 
is not practical for many laboratories.  Molecular techniques such as terminal restriction 
fragment length polymorphism or amplicon length heterogeneity - polymerase chain 
reaction (LH-PCR) can provide many laboratories the ability to study CF bacterial 
communities without costly sequencing.  The aim of this study was to determine if the 
use of LH-PCR with multiple hypervariable regions of 16S rRNA gene could be used to 
identify organisms found in sputum DNA.  This work also determined if LH-PCR could 
be used to observe the dynamics of the lung infection over a period of time. Nineteen 
samples were analyzed with the V1 and the V1_V2 region of the 16S rRNA gene.  Based 
on the amplicon size present in the V1_V2 region, P. aeruginosa was confirmed to be in 
all 19 samples obtained from the patients.  The V1 region provided a higher power of 
discrimination between bacterial profiles of patients.  Both regions were able to identify 
trends in bacterial population over a period of time.  LH profiles showed that the CF lung 
community is dynamic and changes in the community may in part be driven by the 
patient’s antibiotic treatment.  LH-PCR is a tool that is well suited for studing bacterial 
communities and their dynamics.  
Key Words:  LH-PCR, 16S rRNA, V1, V1_V2, cystic fibrosis, AmpliQué, Cystic fibrosis 
microbiome, metagenome 
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2.2  Introduction 
Cystic fibrosis (CF) is an autorecessive disease affecting one in 3500 Caucasian 
live births in the U.S (Patient-registry, 2008).  CF results from a mutation in the gene that 
encodes the cystic fibrosis transmembrane conductance regulator (CFTR) protein 
(Riordan et al., 1989; Wainwright et al., 1985).  A defect in the CFTR protein leads to a 
malfunctioning cyclic-AMP-activated chloride channel in secretory epithelia 
(Kunzelmann, 1999).  This defect in the lung leads to the inability to secrete chloride and 
to the excess re-absorption of sodium (Kunzelmann, 1999).  Thus, there is decreased fluid 
secretion and the mucus becomes immobilized and adheres to the epithelial cells.  
Overproduction of mucus in the airway results in congestion of the respiratory tract and 
increases susceptibility to bronchopulmonary infection. CF patients often suffer from 
infections with Staphylococcus aureus, Haemophilus influenzae, Pseudomonas 
aeruginosa, and Burkholderia cenocepacia (Lyczak et al., 2002).  These chronic 
infections by highly adapted lung microbes cause inflammation and eventually lung 
damage; therefore, lung disease is the major cause of morbidity and mortality among 
these patients (Hull, 2003; Mathee et al., 1999). 
It has also been estimated that less than 1% of eubacteria in the environment can 
be cultured (Ward et al., 1990a; Ward et al., 1990b).  Thus, these identification methods 
will fail to detect all pathogens that might be causing the lung infection. Fortunately, with 
the advent of molecular techniques, culturing for identification purposes can be 
circumvented (van Belkum et al., 2000).  Recent molecular studies using terminal 
restriction fragment length analysis and sequencing have shown that the lung community 
is quite complex. Achromobacter (Alcaligenes) xylosoxidans, Rhodotorula mucilaginosa, 
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Abiotrophia spp., Bacteroides gracilis, Eubacterium brachy, Mycobacterium 
mucilaginosus, Mycoplasma salivarium, Porphyromonas salivae, Ralstonia spp., 
Staphylococcus hominis, Streptococcus anginosus, Treponema vincentii, Veillonella spp., 
Burkholderia gladioli, Stenotrophomonas maltophilia and Pandoraea atypical have all 
been demonstrated to be members of this polymicrobial infection(Bittar et al., 2008; 
Burns et al., 1998; Coenye et al., 2001; Coenye et al., 2002; Coenye et al., 2003; Coenye 
et al., 2005; Harris et al., 2007; Rogers et al., 2003).  
Amplicon length heterogeneity – polymerase chain reaction (LH-PCR) is another 
molecular method that has been used to study various diverse microbial communities 
(Bernhard et al., 2005; Suzuki et al., 1998) including those of CF sputum (Rogers et al., 
2003).  LH-PCR utilizes the 16S rRNA molecular marker to analyze microbial 
populations (Ritchie et al., 2000; Suzuki et al., 1998).  The sequence and length of the 
variable regions within the 16S rRNA gene are often used to determine phylogeny 
(Coenye & Vandamme, 2003).  It should be noted that some bacteria have multiple 
copies of the 16S rRNA gene which can show intragenomic heterogeneity in sequence 
and gene length (Coenye & Vandamme, 2003). This variation is unlikely to have an 
effect on classification at the genus and species level and the marker is routinely used for 
identification (Case et al., 2007).  Identification based on length variation in the 
hypervariable regions of the gene is exploited by LH-PCR.  In this technique, forward 
and reverse primers bind to the conserved regions of the 16S rRNA gene and then 
amplify the varying lengths seen in the hypervariable regions.  LH-PCR has proven to be 
a robust, time efficient and reproducible method (Mills et al., 2003; Moreno et al., 2006; 
Suzuki et al., 1998).  The main advantages of LH-PCR are that it surveys relative gene 
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frequencies within complex mixtures of DNA, is reproducible, requires small sample 
sizes, and can be performed with many samples simultaneously (Moreno et al., 2006; 
Suzuki et al., 1998).  Furthermore, some of the size classes emerging from LH-PCR 
analyses can be related at the genus level to archived database sequences (Suzuki et al., 
1998).  Overall, the attributes of LH-PCR make it useful for quick assessment of the 
diversity of microbial communities for comparative purposes (Suzuki et al., 1998).   
Prior studies have shown that LH-PCR and the hypervariable regions one and two 
(V1_V2) of the 16S rRNA gene can be used to detect eubacteria in sputum from CF 
patients (Miller, 2003; Rogers et al., 2003).  The technique had limited efficacy when 
determining overall diversity and attaining organism identification and it was concluded 
that the small differences in amplicon lengths generated from the organisms was at fault 
(Rogers et al., 2003).  In this study, community profiles of CF sputa were obtained using 
two regions of the 16S rRNA gene (hypervariable region 1 [V1] and [V1_V2]).  Bacterial 
identification based on amplicon length was attempted using a computer program, 
AmpliQué, which determined the theoretical V1 and V1_V2 fragment lengths for known 
organisms.  Community profiles and identification were analyzed using each region 
separately and combined to determine if a combinatorial approach to LH-PCR (i) could 
provide a more detailed analysis of the bacterial community in the CF lung and (ii) could 
be used to observe the dynamics of this community over a period of time.  This work has 
shown that the V1 region provides a more detailed community profile which leads to a 
higher power of discrimination between profiles than the V1_V2 region.  The LH 
analyses provided snapshots of the CF bacterial communities.  However, the analyses are 
limited by their ability to identify community members with the V1 or V1_V2 regions 
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separately or combined.  In addition, through the comparisons of V1_V2 or V1 LH 
profiles over time, it was established that the CF lung community is not only diverse but 
also dynamic.     
 
2.3  Material and methods 
2.3.1  Sample collection.  Nineteen sputum samples were obtained from CF 
patients attending the University of Miami adult CF clinic (Miami, FL).  Samples are 
referred to by UM followed by a letter. The study was carried out in accordance with the 
Declaration of Helsinki (2000) of the World Medical Association and was approved by 
the appropriate institutional review board (FIU IRB approval # 033004-02). Appropriate 
consent was obtained from human subjects. All 19 expectorated sputum samples were 
frozen at -20 °C prior to DNA extraction. Sputum was liquefied using the method of 
Reischl et al and the metagenomic DNA was extracted and cleaned using the GeneClean 
Spin Kit (Qbiogene, Irvine, CA) as per manufacturer’s protocol (Reischl et al., 1994).  
The eluted DNA was quantified and diluted to 10 ng/µL and refrigerated at 4°C until 
further use.   
 
2.3.2  Control bacteria isolates.  Standard DNA manipulations were used to 
extract chromosomal DNA from CF-related pathogens; P. aeruginosa strains PAO1 and 
PA14 (burn wound isolates) and four additional P. aeruginosa strains isolated from CF 
patients (Klockgether et al., 2007), B. cenocepacia (ATCC BAA-246; CF isolate), 
Staphylococcus aureus (ATCC 12600; pleural fluid isolate), and Stenotrophomonas 
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maltophilia (ATCC 17672; sputum isolate) were used as controls in the LH-PCR 
experiments. 
 
2.3.3  LH-PCR.  The metagenomic DNA derived from the extracted sputum 
samples were amplified in triplicate using eubacterial primers for the 16S rRNA gene.  
The V1_V2 region of the 16S rRNA gene were amplified using 27F-6FAM forward 
primer (5’– 6FAM – AGA GTT TGA TCM TGG – 3’) and the 355R reverse primer (5’ – 
GCT GCC TCC CGT AGG AGT -3’) (Doud et al., 2009).  The V1 region was amplified 
using fluorescent primer P1F-6FAM (5’ – 6FAM – GCG GCG TGC CTA ATA CAT GC 
– 3’) and reverse primer P2R (5’ - TTC CCC ACG CGT TAC TCA CC -3’) (Cocolin et 
al., 2001; Doud et al., 2009)  All forward primers are fluorescently labeled with 6-
FAMTM (Integrated DNA Technologies, Shokie, IL).  The final V1_V2 PCR reaction 
mixture was composed of: 1X PCR buffer (supplied with the enzyme by Applied 
Biosystems, Foster City, CA), 2.5 mM MgCl2, 0.25 mM dNTPs, 0.5 µM forward and 
reverse primers, 0.1% bovine serum albumin, 0.025 U of AmpliTaq Gold LD DNA 
polymeraseTM (Applied Biosystems, Foster City, CA), and diethylpyrocarbonate (DEPC) 
water to make up the final volume of 20 μL.  A half a nanogram per microliter of DNA 
template was added per reaction.  The following parameters were used to amplify the 
selected fragments on a MJ Research Peltier Thermal Cycler 200 (Waltham, MA):  initial 
denaturation at 95°C for 11 minutes, 25 cycles of denaturation at 95°C, annealing at 55°C 
and extension at 72°C, each for 1 minute and a final elongation at 72°C for 10 minutes.  
A negative control containing water was amplified for every PCR master mix to check 
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for contamination.  Agarose gel electrophoresis was run to confirm the success of 
amplification.   
 
2.3.4  LH-PCR analysis.  LH-PCR analysis was performed by the Forensic DNA 
Profiling Facility (Florida International University, Miami, FL).  The PCR products for 
the three replicate reactions were detected using the ABI Prism 310 Genetic Analyzer 
(Applied Biosystems, Foster City, CA).  A formamide-size standard mix was prepared 
using a 96:1 ratio of Hi-DiTM (highly deionized) formamide and GeneScanTM 500 ROXTM 
internal standard (Applied Biosystems).  Each PCR product was denatured by adding 
0.50 µl to 9.5 µl of the formamide-size standard mix for 2 minutes at 95°C and snap 
cooling for 5 minutes on ice.  Each sample was run for 28 minutes on the ABI Prism 310.  
Fragments were separated by capillary electrophoresis using polymer POP-4, matrix DS-
3O_6FAM_HEX_NED_ROX and filter D (Applied Biosystems). 
 
2.3.5  Electropherogram analysis.  The output was collected and analyzed using 
GeneMapper® Software Version 3.7 (Applied Biosystems) and Microsoft Excel 
(Microsoft, Redmond, WA).  The ABI PrismTM Genotyper software analysis parameters 
were set to the local Southern Size calling, no correction, and the minimum noise 
threshold was set at 70 fluorescent units (Mills et al., 2003).  For V1_V2, amplicons were 
called if between 300 and 400 base pairs (bp).  Amplicons for V1 region were between 
60 and 120 bp. 
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 2.3.6  Statistical analysis.  Data were imported into MS Excel (Microsoft, 
Redmond, WA), to determine mean relative ratios for each triplicate PCR reaction.  The 
normalized data for each sample were exported into PRIMER 5 statistical software for 
further analyses (PRIMER E Ltd., Plymouth Marine Laboratory, United Kingdom).  Bray 
– Curtis similarity index and non metric multi-dimensional scaling (MDS) was used to 
compare sample data between patients and patient profiles over time (Hartmann et al., 
2005; Rees et al., 2004).  
 
2.3.7  Presumptive identity analysis.  The GeneScanTM 500 ROXTM internal 
standard was used to determine amplicon sizes in base pairs.  Several approaches were 
used to presumptively identify an organism in the CF community based upon the length 
of the amplicon generated.  Chromosomal DNA from isolates of Burkholderia 
cenocepacia, Staphlyococcus aureus, Stenotrophomonas maltophilia, and Pseudomonas 
aeruginosa were used to determine the experimental amplicon length for the V1_V2 and 
V1 regions. Next, in silico analysis was performed in which the expected amplicon length 
was determined based on where the primers of interest would theoretically bind to the 
published sequence.  Lastly, the lengths of the expected amplicons for all bacteria were 
determined using AmpliQué, a newly designed bioinformatics program (Gonzalez et al., 
2009).  The Perl scripts are available at http://biorg.cs.fiu.edu/AmpliQue/.  AmpliQué 
uses the 16S rRNA sequences downloaded from the Ribosomal Database Project II 
(Release 9.60).  It takes a forward and a reverse primer (both of which may be potentially 
degenerate) as input.  The stringency of the primer binding can be set in the program to 
control the exactness of the primer binding site within the 16S rRNA sequences.  The 
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stringency was first set to 100 % (E = 10) to identify the organisms that have exactly the 
same conserved sequences as the primer and subsequently lowered to E = 5,000 which 
allowed a larger database to be created as the conserved regions of the 16S rRNA gene 
are not 100 % identical in sequence.  The resulting output shows the identity of all the 
16S rRNA sequences that will produce an amplicon with a particular pair of primers, 
along with the length(s) of the amplicons.  Thus, one can query the database using any 
primer to determine the theoretical fragment lengths that would be generated from an 
organism when analyzed.  In addition, a list of all bacteria that produce a specific 
fragment length can be generated.  One amplicon length may represent more than one 
bacterium and thus only a presumptive identity of that amplicon can be achieved.   
 
2.4  Results 
2.4.1 PCR amplification of 16S rRNA genes for metagenome profiling.  
Variable regions V1 and V1_V2 were successfully amplified using universal eubacterial 
primers from the metagenomic DNA samples (See Methods).  As expected, the amplicon 
sizes from the 19 samples ranged from 335 to 365 bp for the V1_V2 region (Table 2.1 
and Supplemental Figure 2.6).  Sample UMC had the most complex V1_V2 profile with 
eight amplicons (Figure 2.1A and Table 2.1).  Samples UMF, UMG, UMH, UMJ, UMK, 
UMP, and UMT had the least complex LH profiles with only one amplicon present at 342 
bp (Figure 2.1B and Table 2.1).  The remaining 11 samples produced LH profiles 
containing multiple amplicons (Table 2.1, Supplemental Figure 2.6).  Amplicon 342 was 
observed in all 19 samples (Table 2.1).  Out of these 19 samples, 16 samples (84.2 %)  
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Table 2.1: Amplicons seen in the V1 and V1_V2 regions for samples   
Sample V1_V2 (%)* Total # V1_V2 V1 
Total # 
V1
UMA 342, 349 (39.0), 350 3 60, 62, 63, 65, 68, 69, 70, 72, 73, 75, 76, 77, 78, 81, 82, 83, 86 (17.3), 90, 91, 92, 93, 94, 96, 98, 100, 101, 108 27
UMB 342 (61.7), 347, 365 3 62, 63, 72, 73, 75, 76, 77, 78, 81, 82, 88 (15.7), 91, 93, 94, 98, 100, 102, 103, 112 19
UMC 335, 342 (79.0), 347, 349, 350, 351, 352, 365 8 61, 62, 68, 69, 70, 72, 73, 75, 76, 77, 78, 81, 82, 84, 86, 88 (12.0), 90, 91, 92, 93, 94, 96, 98, 100, 102, 104 26
UMD 342 (93.7), 351, 352, 365 4 64 (14.4), 70, 73, 77, 82, 86, 88, 98, 103, 112 10
UME 342 (99.0), 348 2 60, 62, 64, 66, 67, 68, 69, 71, 72 (12.3), 73, 74, 75, 76, 77, 78, 80, 81, 86, 88, 91, 93, 94, 98, 100, 102, 103, 112, 113, 115, 120 30
UMF 342 (100) 1 60, 61, 62, 65, 68, 70, 72 (12.6%), 73, 75, 77, 78, 85, 91, 93, 94, 98, 103, 112, 113, 115 20
UMG 342 (100) 1 60, 61, 62, 68, 72 (3.6), 73, 75, 77, 78, 86, 91, 93, 98, 103, 112, 113, 115, 119, 120 19
UMH 342 (100) 1 60, 61, 62, 65, 68, 70, 73, 75, 76, 77 (3.9), 78, 80, 81, 84, 85, 86, 88, 90, 91, 93, 94, 96, 98, 101, 103, 111, 112, 113, 115 29
UMJ 342 (100) 1 60, 61, 62, 63, 65, 68, 70, 72, 73, 75, 77, 78, 80, 81, 84, 86, 88, 91, 92, 93, 94, 98, 102 (6.6), 112, 113, 115, 120 27
UMK 342 (100) 1 60, 61, 62, 65, 67, 68, 70, 72, 73, 75, 77, 78, 81, 85, 86, 90, 91, 93, 94, 98, 100, 101 (7.3), 103, 111, 112, 113, 120 27
UML 342, 350, 360 (55.7), 365 4 60, 61, 62, 63, 64, 65, 67, 68, 70, 71, 72, 73, 76, 78, 81, 85, 88, 91, 94 (31.3), 98, 100, 102, 103, 112, 113, 115, 119, 120 28
UMM 342 (98.7), 351, 365 3 61, 62, 65, 68, 70, 73, 75, 76, 77, 78, 81, 82, 84, 86, 88, 91, 94, 98, 101 (4.8), 103, 111, 113, 115, 119, 120 25
UMN 339, 342 (92.7), 347, 352 4 60, 61, 62, 65, 68, 70 (10.2), 73, 77, 78, 81, 85, 86, 88, 90, 91, 92, 94, 98, 100, 103, 108, 112, 113, 115 24
UMO 342 (74.0), 350, 352 3 60, 62, 65, 73, 77, 78, 80, 81, 85, 91, 98, 102 (3.1), 103, 108, 111, 112, 113, 115, 119, 120 20
UMP 342 (100) 1 60, 61, 62, 65, 77, 78, 81, 98, 102 (5.7), 112, 115, 120 12
UMQ 342 (41.3), 348, 350, 365 4 60, 61, 62, 63, 64, 65, 71, 72, 76, 78, 81, 84, 85, 87, 91, 94, 98, 102 (5.3), 103, 112, 115 21
UMR 342, 360 (63.7) 2 60, 62, 63, 65, 73, 77, 78, 80, 81, 82, 85, 94 (13.9), 98, 102, 108, 112, 115, 120 18
UMS 339, 342 (87.7), 347 3 60, 62, 63, 66, 72, 73, 74, 77, 78, 80, 81, 85, 88, 91, 94, 98, 102 (9.9), 103, 111, 112, 113, 115, 119, 120 24
UMT 342 (100) 1 60, 62, 63, 65, 71, 72, 73, 76, 78, 81, 85, 92, 94, 98, 102 (13.2), 111, 112, 115, 120 19  
*Amplicons in bold are the most abundant amplicon in the profile for that particular  
sample.  The number in parenthesis indicates the percentage abundance of the 
dominant amplicon for that region. 
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Figure 2.1: Hypervariable V1_V2 amplicon data graphs.  Panel A represents the 
V1_V2 profile from patient UMC.  Panel B depicts the profile obtained from patients 
UMF, UMG, UMH, UMJ, UMK, UMP, and UMT using the V1_V2 region.   
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had amplicon 342 as the dominant member of the profile.  The most abundant amplicons 
in UMA, UML, and UMR were 349, 360, and 360, respectively (Table 2.1).    
 As predicted, V1 profiles ranged from 60 to 120 bp in length (Table 2.1 and 
Supplemental Figure 2.7).  Unlike V1_V2 profiles, all 19 samples produced more diverse 
profiles containing multiple amplicons in each profile (Table 2.1, Supplemental Figure 
2.7).  The most complex profile contained 30 amplicons for UME (Figure 2.2, Table 2.1).  
The least diverse profile with 10 amplicons belonged to UMD (Table 2.1, Supplemental 
Figure 2.7).  All the samples contained a 98 bp amplicon, though it was not the most 
abundant amplicon (Table 2.1). The 86 bp amplicon was present in 10 out of the 19 
profiles and was the most dominant peak in UMA (17%) (Table 2.1).  The 84 bp 
amplicon was found in five profiles.  Seventeen out of 19 samples contained a 73 bp 
amplicon. 
 
2.4.2  Comparison of LH eubacterial profiles within CF center.  The profiles 
for each sample were compared to each other to determine if the bacterial communities 
were similar between patients that were treated at the same CF center.  The normalized 
abundance data from the V1_V2 region was analyzed using the Bray-Curtis similarity 
index.  The similarity between samples was shown in a dendograph using group linkage 
clustering.  The UMF profile has 100 % similarity to UMG, UMH, UMJ, UMK, UMP, 
and UMT as they all produced 100 % abundance for amplicon 342 (Table 2.1 and Figure 
2.3A). The UMR profile had 36.0 % or less similarity with 13 of the samples, but had a 
91.0 % similarity with UML (Figure 2.3A).  The UMR and UML profiles had two 
amplicons in common. The V1 region was able to discriminate between all samples; no 
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two profiles were exactly the same (Table 2.1 and Figure 2.3B).  The highest similarity 
between two profiles was 79.2 % between UMF and UMG due to the presence of many 
shared amplicons (Figure 2.3B). The most dissimilar profile was between UMD and 
UMQ with 6.2 % similarity.  Four out of the 10 amplicons were common between UMD 
and UMQ (Table 2.1).   
Figure 2.2: Hypervariable V1 amplicon data.  Graph depicts the V1 profile from patient 
UME, which was the most diverse profile found in this study.   
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Figure 2.3:  Similarity based clustering between LH profiles of patients.  Panels A and B 
are dendographs indicating the relatedness of LH profiles of patients generated from the 
V1_V2 and V1 regions, respectively.  Bray – Curtis similarity index and group linked 
clustering were used to determine similarity of bacterial communities. 
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  The similarity of the patients’ bacterial population with both the V1_V2 and the 
V1 data were also compared.  The combination of regions decreased the degree of 
similarity between V1_V2 profiles yet the LH profiles were most dissimilar with the V1 
region analysis (data not shown).   
 
2.4.3  Patient CF flora changes over time.  The lung flora changes over time in 
the CF lung.  It is also known that the bacterial community composition in the lung at any 
one given time is varied due to the compartmentalized structure of the organ (Harrison, 
2007). When working with expectorated sputum, it was assumed that the bacterial 
community within a given patient may vary from sample to sample.  In order to study the 
dynamics of lung flora over a period of time, sampling bias was addressed.  That is, any 
changes seen in community profiles over time may potentially be an artifact from the 
sampling method.  A control experiment was performed to understand the effect of 
sampling.   
 Sputa samples from patient UML were analyzed over the course of two years 
(Month 1 to Month 22).  The samples were referred to as M0, M3, M16, M17, M22.1, 
M22.2, M22.3, M22.4, and M22.5.  Five samples were taken on the same day every three 
hours for twelve hours (M22.1 - M22.5).  The sampling scheme was designed to account 
for the potential variability contributed by the lung structure.  All samples were analyzed 
using the V1 and V1_V2 regions.  Bray-Curtis similarity index was used to determine the 
variation between the community profiles of the patient samples.  The relatedness of 
bacterial communities was shown with dendographs created from the calculated 
similarity (Figure 2.4).  In addition, the relationship between profiles was graphically 
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depicted using non-metric MDS which represents the samples as points in a low-
dimensional space so that the relative distances of the symbols is correlated with the same 
rank order determined by the Bray-Curtis similarity index (Figure 2.5).  These analyses 
visually showed that samples taken on the same day were more similar than LH profiles 
from earlier time points (Figure 2.4 and 2.5).  For the V1_V2 region, the samples in M22 
ranged from 70.6 % to 93.4 % in similarity.  The first three samples M1, M3, and M16 
had less than 42.9 % similarity to any profile produced from the hourly samples.  The LH 
profile M17 and the five profiles in M22 are related with a range of 52.8 % to 78.3 % 
similarity.  M22.4 was more similar to M17 than the other same-day samples (Figure 
2.4A).   
 The V1 profiles for these samples were also analyzed and compared.  Overall, the 
similarities between samplings were much lower when using the V1 versus the V1_V2 
region (Figure 2.4B and 2.5B).  The highest profile similarities were seen within M22 
samples; as high as 96.0 % were seen between M22.3 and M22.5.  M1 and M3 had a 
similarity of 48.1 %; M16 and M17 were 47.1 % similar.  Some of the samplings taken 
months prior to the daily sampling in M22 were completely different (Figure 2.4B).  The 
MDS analysis clearly showed samples taken on the same day (M22) clustered (Figure 
2.5B).     
 Combining LH data from both the V1 and the V1_V2 regions further indicated 
the overall similarity of bacterial community within one day versus over a period of time 
(Figure 2.4C and 2.5C).  The additive effect of the regions created a tighter clustering of 
the same-day samples and increased distances between samples taken in different months 
(Figure 2.4C).   
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Figure 2.4:  Similarity based clustering between LH profiles over time in one patient.  
Panels A and B are dendographs indicating the relatedness of LH profiles of patients 
generated from the V1_V2 and V1 regions, respectively.  Panel C describes the 
community similarity when both V1_V2 and V1 data are combined.  Bray – Curtis 
similarity index and group linked clustering was used to determine similarity of 
bacterial communities. 
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 Figure 2.5:  Similarity between LH profiles over time in one patient.  Panels A and B 
are MDS figures which represent the profiles generated from one patient over a period 
of time using the V1_V2 and V1 regions, respectively.  Panel C is the MDS figure 
representing the combined V1_V2 and V1 data.  Blue diamond, blue pentagon, red 
heart, red diamond, orange cross, green triangle, black hexagon, aqua square, and 
purple circle represent samples from Month 1, Month 3, Month 16, Month 17, Month 
22.1- 22.5, respectively. 
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2.4.4  Antibiotics drive CF community.  After the initial time study with Patient 
UML, two more patients were followed for a period of time to determine the effect of 
antibiotics on the lung microbial flora.  Azithromycin, bactrim, tobramycin and colistin 
were administered at different time points for each patient.  Azithromycin, which is most 
often used to treat Gram-negative bacteria, is a macrolide antibiotic which interferes with 
protein synthesis preventing growth of bacteria (Retsema et al., 1987).  Bactrim is a 
combination of sulfamethoxazole and trimethoprim and it interferes with DNA synthesis 
in bacteria that cause respiratory infections, especially in Stenotrophomonas maltophilia 
(Hughes & Russell, 1982; Muder et al., 1996).  Tobraymcin, an aminoglycoside, prevents 
translation in bacteria.  The inhaled form of the drug targets P. aeruginosa in the lungs 
(Ramsey et al., 1999).  Colistin or polymyxin E is effective against most Gram negative 
bacilli and is often used against multidrug resistant strains of P. aeruginosa (Beringer, 
2001).  The drug regime and sputa samples from two patients referred to as patient UMX 
and patient UMY were analyzed every other month for five months.  The three time 
points are referred to as MO, M3, and M5.  The amplicons of size 60 - 120 bp and 300 – 
400 bp were obtained from the V1 and the V1_V2 region, respectively (Table 2.2). 
Patient UMX was under triple combination therapy with azithromycin, bactrim, 
and tobramycin at least two weeks prior and up to the sampling at month 0 (M0) and 
month 3 (M3).  Two weeks prior to month 5 (M5), the patient stopped taking tobramycin 
but continued the treatment with azyithromycin and bactrim.  The number of amplicons 
for the V1_V2 and V1 LH profiles varied for the three time points (Table 2.2). The 
dominant 342 bp amplicon was present in each time point (93.7 %, 100 % and 74 % at 
M0, M3, and M5, respectively) for the V1_V2 region (Table 2.2).    
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Table 2.2: Amplicon contributions for Patients UMX and UMY over a five-month time 
period 
Amplicon 
(bp)* M0
a (%) M3a (%) M5b (%)
Amplicon 
(bp) M0
c (%) M3d (%) M5d (%)
352 P (2.34) P (13.00)
351 P (1.67)
348 348 P (1.00) P (33.88)
347 347 P (35.33)
120 P (1.88) P (5.88) 120
119 P (1.88) P (3.53) 119
113 P (3.77) P (2.35) 113
111 P (3.53) 111
108 P (18.82) 108
100 100 P (4.66)
94 94 P (0.99) P (0.81) P (1.85)
87 87 P (2.47)
84 84 P (1.23)
76 76 P (1.84) P (1.63) P (4.94)
74 74 P (0.81)
71 71 P (4.07) P (6.79)
70 P (4.36) 70
69 69 P (0.81)
67 67 P (0.81)
66 66 P (0.81)
65 65 P (3.70)
63 63 P (3.25) P (3.09)
342 P (93.67) P (100) P (74.00) 342 P (61.67) P (99.00) P (34.16)
365 P (2.00) 365 P (3.00) P (2.20)
350 P (13.00) 350 P (29.75)
115 P (3.77) P (2.35) 115 P (0.81) P (2.47)
112 P (16.50) P (3.77) P (4.71) 112 P (10.31) P (0.81) P (3.09)
Shared Amplicons
Patient UMX Patient UMY
Unique Amplicons
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Amplicon 
(bp)* M0
a (%) M3a (%) M5b (%)
Amplico
n (bp) M0
c (%) M3d (%) M5d (%)
103 P (4.85) P (9.43) P (5.88) 103 P (2.68) P (1.23)
102 P (10.59) 102 P (8.62) P (3.25) P (29.63)
98 P (5.66) P (8.24) 98 P (6.92) P (6.50) P (3.70)
93 P (3.77) 93 P (0.99) P (0.81)
91 P (3.77) P (4.71) 91 P (3.53) P (1.63) P (2.47)
88 P (12.13) 88 P (19.92) P (1.63)
86 P (1.88) 86 P (13.01)
85 P (7.06) 85 P (6.79)
82 P (14.07 82 P (2.97)
81 P (1.18) 81 P (2.12) P (3.25) P (3.70)
80 P (1.18) 80 P (2.44)
78 P (3.77) P (1.18) 78 P (1.69) P (3.25) P (1.85)
77 P (8.73) P (3.77) P (5.88) 77 P (4.24) P (1.63)
75 P (1.88) 75 P (2.26) P (2.44)
73 P (8.73) P (3.77) P (3.53) 73 P (2.26) P (3.25)
72 P (20.75) 72 P (1.27) P (30.08) P (11.73)
68 P (3.77) 68 P (0.81)
64 P (21.35) 64 P (0.81) P (1.23)
62 P (3.77) P (4.71) 62 P (18.79) P (1.63) P (2.47)
61 P (3.77) 61 P (1.23)
60 P (15.09) P (4.71) 60 P (12.20) P (3.70)
Patient UMX Patient UMY
Shared Amplicons
 
 
*V1_V2 amplicons range from 300 - 400 whereas V1 amplicons range from 60 -120 bp. 
M0, M3 and M5 refers to collection of samples at time 0, 3 and 5 months  
P indicates presence of amplicon with its percentage abundance in the individual profile 
for that specific region 
aPatient UMX was treated with Azithromycin, Bactrim, & Tobramycin 
bPatient UMX was treated with Bactrim  
cPatient UMY was treated with Levaquin  
dPatient UMY was treated with Colistin   
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The dominant amplicons in V1 for the three time points, M0, M3 and M5 were 64 
(21.4 %), 72 (20.8 %) and 108 (18.8 %) bp, respectively. For the V1 profile, amplicons 
73, 77, 103, and 112 bp were present at all time points.  The amplicons 64, 70, 82, 88, 
351 and 365 bp were present only during M0.  The 352 bp amplicon was found during 
M0 was absent in M3 and then present again at M5.  Amplicons with 61, 68, 72, 75, 86, 
and 93 bp were only present during M3.  Amplicons with 60, 62, 78, 91, 98, 113, 115, 
119, and 120 bp appeared at M3 and were also detected at M5.  M5 unique amplicons 
had 80, 81, 85, 102, 108, 111, and 350 bp. 
Patient UMY was taking levaquin two weeks prior to the M0 sampling.  At least 
two weeks prior to the second sampling, M3, the therapy was changed to colistin.  The 
LH profiles (number and abundance) varied over time (Table 2.2).  The 342 bp amplicon 
in the V1_V2 region was the most abundant with 61.7 % at M0 and 99.0 % at M3.  
However, this amplicon was drastically decreased at M5 (34.2 %) (Table 2.2).  The V1 
amplicons with 62, 72, 76, 78, 81, 91, 94, 98, 102, and 112 bp were found at all three 
time points. The amplicons with 63, 103, and 365 bp were present in M0 and M5 but 
absent in M3.  Amplicons unique to M0 were 82, 100, and 347 bp. Amplicons present at 
M0 and M3 but absent in M5 were 73, 75, 77, 88 and 93 bp.  M3 and M5 shared 
amplicons with 60, 64, 71, and 115 bp.  The six unique amplicons present in M5 had 61, 
65, 84, 85, 87, and 350 bp (Table 2.2). 
 
2.4.5  Presumptive identity analysis.  Based on amplicon lengths for both the 
V1_V2 and V1 regions, separately or combined, a presumptive identity for an organism 
can be determined. In attempt to achieve identification of an amplicon, chromosomal 
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DNA from several CF related pathogens were amplified using V1_V2 primers and V1 
primers.  All strains of Pseudomonas aeruginosa used in this study amplified a 342 and a 
83 bp amplicon for the V1_V2 and V1 regions, respectively.  Stenotrophomonas 
maltophilia amplified a 350 and a 87 bp amplicon for the V1_V2 and V1 regions, 
respectively.  A 353 bp amplicon was generated for Staphylococcus aureus for the 
V1_V2 region.  However, V1 primers amplified two peaks at 77 and 88 bp for S. aureus.  
Burkholderia cenocepacia produced a 339 bp and a 85 bp amplicon for V1_V2 and V1, 
respectively.   
Many LH profiles did contain amplicons that correspond to these bacterial 
isolates’ fragment sizes.  Nineteen LH V1_V2 profiles may have contained the pathogen 
P. aeruginosa but only one sample contained the corresponding V1 amplicon (83 bp) 
(Table 2.1).  Five samples had the 350 bp amplicon which may be from 
Stenotrophomonas maltophilia but only one sample had the corresponding V1 amplicon.   
None of the samples had Staphylococcus aureus specific V1_V2 fragment of 353 bp.  
However, the V1 specific fragments (77/88) were present in 16 samples; nine of these 
samples contained both fragments.  The 339 and 85 bp which may correspond to B. 
cenocepacia were present in two and ten samples, respectively.  Two samples contained 
both amplicons.   
The theoretical amplicon lengths for bacteria were determined manually using in 
silico analysis and AmpliQué and then compared to the LH profiles of the strains.  The 
manual in silico analysis determined the V1_V2 fragment length for one specific strain of 
a CF pathogen.  These results agreed with the experimental data.  The AmpliQué 
program was developed to determine the V1_V2 fragment lengths for all bacterial strains 
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which had a 16S rRNA sequence in RDPII.  The data generated from the program did 
agree with the experimental data for some strains yet showed different fragments for 
other strains.  For example, in the database some strains of Stenotrophomonas 
maltophilia produce the same 350 bp fragment as the LH result.  In addition, many more 
fragment lengths (304-344 and 346-351 bp) were identified for various strains of S. 
maltophilia.  Various isolates of P. aeruginosa produced theoretical fragments ranging 
from 337-345 bp.  Only two fragments, 347 and 348, were produced for this region based 
on H. influenzae sequences.  AmpliQué determined different isolates of Staphylococcus 
aureus have a V1_V2 length of 340-344 and 346-351 bp.  Based on B. cenocepacia 
sequences, any of the fragments 327, 335, 337, 338, 340, 344, or 346 bp could be 
generated using the V1_V2 primers.  Most bacterial species produced multiple hits for 
the V1_V2 region (data not shown). 
AmpliQué was unable to determine the fragment sizes for many CF related 
pathogens including P. aeruginosa.  In silico analysis was able to determine the fragment 
lengths of CF pathogens as that the site of primer binding could be detected manually. 
Again, fragment lengths generated from sequences of individual strains varied from the 
actual LH results for the specific control strain.  Four different isolates of P. aeruginosa 
produced an 86 bp fragment for the V1 region while experimentally the region was 83 bp 
long.  Some strains of Stenotrophomonas maltophilia produced the same 87 bp fragment 
as the control strain while others were determined to have a fragment of 85 or 88 bp.  
Staphylococcus aureus strains were 91 bp long in that region but the test strain did not 
produce this fragment.  B. cenocepacia was three bp longer (88 bp) than the LH isolate’s 
profile (85 bp). 
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2.5  Discussion 
LH analysis of 16S rRNA genes has been used to detect both known and novel 
organisms that may be present in many complex microbial communities including sputa 
from CF patients (Miller, 2003; Mills et al., 2003; Rogers et al., 2003; Suzuki et al., 
1998).  In these previous studies, only one region of the 16S rRNA was used to identify 
bacteria present in the community at one time point (Miller, 2003; Rogers et al., 2003).  
Identification based on one region is difficult and it is hypothesized that the use of 
multiple regions might provide more information about the community.  In this study, the 
V1 and V1_V2 regions (separately and combined) were analyzed with LH-PCR to 
determine the diversity and dynamics of the CF lung.  Identification of the most abundant 
amplicon lengths in the LH profiles was attempted through in silico analysis and 
AmpliQué, a newly designed bioinformatics program.  Lastly, the dynamics of the 
eubacterial community in the sputum over a period of time was further studied using data 
generated from the LH profiles.  
 
2.5.1  The V1 region of the 16S rRNA gene provides a more detailed look at 
the complex bacterial community in the CF lung.  The 16S rRNA gene contains nine 
variable regions.  In this study, the V1 region and the V1_V2 regions were used to 
produce bacterial LH profiles of the CF sputa samples (Table 2.1).  The V1_V2 profiles 
were identical for seven patients and hence were unable to discriminate between patients.  
The 342 bp amplicon produced a high relative fluorescence in the electropherograms 
which may have caused the less dominant amplicons to be below the threshold limit and 
inadvertently ignored (Table 2.1).  PCR amplification bias may have also decreased the 
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detection of other bacteria that were less abundant than the organism(s) represented by 
the 342 bp amplicon.  Therefore, it appeared that seven CF samples had identical 
bacterial communities.  Statistically, the V1_V2 profiles cannot discriminate between 
patients at the UM center (Figure 2.3A).  The V1 LH profiles were more complex and 
statically discriminated between samples to a higher degree than the V1_V2 region 
(Figure 2.3).  The V1 profiles which were unique to each patient contained multiple 
amplicons per sample (Table 2.1).    
The use of multiple regions to increase discrimination between samples was not 
beneficial.  The identical communities shown in the V1_V2 profiles negated the 
discriminatory power of the V1 region when analyzed in conjunction with each other.  
The discriminatory strength of the V1 region as compared to the V1_V2 region was also 
evident in a soil community LH study (Moreno et al., 2006).  Prior LH analysis on CF 
sputa used only the V1_V2 region and more information may have been gained by using 
the V1 region (Rogers et al., 2003).  Using the profiles from the two regions together did 
not differentiate profiles to the same extent as the V1 region.  The combinatorial 
approach may be of more use in amplicon identification or observing community 
dynamics.  
 
2.5.2  CF patients harbor diverse bacterial communities.  The 19 sputum 
samples obtained from South Florida patients produced unique profiles.  No two LH 
profiles for the V1 region were the same (Table 2.1 and Figure 2.3B).  The V1_V2 region 
profiles all contained the amplicon length of 342 bp, which presumptively could be 
identified as Pseudomonas species, Burkholderia species (but not B. cenocepacia), or 
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Ralstonia species.  The 342 bp amplicon is indicative of P. aeruginosa since control CF 
isolates produced the same fragment.  In addition, the patients were clinically diagnosed 
with P. aeruginosa.  The high relative fluorescence of the 342 bp amplicon also indicated 
a severe infection which would be in agreement with culturing results.  The intense 
fluorescence of the fragment in seven samples may have skewed the community profile 
causing it to appear as if there was only one bacteria present.  The V1 region for these 
seven samples show some shared amplicons, but largely they had very diverse microbial 
communities. Though some amplicons (presence not abundance) were common to 
patients, no two overall profiles were identical to each other (Table 2.1 and Figure 2.3B). 
It was thought that there are only a few pathogens commonly found in the lungs 
of CF patients due to clinical diagnostic procedures (Govan & Nelson, 1993).  Molecular 
techniques have revealed that many more organisms plague the CF lung which is in 
agreement with our findings (Harris et al., 2007; Rogers et al., 2003).  Many of the 
samples in this study produced LH profiles that contained numerous amplicons, some in 
low abundance.  These less dominant amplicons may represent bacteria that are not 
routinely cultured and are potentially responsible for some of the differences seen in 
disease manifestation between CF patients with the same genetic mutations. Recent 
Sanger sequencing projects have identified uncultured bacteria in the CF lung (Bittar et 
al., 2008; Harris et al., 2007) Deeper sequencing techniques such as 454 could be used to 
identify other less abundant and potentially uncultured organisms (Margulies et al., 
2005).  In order to understand the significance of these organisms within the CF lung, 
proper statistical tools for comparative metagenomics need to be developed. 
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2.5.3  Challenges of identifying organisms in complex communities.  One of 
the downsides to the LH technique is that the organism found in a sample cannot be 
conclusively identified.  We hypothesized that organisms could be presumptively 
identified based on the V1_V2 and V1 amplicon lengths that would be generated from 
LH-PCR.  In this study, the fragment lengths for both regions were experimentally 
determined for one strain of four known CF pathogens.  In addition, in silico analysis and 
AmpliQué were used to determine the expected amplicon length of a variable region for 
any given organism.  This information was correlated with the LH profile in an attempt to 
identify bacteria present in the CF sputum.  The bioinformatics approach highlighted the 
presence of intraspecies length variation present in both regions.  The high degree of 
variation seen in different isolates drastically decreased the ability to identify a bacteria 
based on the length of one hypervariable region.  It was previously known that one 
amplicon length could represent multiple species; thereby allowing only a presumptive 
identification.  Based on the absence of a peak, a specific genus or species could be ruled 
out from being a member of the community.  The AmpliQué output clearly demonstrates 
that one V1_V2 fragment could represent a multitude of species or genera.  The wide 
range of fragment lengths generated for different isolates of the species may be accurate 
or it may be due to problems related to the database used in the program.  The database 
contains sequences which are determined by various users.  It is possible that some of the 
length heterogeneity at the isolate level may arise from poor sequencing reads, incorrect 
trimming of sequences, and old taxonomy references (some organism names have 
changed).  Database issues will change as more genome wide sequencing is performed.  
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As it stands currently, identification is nearly impossible based solely on amplicon length 
from the V1_V2 region.   
The V1 region, which was more informative when looking at the community 
profile as a whole, proved to be more problematic when analyzing individual peaks.  
Chromosomal DNA of P. aeruginosa, Staphylococcus aureus, Stenotrophomonas 
maltophilia, and B. cenocepacia were amplified using the V1 primers and the fragment 
lengths were detected.  In silico analysis was used to determine fragment lengths for the 
CF associated lung pathogens including those listed above (though not always the same 
isolate).  The initial analysis indicated the presence of length heterogeneity within 
species.  AmpliQué was used to determine the degree of strain variation present in the V1 
region.  The primer binding parameter was initially set to 100 % stringency which 
resulted in a very small database of organisms and their corresponding fragment lengths.  
Many CF pathogens including P. aeruginosa were not present at this high stringency.  By 
lowering the stringency, AmpliQué generated more results yet no information was given 
for P. aeruginosa.  The V1 region primers (P1F and P2R) experimentally amplified P. 
aeruginosa PAO1.  To determine the putative primer binding site, the 16S rRNA 
sequence for PAO1 was manually examined.  Both the forward and reverse primer 
sequences show some degeneracy.  Lowering the stringency parameter was unable to 
correct for this degeneracy.  This issue can be resolved by determining the binding motif 
of the primers using programs such as iterative enhancement of motifs (IEM) (Zeng et 
al., 2007a) and then using that motif in AmpliQué.  Although P1F is a common V1 
primer used extensively in the lab, other less degenerate V1 forward primers such as 27F 
(which was used to amplify V1_V2) could be used when attempting to identify 
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organisms based on amplicon length.  Selection of primers for LH-PCR is critical to 
ensure that all bacteria are being amplified and to increase the success of identification 
based on fragment length.  The widely used primers, 27F and 355R, are based on E. coli 
sequence and should be thought of as generalized primers and not universal primers 
(Wang & Qian, 2009).  Primers that have been developed with a bioinformatics approach 
may prove to be more useful in future LH studies (Wang & Qian, 2009).   
Due to the limitations of the V1 AmpliQué database, identification using two 
regions simultaneously could not be performed.   Therefore, identification based on two 
regions has yet to be proven.  Further modification of AmpliQué and/or the use of 
different primers or variable regions may eventually lead to LH-PCR being used as an 
identification technique.  At this time, LH- PCR can still be useful when looking at a 
bacterial community as a whole. 
 
2.5.4  The eubacterial communities in CF lungs are dynamic.  The LH-PCR 
profiles provided a view of the CF bacterial community as a whole.  It is known that in 
soil and water samples, the members and their abundances change and these changes can 
be driven by external factors (Fierer & Jackson, 2006; Shade et al., 2008).  Thus, it is 
hypothesized that the bacterial community within the CF lung also changes based on 
external factors.  To understand the changes in the community, LH-PCR was used to 
profile three patients over a period of time.  Samples from patient UML were used to 
determine the bacterial community variation over a short period of time (3 hours) and 
over a long period of time (two years).  UMY and UMX were used to study how 
antibiotics may affect the lung community. 
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Sputum samples from patient UML were analyzed over the course of two years 
(M0, M3, M16, M17, M22.1, M22.2, M22.3, M22.4, and M22.5).  Five samples were 
taken on the same day every three hours for twelve hours (M22.1 - M22.5).  For both the 
V1 and the V1_V2 LH profiles, the overall bacterial community was more similar within 
the one day then across multiple time periods over two years (Figure 2.4 and 2.5).  The 
LH profiles from the samples taken in one day were not identical.  These variations may 
arise from transient bacteria that were present in the oral cavity at the time of sampling 
such as Lactobacillus from yogurt.  Analyzing the samples with both regions further 
demonstrated that bacterial communities change over time.  By combining regions, the 
data indicated increased similarity of the samples taken in one day which was a result of 
the more abundant organisms, not the less dominant amplicons in the profile that may 
represent the transient bacteria in the oral community.  The dissimilarity between the 
samples taken months apart was increased due to the presence of the more dominant 
possibly disease-causing organisms (Figure 2.4C and 2.5C).  This LH analysis is the first 
to show that colonization of the CF lung is dynamic and these changes can be tracked.   
To date the dynamics of the bacterial community in the CF lung in response to 
external drivers such as the presence of antibiotics has yet to be studied.  Thus, a short 
term study was performed in an attempt to understand how the overall community in the 
lung changes when under attack by antibiotics.  To begin, CF sputum samples from 
Patient UMX and Patient UMY were analyzed every other month for five months.  
During this time, patients were taking a combination of antibiotics. 
During the five-month period, Patient UMX was taking azithromycin, bactrim and 
tobramycin.  Shortly before the third time point, the patient stopped taking tobramycin.  
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The patient’s profiles contain a large number of V1 amplicons whose presence and 
abundance change throughout the time course (Table 2.2).  For V1_V2, Patient UMX’s 
profiles consisted predominately of the 342 bp amplicon at all time points (Table 2.2). 
This fragment was presumptively identified as P. aeruginosa which concurred with the 
patient’s clinical diagnosis. Interestingly, UMX had been prescribed tobramycin (which 
targets P. aeruginosa) for the majority of the sampling period, yet the 342 bp amplicon 
was always present in large abundance (74 – 100 %).  LH analysis with both the V1 and 
V1_V2 regions indicate a dynamic environment within the lungs of UMX.  These 
changes seen over the time period are likely to be an effect of the antibiotic regime.   
Patient UMY’s profile was more dynamic than Patient UMX.  Patient UMY’s 
sputum showed a high level of abundance for the 342 bp amplicon between the first two 
samplings  followed by a drastic decrease in the abundance of the 342 bp amplicon in the 
profile from the third sampling (Table 2.2).  This change in profile may correspond to the 
patient’s antibiotic regime; specifically, colistin replacing levaquin.  This may have 
caused the pathogen associated with that amplicon to disappear.  As the abundance of the 
342 bp amplicon decreased, a 348 bp amplicon emerged.  It is possible that as one 
pathogen was cleared, it was replaced with another bacterium that fit that niche (Boni & 
and Feldman, 2005).  The decreasing 342 bp amplicon may represent P. aeruginosa, 
which had been cultured from the patient.  Levaquin and colistin are both used to target 
against this pathogen.  There are studies that have demonstrated levaquin being less 
effective in treating P. aeruginosa than the first generation fluoroquinolones (Phillips et 
al., 2000).  Antibiotic resistant strains of P. aeruginosa are often treated with colistin 
(Canton et al., 2005; Scheld, 2003) .  It could be hypothesized that Patient UMY was 
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infected with an antibiotic resistant strain of P. aeruginosa which may have been 
susceptible to the stronger antibiotic.  The patient’s lung infection was then dominated by 
a bacterium represented by the 348 bp amplicon, which may belong to H. influenzae or 
Stenotrophomonas maltophilia.  Changes in the bacterial community were also seen in 
the V1 profiles (Table 2.2).  Due to the limitations of AmpliQué, it is not clear if similar 
changes in abundance were seen in peaks that may represent P. aeruginosa. 
The microbial community was more dynamic in UMY (a 60-year-old Caucasian 
man) than UMX (a 23 year-old Hispanic woman). The number of unique amplicons in 
UMX and UMY were eight and 14, respectively.  UMX had five (73, 77, 103, 112, and 
342 bp) and UMY had 11 (62, 72, 76, 78, 81, 91, 94, 98, 102, 112, and 342 bp) 
amplicons that were present at all three time points.  These constant amplicons may come 
from chronic colonizers that no longer respond to the treatment regimen.  The 
uniqueness, diversity and selective abundance of certain amplicons could be attributed to 
the age, gender and ethnicity.  The patients’ respective lung flora may have adapted to the 
patient’s immune response and the presence of antibiotics differently. The variations in 
profiles due to age and antibiotic treatment have been previously demonstrated (Beringer 
& Appleman, 2000; Lyczak et al., 2002).    
Clearly, LH can be used to analyze changes in a microbial community.  Although 
this study used a small sample size over a relatively short period of time, changes in the 
presence and abundance of amplicons in the LH profiles could be seen. To accurately 
identify the drivers of the community, a more comprehensive long term study needs to be 
performed.  Armed with the patient’s antibiotic information and long term sampling, it 
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should be possible to determine the effectiveness of a drug against pathogens in the CF 
lung.  This could eventually lead to more effective treatments.   
In conclusion, LH-PCR analysis detected the dynamic and complex flora that is 
present in South Florida CF patients.  Although LH-PCR could not be used to identify 
bacteria in this study, it still proved to be a useful community profiling technique.  LH-
PCR of the V1_V2 and to a greater extent the V1 region of the 16S rRNA gene can be 
used to compare microbial communities between samples.  Interpreting LH profiles may 
provide insight into the evolution of a microbial community and identify the factors that 
drive these changes.  Technologies such as pyrosequencing will likely be used to identify 
the members present in the bacterial community.  However, LH-PCR is still an accessible 
tool that can be implemented to study microbial communities. 
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Supplemental Figure 2.6:  Hypervariable region V1_V2 amplicon data graphs.  Panels A – E represents patients UMA – UME.  
Panels F – I refers to patients UML, UMM, UMN, UMO, respectively.  Panels J, K, and L represents patients UMQ, UMR, and 
UMS, respectively. Panel M represents profiles from patients UMF, UMG, UMH, UMJ, UMK, and UMT. 
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Supplemental Figure 2.7: Hypervariable region V1 amplicon data graphs.  A-H are the graphs for patients UMA-UMH, 
respectively.  I-S refers to patients UMJ-UMT, respectively. 
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Supplemental Figure 2.7 
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Chapter 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Cystic Fibrosis Lung Eubacteriome and  
Mycobiome as Revealed by 454 Sequencing” 
 
 
 
 
 111 
 
3.1  ABSTRACT  
 Community profiling and Sanger sequencing projects have been used to study the 
polymicrobial nature of the cystic fibrosis (CF) lung.  These studies have shown that the 
bacterial communities are diverse and unique to each patient.  Additionally, species 
specific PCR and culturing have demonstrated the presence of fungi in the CF lungs.  
However, the diversity of the fungal community remains to be elucidated.  In this study, 
MultiTag PyrosequencingTM (454) was used to resolve the bacterial and fungal 
community in sputa from 18 south Florida CF patients.  Sequencing results corroborated 
the polymicrobial nature of the lungs.  CF sputa contained DNA from known pathogenic 
genera, Pseudomonas, Staphylococcus, Haemophilus, Stenotrophomonas, and 
Burkholderia.  A large percentage of sequenced genera were associated with oral 
microbiota which may play a role in the progression of lung disease.  Potentially novel 
bacteria, Chryseomonas and Flavimonas were also identified.  In addition, the CF 
mycobiome dataset contained 33 genera.  Many of the species were associated with the 
environment.  Though patients were not being treated for a fungal infection, DNA from 
pathogenic species of Aspergillus, Exophilia, Cryptococcus, Wangiella, Candida, and 
Pichia were sequenced from the sputa.  The CF microbiomes were unique to each patient 
and dissimilar to the microbiomes present healthy oral rinses. 
 
Key words: cystic fibrosis, 454 sequencing, microbiome, mycobiome, eubacteriome, 
bacterial community, fungal community, MultiTag Sequencing 
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Abbreviations: CF, cystic fibrosis; BAL, bronchoalveolar lavage; MTPS, MultiTag 
Pyrosequencing; MDS, non-metric multidimensional scaling; PCO, principle coordinate 
analysis; T-RFLP, terminal restriction fragment length polymorphism 
 
3.2  Introduction 
 The major cause of morbidity and mortality in CF patients is lung disease as a 
result from chronic infections (Buzzetti et al., 2009; Patient-registry, 2008).  These 
infections are most often caused by bacteria, many of which are resistant to antibiotics.  
Pseudomonas aeruginosa, Burkholderia cenocepacia, Staphylococcus aureus, and 
Haemophilus influenzae are routinely cultured from CF sputa (Patient-registry, 2008).  
Recently, two Sanger sequencing projects have identified the presence of numerous 
bacteria, many of which were rarely if at all cultured from CF sputa or bronchiolavage 
samples (Bittar et al., 2008; Harris et al., 2007).  Based on sequence analysis, known 
pathogens, aerobic and anaerobic species were detected in the CF samples.  Emerging 
pathogens such as Stenotrophomonas maltophilia, Serratia marcescens, and 
Achromobacter xylosoxidans were also identified (Bittar et al., 2008; Harris et al., 2007).  
In addition, organisms not readily associated with CF, such as  Moxaxella cattharalis, 
Granulicatella elegans, Inquilinus limosus, Granulicatella adiacens, Rothia 
mucilaginosa, Dialister pneumosintes, Dolosigranulum pigrum, Lysobacter, and 
Coxiellaceae were identified from either bronchoalveolar or sputum samples from CF 
patients (Bittar et al., 2008; Harris et al., 2007; Rogers et al., 2003).  Oral bacteria, 
Prevotella, Veillonella, Porphyomonas, and Streptococcus were present in numerous 
samples (Bittar et al., 2008; Harris et al., 2007).  Another method, 454 sequencing, (ultra-
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deep, high throughput, parallel-sequencing), was used to analyze the lung bacterial 
community in one adolescent CF girl (Armougom et al., 2009).  In this study, 1,000 bp of 
the 16S rRNA gene present in the metagenomic DNA was amplified.  The PCR products 
were analyzed using 454 sequencing (Armougom et al., 2009).  The most commonly 
identified organisms were M. catarrhalis, D. pigrum, G. adiacens, H. influenzae and 
Streptococcus mitis.  Sequencing techniques have identified numerous bacteria in the CF 
lung eubacteriome that have previously gone undetected with culturing methods   
CF individuals can also suffer from fungal infections.  Candida albicans and 
Aspergillus fumigatus are the most commonly diagnosed fungal pathogens (Bakare et al., 
2003; Cimon et al., 2001; Mearns et al., 1967).  Other fungi such as Scedosporium 
apiospermum, Scedosporium prolificans, Aspergillus terreus, Acrophialophora fusispora, 
Exophiala dermatitidis and Penicillium emersonii have been shown to infect CF patients 
(Bakare et al., 2003; Cimon et al., 1999; Cimon et al., 2003; Cimon et al., 2005; 
Defontaine et al., 2002; Hennequin et al., 1997; Horré et al., 2004).  Recent statistics 
have shown an increase in the prevalence of fungi in the lung which may have resulted as 
a consequence of aggressive antibacterial therapy (Nagano et al., 2007).   
The prevalence of fungal infections in the CF population varies from one study to 
another.  Using culturing and microscopy analysis, A. fumigatus and C. albicans were 
detected in 45.7 % and 75. 5%, respectively of the 369 samples obtained from 94 CF 
patients over a period of time.  In another study, 24.5 % of 201 patients were culture 
positive for A. fumigatus (Burns et al., 1998).  Detection of fungal infections is crucial as 
the infection can lead to complications such as allergic bronchopulmonary aspergillosis 
(ABPA) and post-transplant fungaemia (Fahy et al., 1991; Kubak, 2002; Mastella et al., 
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2000; Nagano et al., 2007; Stevens et al., 2003)  It is also possible for a fungal infection 
to become chronic which leads to bronchitis (Nagano et al., 2007).   
The total composition of the fungal community (mycobiome) within the CF lung 
has not been well explored and many of the fungi were identified using culturing and 
microscopy.  Some fungi, such as Scediosporim and Pseudallescheria are difficult to 
identify with these methods (Horré et al., 2009; Williamson et al., 2001).  In those cases, 
molecular analysis using fungal ribosomal rRNA genes and the associated internal spacer 
regions (ITS) are employed (Bouchara et al., 2009; Hinrikson et al., 2005; Kumeda & 
Asao, 1996; Schmidt & Rath, 2003; Williamson et al., 2001; Zeng et al., 2007b).  Most 
PCR-based assays only identify one organism.  An oligonucleotide array can identify 20 
fungi simultaneously in CF samples but the panel may not include all fungi present in the 
mycobiome (Bouchara et al., 2009).  Therefore, the CF lung mycobiome may be better 
characterized with sequencing technique, such as 454 sequencing. 
The 454 sequencing technique has been used to used to analyze the fungal 
mycobiome in the healthy human mouth (Ghannoum et al., 2010).  The technique has 
also identified members of the bacterial communities present in the  healthy oral cavity, 
gut, and vagina (Aas et al., 2005; Keijser et al., 2008; Spear et al., 2008; Turnbaugh et 
al., 2009; Zaura et al., 2009).  The method has also been used to characterize the lung 
eubacteriome from one CF individual (Armougom et al., 2009).  The 454 sequencing 
technique has been shown to provide a more accurate estimation of diversity and a more 
reliable estimate of the relative abundance of bacterial species (Armougom et al., 2009; 
Quince et al., 2009; Sogin et al., 2006).   
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Sanger sequencing projects have shown the CF lung eubacteriome to be large and 
phylogenetically diverse.  Eubacteriomes are unique to each individual and the 
differences in microbiota may be influenced by host’s factors such as gender, ethnicity, 
and cftr mutation.  Therefore, it can be hypothesized south Florida CF patients 
eubacteriomes will differ and may harbor novel bacteria.  It is also likely the lung 
mycobiome is more diverse than previously determined by culturing and species-specific 
PCR.  This study proposes to resolve the eubacteriome and mycobiome associated with 
CF sputum from 19 south Florida CF patients by using MultiTag PyrosequencingTM.  
This analysis will provide a more accurate estimation of diversity for the CF lung 
microbiome.  In addition, the CF sputa microbiomes will be compared with healthy oral 
rinse microbiomes.   
 
3.3  Materials and methods  
3.3.1  Ethics statement.  Written informed consent was obtained from all 
participants in this study. Recruitment of study participants was performed according to 
protocol (number 040407-01) approved by the Human Subjects Institutional Review 
Board (IRB) of Florida International University, Miami, Fl. 
 
3.3.2  Study participants.  Sputum samples were obtained from 19 adult CF 
individuals.  The individuals were patients at the University of Miami adult cystic fibrosis 
care center. Summary demographic information of the study participants was provided in 
Table 3.1.  All CF patients were of the Caucasian race as defined by the United States 
Census Bureau.  Ethnicities, Hispanic and not Hispanic, were included in the 
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demographics (Table 3.1).  Inclusion criteria were >18 years of age, diagnosed to have 
CF, and proficient in English.  Samples were taken during routine visits or during 
exacerbations.  All participants gave an expectorated sputum sample which was 
immediately kept frozen until analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Patient Gender Ethnicity* 
CF1 Male NH 
CF2 Female NH 
CF3 Male H 
CF4 Male H 
CF5 Female NH 
CF6 Male NH 
CF7 Female H 
CF8 Male H 
CF9 Female NH 
CF10 Female H 
CF11 Female NH 
CF12 Male NH 
CF13 Male NH 
CF14 Male NH 
CF15 Female NH 
CF16 Male NH 
CF17 Male H 
CF18 Female H 
CF19 Male H 
*NH refers to non-Hispanic  
  H refers to Hispanic 
Table 3.1:  Patient demographics.  Patient number, gender and ethnicity of the study 
subjects are listed.   
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3.3.3  DNA extraction.  The sputum samples were liquefied using a freeze/boil 
method (Reischl et al., 1994).  Each sample was separated into three aliquots which were 
used for metagenomic DNA extraction.  The DNA was extracted and cleaned using the 
FastDNA® Spin Kit (Qbiogene, Irvine, CA) according to the manufacture’s protocol.  
Briefly, liquefied sputa were homogenized and cells were mechanically lysed using the 
FastPrep® instrument (Qbiogene) and the lysing matrix.  The DNA was cleaned using the 
GeneClean® procedure included in the kit.  The DNA obtained from the three aliquots 
was combined to ensure that the total DNA present in each sputum sample would be 
analyzed.  The eluted DNA was quantified and diluted to 100 ng/µL and refrigerated at 
4°C until further use.   
 
3.3.4  Metagenome analysis.  The eubacteriome and mycobiome analysis of the 
sputum samples were performed using the MultiTag PyrosequencingTM (MTPS) 
technique (Gillevet, 2006).  Bacteria were identified by sequencing the hypervariable 
region 1 and 2 (V1_V2) of the 16S rRNA gene using the forward primer 27F (5’- AGA 
GTT TGA TCM TGG CTC AG-3’) and the reverse primer 355R (5’- GCT GCC TCC 
CGT AGG AGT-3’) (Figure 1.13) (Doud et al., 2009; Suzuki et al., 1998).  Fungi were 
identified by sequencing the ITS 1 region using the forward ITS1 primer (5’-TCC GTA 
GGT GAA CCT GCG G-3’) and the reverse primer ITS2 (5’-GCT GCG TTC TTC ATC 
GAT GC-3’) (Figure 1.14) (White et al., 1990). 
MTPS technique is a variation of 454 pyrosequencing in which a molecular 
barcode is incorporated into the fusion primer (Gillevet, 2006).  In general, the fusion 
primers, referred to as Adapter A/B consist of a 20 base sequencing primer, a four base 
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sequence key (used to calibrate base calling during pyrosequencing), and a PCR primer.  
In MTPS, Adapter A also contains a 7 base “barcode”.  This barcode is used to sort the 
sequencing reads for downstream analyses.  For this experiment, a set of 42 emulsion 
PCR fusion primers were designed to amplify the microbial DNA.  The fungal Adapter A 
and B were designed to have the ITS1 and ITS2 sequences, respectively.   Similarly, the 
bacterial Adapter A and B contained the 27F and 355R primer, respectively.  Therefore, 
each DNA sample was amplified with sets of uniquely barcoded fungal and bacterial 
forward and reverse primers.  All sequences were read from the A adapter side (forward 
PCR primer) using the GS-FLX pyrosequencer (454 Life Sciences-Roche, Branford, CT).  
The incorporated nucleotides were detected by the generation of a bioluminescent signal 
that is dependent on a luciferase mediated reaction.  The intensity of the signal was 
proportional to the number of incorporated nucleotides.  The signals were detected and 
analyzed by the instrument in real time and a pyrogram composed of a series of peaks 
reflecting the DNA sequence was generated.   
 
3.3.5  Data analysis.  A custom PERL script was developed to sort the 
sequencing reads into bacterial and fungal bins per each patient.  The Ribosomal 
Database Project II (Release 9) Bayesian classifier was used to obtain a classification for 
each sequence (Maidak et al., 1999).  The annotations for each sequence were 
downloaded, and the PERL script sorted the output into taxa per sample.  Using the 
PERL script, the fungal ITS sequencing data was automatically compared against 
GenBank (Benson et al., 2008) and identity of the sequence was determined at a 98 % 
cutoff.  The classifications per sequence were again sorted into taxa per sample.  The 
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final output of the PERL script for both the bacterial and fungal data was a table (one 
table per community) showing the taxon in each sample and its associated abundance 
determined as number of taxon sequence reads divided by total number of sequenced 
read per sample   
The bacterial data were imported into Primer 5 (Primer-E, Ltd, Ivybridge, United 
Kingdom) and square root transformed to reduce the influence of the more common 
organisms (Grant & Ogilvie, 2003; Mills et al., 2003).  To determine similarity between 
bacterial communities, a similarity matrix was calculated using the Bray-Curtis similarity 
index (Bray & Curtis, 1957; Doud et al., 2009; Mills et al., 2006; Moreno et al., 2006; 
Rees et al., 2004).  Principal coordinate analysis (PCO) was performed on the Bray 
Curtis distance matrix generated from the CF communities using Multivariate Statistical 
Package, MVSP (Kovach, Wales, UK; (Ghannoum et al., 2010).  Graphically, the PCO 
analysis plots each community as a rotation of data points in multidimensional space so 
that the axis with the greatest variance is the first principle component axis (Ghannoum et 
al., 2010).  This analysis will group or separate the samples in the dataset revealing which 
samples are more similar in the dataset.  PCO analyses were used to identify similarities 
between bacterial communities, bacterial community and age/gender, and between CF 
sputa and healthy oral rinse eubacteriomes.   
Similarities between fungal communities and host’s age/gender were determined 
using the same method.  Healthy fungal communities from oral rinses was also compared 
to the CF sputa mycobiomes (Ghannoum et al., 2010).  Presence/absence of taxa were 
used to construct a Sørenson similarity matrix between the two communities (Sorensen, 
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1948).  Unweight pair group average clustering was performed on the matrix and results 
were plotted on a dendograph. 
 
 
3.4  Results 
 3.4.1  Participant demographics.  The CF samples were obtained from 11 males 
and eight females.  Of these individuals, 11 were Caucasian of non-Hispanic origin and 
eight were Caucasian of Hispanic origin (Table 3.1). 
 
 3.4.2  Identification of bacterial taxa in CF samples.  Of the 19 samples, 18 
samples produced on average 2,809 MTPS reads.  Only 11 reads were obtain from 
CF_11.  Thus, the sample from a female of non-Hispanic origin was removed from all 
bacterial analyses.  Using a cutoff of ≥ 1% of abundance, a total of 34 taxa were 
identified from the remaining 18 CF samples (Figure 3.1 and Table 3.2).  Sputum 
samples contained between four and 16 different taxa with the average of 9.6 ± 3.3 
genera.  Sixteen samples contained sequences belonging to Pseudomonas (absent from 
CF4 and CF16) and Streptococcus (absent from CF2 and CF18).  Chryseomonas was 
present in 15 samples (absent from CF2, CF4, and CF16).  Fourteen samples contained 
sequences from Micrococcineae (absent from CF10, CF13, CF18, and CF19) and 
Prevotella (absent from CF1, CF4, CF7, and CF17).  Ten taxa (Burkholderia, 
Coriobacteriaceae 2, Elkenella, Haella, Moryella, Propionbacterineae, Schlegelella, 
Spingobacterium, and Stenotrophomonas) were not present in multiple samples.  The 
most abundant taxon in 14 samples was Chryseomonas.  CF18 was more abundant with  
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Chryseomonas Coriobacterineae Eikenella
Flavimonas Fusobacterium Gemella
Haemophilus Hallella Lactobacillus
Leptotrichia Megasphaera Micrococcineae
Moryella Neisseria Oribacterium
Porphyromonas Prevotella Propionibacterineae
Proteus Pseudomonas Schlegelella
Shigella Shuttleworthia Sphingobacterium
Staphylococcus Stenotrophomonas Streptococcus
Veillonella
Figure 3.1:  Bacteria taxon present ≥1% abundance in CF sputum samples.  Each 
color represents a different genus.  The height of the color represents the abundance of 
the reads for that genus in comparison to the total number of sequencing reads for the 
sample.  
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Table 3.2:  Frequency distribution (%) of bacteria present with at least 1 % abundance in the CF sputa eubacteriome 
Organism CF1 CF2 CF3 CF4 CF5 CF6 CF7 CF8 CF9 CF10 CF12 CF13 CF14 CF15 CF16 CF17 CF18 CF19 #
Achromobacter 10.42 4.24 6.05 5.41 4
Actinomycineae 4.90 1.98 1.13 3.48 2.70 2.16 4.31 7
Burkholderia 23.47 1
Campylobacter 1.03 1.22 2
Capnocytophaga 1.09 5.03 2
Carnobacteriaceae 4.60 2.13 1.75 1.51 2.25 1.65 1.44 7
Chryseomonas 67.03 15.73 23.00 25.91 58.39 52.11 14.29 42.93 27.45 19.74 6.45 48.68 32.53 44.08 38.76 15
Coriobacterineae 1.76 1
Eikenella 1.72 1
Flavimonas 23.18 1.39 1.18 3.07 1.59 1.40 1.02 1.52 8
Fusobacterium 1.30 2.15 1.91 3.84 2.30 5
Gemella 2.69 1.35 1.16 1.13 2.18 1.32 1.29 2.74 8
Haemophilus 1.13 1.72 1.37 9.62 3.57 1.97 6
Hallella 1.12 1
Lactobacillus 1.74 1
Leptotrichia 15.17 19.67 1.14 9.09 7.34 1.91 1.14 7
M egasphaera 1.12 1.53 2
M icrococcineae 5.02 24.37 14.55 3.55 30.31 4.12 1.45 3.59 1.42 1.43 16.62 1.79 2.51 1.46 14
M oryella 2.44 1
Neisseria 2.23 2.85 1.85 4.37 8.20 1.06 6
Oribacterium 1.19 1.45 2
Porphyromonas 15.76 6.18 3.34 6.53 4
Prevotella 2.38 9.34 3.83 21.02 1.74 22.05 2.44 5.91 13.67 2.90 6.61 18.35 7.23 2.09 14
Propionibacterineae 1.85 1
Proteus 47.58 2.24 32.79 3
Pseudomonas 4.04 2.38 6.32 12.33 15.50 15.63 17.95 3.74 29.09 1.45 6.88 3.82 12.00 18.23 45.07 12.51 16
Schlegelella 7.37 1
Shigella 1.46 1.16 2
Shuttleworthia 1.74 2.04 2
Sphingobacterium 2.12 1
Staphylococcus 35.38 14.63 30.72 4.09 4
Stenotrophomonas 7.55 1
Streptococcus 6.62 34.09 4.53 14.16 9.50 9.22 10.02 4.93 4.88 14.82 30.71 23.34 6.08 26.63 4.12 6.47 16
Veillonella 2.66 4.08 7.63 1.91 2.21 7.80 7.68 7
Count* 6 10 11 6 10 7 8 9 11 6 11 10 16 12 15 7 4 14  
 
  
#  is the total samples that contained that specific taxon 
* is the total number of taxa present per sample 
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hits belonging to the Pseudomonas genus.  Micrococcineae, Proteus and Prevotella were 
the most sequenced organism in CF2, CF4 and CF15, respectively (Table 3.2). 
 
3.4.3  Relationship between gender,  ethnicity and the eubacteriome.  A PCO 
analysis was performed on the Bray-Curtis similarity matrix constructed from the CF 
eubacteriomes to determine if there was an association between the communities and the 
patient gender and/or ethnicity (Figure 3.2).  No clustering was present on the PCO plot 
regardless of bacterial community profile, patient gender, or ethnicity. 
 
3.4.4  Healthy oral eubacteriome.  Oral rinse samples were obtained from 25 
healthy individuals (data obtained from collaborator).  The bacterial community for each 
sample was determined using MTPS.  The data was processed in the same manner as the 
CF data.  Only taxa with greater than 1 % abundance were included in the analysis (Table 
3.3).  The 25 samples had between eight and 18 bacterial taxa with the average of 12.84 ± 
2.37 taxa.  Prevotella, Streptococcus, and Veillonella were present in all samples.  
Micrococcineae was present in all except for H9.  Twenty-three taxa were not present in 
multiple samples i.e. each taxon was only sequence from one sample, and not necessarily 
the same sample.  The most abundant organism in 12 samples was Streptococcus.  
Neisseria and Prevotella were most abundant in six (H8, H11, H12, H21, H23, and H25) 
and five (H2, H3, H6, H18, H24) samples, respectively.  Porphyromonas, Lepotrichia, 
and Haemophilus and were found to be most abundant in one sample (H9, H10, and H13, 
respectively).   
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Figure 3.2:  Relationship between the host and the eubacteriome.  Principal coordinate 
analysis (PCO) was used to represent the relationship between the bacterial 
communities as represented by the Bray-Curtis similarity matrix.  Lilac squares are 
samples from females.  Males are represented by green squares.  Numbers in black 
indicate samples from non-Hispanic subjects while red text represents Hispanic 
samples. 
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Table 3.3:  Frequency distribution (%) of bacteria present with at least 1 % abundance in the healthy mouth eubacteriome 
 
Organism H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14 H15 H16 H17 H18 H19 H20 H21 H22 H23 H24 H25 #
Achromobacter 21.01 1
Actinobacillus 3.61 4.77 1.03 1.61 1.89 5
Actinomycineae 1.86 2.09 2.71 2.87 2.45 5.67 1.53 2.16 4.15 1.75 3.71 11
Aggregatibacter 1.13 1.88 1.38 3
Alkaliflexus 1.17 1
Aquitalea 1.26 1
Bacteroides 1.91 1.33 1.32 1.93 1.39 1.89 1.59 3.71 8
Bergeyella 3.58 1
Bulleidia 1.58 1
Burkholderia 1.18 1
Campylobacter 1.55 1.69 1.26 2.06 2.30 1.02 6
Capnocytophaga 1.39 2.97 2.18 2.12 4
Carnobacteriaceae 2 2.01 1.69 1.67 3.19 1.53 1.28 1.64 2.27 2.32 3.67 1.14 1.06 1.18 13
Coriobacterineae 1.65 1
Corynebacterineae 2.14 1
Delftia 2.02 1
Eikenella 1
Elizabethkingia 3.22 1
Empedobacter 1.83 1
Enhydrobacter 1.30 1
Filifactor 4.22 1
Fusobacterium 2.79 6.23 4.50 6.76 7.38 3.26 4.58 7.76 5.14 9.21 1.27 4.74 1.75 2.39 5.67 2.90 3.42 5.49 3.22 3.18 4.34 21
Gemella 5.06 2.06 1.88 2.62 4.91 5.30 1.45 2.67 4.54 1.90 1.81 11
Haemophilus 8.15 12.98 9.75 11.13 9.15 5.24 6.11 1.77 5.89 6.54 12.44 24.40 16.64 7.87 17.16 12.58 6.60 7.37 10.18 8.42 2.10 8.50 8.14 14.26 24
Hallella 1.51 1.02 2
Kingella 1.22 1
Kordia 1.18 1.41 1.52 1.22 1.48 1.05 6
Leptotrichia 10.42 2.46 1.79 1.03 1.17 1.15 4.63 11.52 3.02 3.55 1.01 6.20 1.06 1.36 14
M egasphaera 1.21 1
M icrococcineae 3.20 10.15 2.98 7.09 1.13 1.54 11.32 6.82 2.40 7.68 7.14 10.61 13.44 9.27 4.81 1.01 13.53 11.80 2.71 2.97 2.69 1.90 8.26 2.32 24
M ycoplasma 1.39 1.96 2
Neisseria 15.02 11.91 2.12 22.90 21.81 17.36 27.81 11.34 10.40 20.21 24.53 11.31 1.45 11.81 13.94 3.27 22.03 24.53 33.07 6.22 21.78 15.13 22
Oribacterium 1.03 1.25 1.04 2.17 1.15 2.06 1.63 3.37 1.69 9
Pasteurella 1.75 1
Pelomonas 1
Phocoenobacter 1.17 1.11 2
Porphyromonas 1.24 4.22 16.94 1.15 11.86 3.95 5.34 22.49 6.38 2.23 3.02 3.24 1.16 4.28 7.89 2.98 3.18 8.23 1.26 7.32 8.44 21
Prevotella 10.01 14.52 19.99 9.55 4.85 19.09 14.98 6.11 15.22 6.34 16.54 16.78 13.80 16.17 5.76 2.16 11.06 22.33 4.96 3.85 8.05 1.76 13.58 26.42 9.86 25
Propionibacterineae 9.83 1
Proteiniphilum 1.32 1.14 1.36 3
Ralstonia 1.01 1
Schlegelella 1.72 3.16 1.73 1.54 3.52 1.23 2.84 4.35 8
Sebaldella 5.37 1
Selenomonas 1.05 1
Sneathia 1.09 1
Sphingomonas 1.34 1
Streptococcus 18.63 9.93 15.02 28.48 23.53 14.61 38.51 19.79 6.37 10.47 8.77 6.75 16.10 21.41 38.00 30.29 30.56 15.63 28.14 28.46 23.06 26.39 17.68 25.17 14.56 25
Tannerella 1.32 1.19 2
Treponema 4.04 2.41 2
Veillonella 6.50 8.98 12.57 4.54 3.48 4.10 7.46 7.20 2.00 7.70 3.32 8.72 3.47 12.10 7.11 1.51 9.92 10.16 1.87 1.22 5.30 3.19 8.16 12.08 5.21 25
Count* 13 15 12 10 13 12 12 12 16 18 12 14 11 12 8 15 13 12 12 15 8 16 14 11 15  
 #  is the total samples that contained that specific taxon 
* is the total number of taxa present per sample 
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3.4.5  Comparison of CF and healthy eubacteriomes.  Twelve taxa were 
present in CF samples but not in healthy samples (Table 3.4).  Common CF pathogens 
Pseudomonas, Staphylococcus, and Stenotrophomonas were only sequenced in the CF 
samples.  In addition, Chryseomonas, Eikenella, Flavimonas, Lactobacillus, Moryella, 
Proteus, Shigella, Shuttleworthia, and Sphingobacterium were exclusively present in CF 
samples.  Twenty-seven taxa were unique to healthy oral samples (Table 3.4).  A 
similarity index of the two dataset was calculated using the Bray-Curtis similarity index 
on the square root transformed abundance data.  The similarity matrix was used in the 
PCO analysis.  The PCO graph showed the data points (blue triangles) representing the 
healthy oral rinse microbiomes clustered closer to each other than the CF microbiomes 
(red circles) (Figure 3.3).   
 
Table 3.4: Bacteria sequenced in CF sputa and/or mouth rinse from healthy individuals 
 
 
Only in CF
Chryseomonas Actinobacillus Kordia Achromobacter Neisseria
Eikenella Aggregatibacter Mycoplasma Actinomycineae Oribacterium
Flavimonas Alkaliflexus Pasteurella Burkholderia Porphyromonas
Lactobacillus Aquitalea Pelomonas Campylobacter Prevotella
Moryella Bacteroides Phocoenobacter Capnocytophaga Propionibacterineae
Proteus Bergeyella Proteiniphilum Carnobacteriaceae 2 Schlegelella
Pseudomonas Bulleidia Ralstonia Coriobacterineae Streptococcus
Shigella Corynebacterineae Sebaldella Fusobacterium Veillonella
Shuttleworthia Delftia Selenomonas Gemella
Sphingobacterium Elizabethkingia Sneathia Haemophilus
Staphylococcus Empedobacter Sphingomonas Hallella
Stenotrophomonas Enhydrobacter Tannerella Leptotrichia
Filifactor Treponema Megasphaera
Kingella Micrococcineae
Only in Healthy Present in Both
 127 
 
 
 
 
 
 
 
 
3.4.6  Identification of fungal taxa in CF samples.  Of the 19 samples, 18 
samples produced between 5,467 and 45,178 reads with the average read count of 21,976.  
Only 3453 reads were obtained from CF_10, a female Hispanic patient.  The number of 
sequencing reads is low in comparison to the rest of the samples and thus CF_10 was 
removed from all fungal analyses.  Using a cutoff of ≥ 1% of abundance, 33  taxa were 
identified from the remaining 18 CF samples (Figure 3.4 and Table 3.5).  Sputum 
samples contained between 13 and 30 different taxa with an average of 26 ± 3 (Table 
3.5).  Sample CF1 was the most diverse community with 30 taxa.  Twenty-nine and 28 
taxa were present CF16 and CF5, respectively.  Twenty-seven taxa were sequenced in  
Figure 3.3:  PCO analysis of healthy mouth rinse and CF eubacteriomes.  Bray-Curtis 
similarity matrix and PCO was used to compare the sequenced eubacteriomes from 
healthy mouth rinse samples (blue triangles) and CF sputa (red circles).   
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Figure 3.4:  Fungi genera present in ≥1% abundance in CF sputum samples.  Each 
color represents a different genus.  The height of the color represents the abundance of 
the reads for that genus in comparison to the total number of reads for the sample.  
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Table 3.5:  Frequency distribution (%) of fungi present with at least 1 % abundance in the CF sputa mycobiome
Organism CF1 CF2 CF3 CF4 CF5 CF6 CF7 CF8 CF9 CF11 CF12 CF13 CF14 CF15 CF16 CF17 CF18 CF19 #
Amanita 1.06 1
Aspergillus 2.10 2.93 2.67 3.13 2.60 2.89 1.78 2.29 2.76 2.59 2.46 2.80 2.92 2.51 2.16 2.58 2.32 1.69 18
Blastocladiella 1.05 1.44 1.33 1.59 1.31 1.44 1.18 1.38 1.28 1.31 1.29 1.46 1.28 1.06 1.29 1.19 1.30 17
Bulleromyces 1.07 1.48 1.35 1.60 1.32 1.46 1.23 1.39 1.30 1.33 1.31 1.47 1.30 1.12 1.32 1.21 1.32 17
Candida 5.42 4.99 3.31 4.84 4.47 1.78 5.26 1.39 8
Capronia 5.68 6.07 5.82 6.44 5.59 5.94 4.24 5.26 6.03 5.25 5.58 5.41 5.97 5.21 5.18 5.48 5.20 5.52 18
Cladophialophora 3.52 3.08 3.09 3.22 2.95 3.01 2.34 2.78 3.23 2.62 2.90 2.78 3.00 2.60 2.91 2.83 2.73 2.86 18
Cladosporium 6.85 1.80 1.43 2.31 2.39 1.07 6
Cryptococcus 1.07 1.49 1.36 1.61 1.32 1.46 1.21 1.39 1.30 1.33 1.31 1.48 1.29 1.12 1.31 1.21 1.32 17
Debaryomyces 1.08 1.49 1.36 1.61 1.32 1.46 1.23 1.40 1.30 1.34 1.31 1.48 1.30 1.12 1.32 1.21 1.32 17
Dipodascus 1.07 1.49 1.36 1.61 1.32 1.46 1.23 1.40 1.30 1.33 1.31 1.49 1.30 1.12 1.32 1.21 1.32 17
Eutypella 1.03 1
Exophiala 1.08 1.49 1.36 1.61 1.32 1.46 1.23 1.40 1.31 1.34 1.31 1.49 1.30 1.13 1.32 1.23 1.33 17
Fonsecaea 1.08 1.49 1.36 1.61 1.32 1.46 1.23 1.40 1.31 1.34 1.31 1.49 1.30 1.13 1.32 1.23 1.33 17
Geotrichum 1.08 1.49 1.36 1.61 1.32 1.46 1.23 1.40 1.31 1.34 1.31 1.49 1.30 1.13 1.32 1.23 1.33 17
Glomus 1.08 1.50 1.36 1.61 1.32 1.46 1.23 1.40 1.31 1.34 1.31 1.49 1.30 1.13 1.32 1.23 1.33 17
Hortaea 2.76 1.32 2
Hypocrea 2.17 1.42 4.49 2.27 2.22 1.64 1.98 2.30 2.09 1.81 1.98 11
M etschnikowia 1.04 1.44 1.32 1.55 1.29 1.44 1.15 1.36 1.29 1.31 1.28 1.46 1.25 1.06 1.27 1.18 1.29 17
M ucor 1.04 1.44 1.32 1.55 1.29 1.44 1.15 1.37 1.28 1.31 1.29 1.46 1.27 1.06 1.28 1.18 1.29 17
M yrothecium 12.11 1.01 4.75 0.00 7.94 2.37 24.79 12.62 2.68 12.23 8.95 10.89 1.54 12.70 11.32 10.00 11.62 3.10 17
Olpidium 1.08 1.49 1.36 1.61 1.32 1.46 1.23 1.40 1.31 1.34 1.31 1.49 1.30 1.13 1.32 1.23 1.33 17
Penicillium 2.13 2.98 2.71 3.21 2.64 2.92 1.89 5.28 2.78 2.61 2.73 2.62 3.06 2.75 2.23 2.63 5.03 13.46 18
Phialophora 4.31 3.17 3.56 3.35 4.01 3.36 6.31 4.71 3.26 4.82 4.27 4.59 3.24 4.83 4.35 4.43 4.40 3.20 18
Pichia 15.61 21.49 19.81 23.21 19.35 21.46 13.73 17.12 20.46 19.28 19.71 19.25 21.88 18.83 15.99 19.10 17.61 19.42 18
Rhinocladiella 2.15 2.99 2.72 3.22 2.65 2.93 1.90 2.46 2.79 2.62 2.68 2.62 2.97 2.60 2.27 2.64 2.46 2.66 18
Rhizoctonia 14.82 19.53 17.80 21.03 17.65 19.27 13.20 16.33 18.44 18.45 18.11 17.90 19.48 17.97 14.67 18.05 16.52 17.33 18
Rhodosporidium 1.08 1.49 1.36 1.61 1.32 1.46 1.23 1.40 1.31 1.34 1.31 1.49 1.30 1.13 1.32 1.23 1.33 17
Rhodotorula 1.08 1.49 1.36 1.61 1.32 1.46 1.23 1.40 1.31 1.34 1.31 1.49 1.30 1.13 1.32 1.23 1.33 17
Saccharomyces 8.29 1
Schizosaccharomyces 4.32 4.48 4.51 4.83 4.68 4.61 5.09 4.83 4.43 5.05 4.85 4.92 4.59 5.04 6.51 4.86 4.78 4.27 18
Tricholoma 2.15 2.99 2.72 3.22 2.65 2.93 1.90 2.46 2.79 2.64 2.68 2.62 2.97 2.60 2.27 2.64 2.46 2.66 18
Wangiella 1.38 1
Count* 30 26 27 24 28 26 13 26 27 26 27 26 26 26 29 27 26 26   
#  is the total samples that contained that specific taxon 
* is the total number of taxa present per sample 
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four samples (CF3, CF9, CF12, and CF17).  Twenty-six taxa were present in nine 
samples (CF2, CF6, CF8, CF11, CF13, CF14, CF15, CF18, and CF19).  Twenty-four and 
13 taxa were identified from samples CF4 and CF7, respectively.   
Ten genera were present in all 18 samples (Aspergillus, Capronia, Penicillum, 
Phialophora, Pichia, Rhinocladiella, Rhizoctonia, Schizosaccharomyces, and 
Tricholoma).  Fiveteen genera were also common in 17 samples (Blastocladiella, 
Bulleromyces, Cryptococcus, Debaryomyces, Dipodascus, Exophiala, Fonsecaea, 
Geotrichum, Glomus, Metschnikowia, Mucor, Myrothecium, Rhodosporidium, and 
Rhodotorula.  Sequences for Amanita and Saccharomyces were sequenced in sample 
CF16.  Eutypella and Wangiella were present in CF1.  The species for each genera are 
listed in Supplemental Table 3.8. 
In regards to abundance, the most sequenced genus in 17 samples was Pichia with 
sequences from P. anomala, P. membranaefaciens, and Pichia sp.  CF7 was the 
exception with a 24.8 % abundance for the genus Myrothecium.  The second most 
abundant genera in all 17 samples was Rhizoctonia (Table 3.5). 
 
3.4.7  Relationship between gender and ethnicity and the mycobiome.  A 
Bray-Curtis similarity matrix was constructed from the fungal abundance table.  The 
results were plotted using PCO to identify relationships between the communities and the 
gender and/or ethnicity of the subjects (Figure 3.5).  No clustering of community based 
on gender and/or ethnicity was seen. 
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 3.4.8  Healthy oral mycobiome.  Fungal DNA was sequenced from 20 oral rinse 
samples from healthy individuals.  The data were analyzed separately from CF sequences 
and have been published (Ghannoum et al., 2010).  With author’s permission, the 
summary of results and tables showing the genera and species (≥1% of the community) 
identified in the oral rinse samples have been included (Table 3.6 and Supplemental 
Table 3.9).  All samples contained organisms identified as non-culturable; this group was 
included in all diversity accounts.  Between three (H14) and 16 (H2) genera were 
Figure 3.5:  Relationship between the host and the fungal community.  Principal 
coordinate analysis was used to represent the relationship between the fungal 
communities as represented by the Bray-Curtis similarity matrix.  Lilac squares are 
samples from females.  Males are represented by green squares.  Numbers in black 
indicate samples from non-Hispanic subjects while red text represent Hispanic samples.  
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sequenced from the healthy dataset with the average diversity of 10.85 ± 3.07.  Fifteen 
genera were present in two samples (H10 and H16).  Thirteen genera were sequenced 
from H1, H8, and H19.  Twelve genera were identified in three samples (H6, H7, 
andH18).  Eleven genera were sequenced H13 and H17.  Three samples had ten genera 
(H5, H9, and H11) while H3 was the only samples with nine fungal taxa.  Eight genera 
were present four samples (H4, H12, H15, and H18) (Ghannoum et al., 2010). 
Excluding the non-culturable group, the most commonly sequenced genus was 
Candida (15/20) followed by Cladosporium (13/20), Auereobasidium (10/20) and the 
family Saccharomycetales (10/20) (Table 3.6).  Thirty-nine fungal taxa were not present 
in more than one sample (Ghannoum et al., 2010).  The unculturable group was the most 
abundant in 12 samples.  Cladosporim was the most abundant sequence in H11, H13, and 
H15.  Schizosaccharomyces, Aspergillus, Saccharomyces, Nigrospora, and Ophiostoma 
were the most abundant taxon in H1, H8, H9, H12, and H20, respectively (Table 3.6).  
The species present for each genera were listed in Supplemental Table 3.9. 
 
3.4.9 Comparison of CF and healthy mycobiomes.  To compare the 
communities, a Sørenson similarity matrix was calculated based on the presence/absence 
of organisms sequenced in the two communities (Sorensen, 1948).  The matrix was used 
for unweight pair group average clustering.  The results, represented on a dendograph, 
showed no healthy mycobiomes clustered with the CF mycobiomes (Figure 3.6).  There 
were 22 genera that were sequenced in CF sample and not found in the healthy samples 
(Table 3.7).  In addition, there were 63 genera unique to the healthy samples.  Eleven 
genera but only one organism, C. albicans, were present in both datasets.   
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Table 3.6:  Frequency distribution (%) of fungi present with at least 1 % abundance in 
the healthy oral mycobiome   
Organism H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14 H15 H16 H17 H18 H19 H20 #
Acremonium 1.17 1
Alternaria 3.10 1.84 1.03 1.57 2.72 3.32 2.82 1.94 8
Amanita 5.04 1
Ascomycete 3.00 2.26 2
Aspergillus 8.50 3.90 8.79 34.75 12.07 2.77 4.03 7
Atractylodes 6.03 7.23 2
Aureobasidium 6.49 4.70 2.35 1.94 11.29 11.76 3.02 5.96 4.52 6.91 10
Avena 5.04 1
Bagnisiella 7.99 1
Campylobacter 2.47 1
Candida 1.44 5.47 12.05 11.24 0.00 11.81 14.39 1.05 2.27 14.64 14.98 2.97 2.41 1.18 2.58 2.69 15
Chaetomium 1.24 1
Cladosporium 1.55 2.47 7.39 5.41 3.30 56.18 3.49 31.83 42.02 3.95 14.08 15.70 2.42 13
Claviceps 1.20 1
Clavispora 2.46 1
Conoplea 3.40 1
Corynespora 2.42 1
Cryptococcus 1.06 3.79 2.45 5.55 4
Cystofilobasidium 3.66 1
Davidiella 1.06 1
Dothideomycete 10.72 1.45 4.11 3
Dothioraceae 3.01 1.73 1.94 5.34 4.20 1.61 2.77 1.29 2.34 9
Emericella 1.73 1.01 2
Epicoccum 1.26 1
Eurotium 10.97 1.30 4.74 1.44 17.80 5
Filobasidiales 1.85 1
Flammulina 8.83 1
Fusarium 4.08 2.18 2.00 2.20 3.70 5.26 6
Gibberella 1.66 1.65 3.91 17.90 4
Gigaspora 1.15 1
Glomus 5.40 13.14 2.02 1.82 7.15 5
Guignardia 5.04 1
Hormonema 1.03 1.18 2
Hypocreales 1.03 5.16 2
Issatchenkia 1.65 1
Lasiodiplodia 2.87 1
Lecania 4.45 1
Lewia 1.10 2.36 2
M acrophomina 3.54 1
Nectria 1.03 1
Nigrospora 1.24 48.37 2
Ochroconis 3.45 7.65 2
Ophiostoma 41.33 1
Orpinomyces 2.09 1
Paecilomyces 1.08 1.61 2
Penicillium 2.81 12.82 1.92 3
Peziza 3.71 1
Phaeosphaeria 1.51 1
Phoma 2.55 1.72 2
Pichia 1.10 1.13 2
Pleosporaceae 8.39 1.15 2
Pongo 4.03 1
Pueraria 1.44 1
Pyrenophora 2.11 1
Rhizopogon 6.10 1
Saccharomyces 10.02 49.05 2.47 1.18 3.39 29.39 6
Saccharomycetales 5.64 13.65 1.11 12.36 5.99 8.04 1.85 18.09 1.41 7.26 10
Schizophyllum 14.75 2.57 2.22 3
Schizosaccharomyces 20.10 1.10 2
Sebacina 1.84 1
Sordariomycete 1.70 1.32 2
Stachybotrys 6.18 1.34 1.20 3
Stemphylium 6.45 1
Subulispora 2.47 1
Teratosphaeria 1.24 1.87 17.14 1.12 17.66 16.81 1.09 10.87 5.37 9
Torulaspora 2.05 1
Tremellales 1.87 1
Trichaptum 2.34 1
Trichocomaceae 2.61 2.80 2.27 3
Trichosporon 1.10 4.12 2
Verticillium 1.37 1
Wallemia 7.31 1
Xylariales 7.71 31.27 2
Zygosaccharomyces 3.96 0.00 1
Non-culturable 16.37 34.44 34.98 52.08 57.11 53.02 29.47 25.61 20.80 44.69 1.94 8.32 19.92 62.26 6.72 31.85 39.03 34.34 53.39 6.09 20
Count* 13 16 9 8 10 12 12 13 10 15 10 8 11 3 8 15 11 12 13 8   
#  is the total samples that contained that specific taxon 
* is the total number of taxa present per sample 
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Table 3.7: Fungi sequenced in CF sputa and/or mouth rinse from healthy individuals 
Only in CF Only in Healthy Present in Both 
Blastocladiella Acremonium Nectria Amanita 
Bulleromyces Alternaria Nigrospora Aspergillus 
Capronia Ascomycete Ochroconis Candida 
Cladophialophora Atractylodes Ophiostoma Cladosporium 
Debaryomyces Aureobasidium Orpinomyces Cryptococcus 
Dipodascus Avena Paecilomyces Glomus 
Eutypella Bagnisiella Peziza Hypocreales 
Exophiala Camplobacter Phaeosphaeria Penicillium 
Fonsecaea Chaetomium Phoma Pichia 
Geotrichum Claviceps Pleosporaceae Saccharomyces 
Hortaea Clavispora Pongo Schizosaccharomyces 
Metschnikowia Conoplea Pueraria   
Mucor Corynespora Pyrenophora   
Myrothecium Cystofilobasidium Rhizopogon   
Olphidium Davidiella Saccharomycetales   
Phialophora Dothideomycete Schizophyllum   
Rhinocladiella Dothioraceae Sebacina   
Rhizoctonia Emericella Sordariomycete   
Rhodosporidium Epicoccum Stachybotrys   
Rhodotorula Eurotium Stemphylium   
Tricholoma Filobasidiales Subulispora   
Wangiella Flammulina Teratosphaeria   
 
Fusarium Torulaspora   
  Gibberella Tremellales   
  Gigaspora Trichaptum   
  Guignardia Trichocomaceae   
  Hormonema Trichosporon   
  Issatchenkia Verticillium   
  Lasiodiplodia Wallemia   
  Lecania Xylariales   
  Lewia Zygosaccharomyces   
  Macrophomina     
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Figure 3.6: Relationship between CF sputa and healthy oral rinse mycobiomes.  A 
Sørenson similiarity matrix based on presence/absence of fungi was used with 
unweighted pair group average clustering to determine the similarity between CF and 
healthy oral fungal communities.   The length of the branch connecting two samples 
indicates the dissimilarity between the samples.   
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3.5  Discussion 
 The leading cause of morbidity and mortality in CF is lung disease is a result of 
chronic infections.  Through the use of molecular techniques, the CF lung was shown to 
contain numerous bacteria.  Sanger sequencing projects have identified both known and 
novel pathogens revealing a complex bacterial community (Bittar et al., 2008; Harris et 
al., 2007).  Though fungal infections occur in the CF lung, the composition of the 
community has not been determined.  This study further characterizes the eubacteriome 
and mycobiome by identifying organisms using MTPS which has been shown to provide 
a more accurate estimation of diversity.  In addition, the CF microbiomes from 18 sputa 
samples were compared to the communities in healthy oral samples.   
 
3.5.1  MTPS shows greater diversity in the CF bacterial community as 
compared to clonal sequencing.  The sputa samples were sequenced for bacteria using 
the first two hypervariable regions of the 16S rRNA gene.  After the data was processed, 
every sample was revealed to contain anywhere from four to 16 genera with an average 
of 9.6 ± 3.3 genera.  The diversity per patient was greater than the previous 
cloning/sequencing study by Bittar et al. (one to 14 with an average 7.2 ± 3.9 species) 
(Bittar et al., 2008).  The sequences in this study were identified to the genus level or 
higher.  It is likely that multiple species were present for some genera which would 
further increase the diversity of organisms in the lung.  As with other 454 sequencing 
studies, the estimation of diversity within the CF sputa community was higher than other 
sequencing and community profiling methods have shown (Armougom et al., 2009; 
Quince et al., 2009; Sogin et al., 2006).    
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The number of genera associated with CF dataset was similar to the earlier clonal 
sequencing studies.  In total, sequences were identified from 34 genera.  In comparison, 
the Sanger sequencing study using sputa by Bittar et al. identified 53 species from 32 
genera (Bittar et al., 2008).  The other study by Harris et al. sequenced DNA belonging to  
65 species from 35 defined genera and one unidentified organism (Harris et al., 2007).  
All three studies highlighted the bacterial diversity within the CF lung. 
 
3.5.2 Common and emerging pathogenic bacteria are present in CF lungs.  
CF samples are routinely culture positive for Burkholderia, Haemophilus, Pseudomonas, 
and Staphylococcus.  Therefore, it was not surprising to identify these pathogens from the 
samples (Figure 3.1 and Table 3.2).  Of these organisms, Pseudomonas was present in 16 
of the 18 samples.  This was expected as P. aeruginosa is quite common in adult patients 
(Patient-registry, 2008).  Haemophilus and Staphylococcus were present in some 
samples.  This agrees with epidemiology reports which show that less than 10 % and less 
than 40 % of patients at the age of 35 have culturable Haemophilus and S. aureus 
infections, respectively (Patient-registry, 2008).  Though Burholderia cenocepacia is 
associated with CF, it was surprising to identify Burkholderia sequences in one sample at 
a 23.4 % abundance.  This individual has never been culture positive for any members of 
the Burkholderia cenocepacia complex.  Burkholderia infections are extremely difficult 
to treat and are considered a poor indication of the prognosis for the patient (Jones et al., 
2004).  The identity of the species should be determined using other techniques to ensure 
the patient is undergoing proper treatment.      
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There are other pathogens that are cultured less frequently from CF sputa (De 
Baets et al., 2007; Demko et al., 1998; Goss et al., 2004; Lambiase et al., 2009; Mentasti 
et al., 2008; Ojeda-Vargas et al., 1990; Reina et al., 1992; Spicuzza et al., 2009).  The 
less prevalent pathogens Achromobacter, Stenotrophomonas, Proteus, and 
Sphingobacterium were also sequenced from the samples.  Of these genera, Proteus was 
the only organism to dominate a community (CF4).  Pseudomonas was not present in the 
sample which may suggest they share similar resources and Proteus outcompeted 
Pseudomonas for the niche (Figure 3.1 and Table 3.2).     
 
3.5.3 Oral microbiota may play a role in disease progression.  Some sequences 
obtained belong to genera that are known to be found in the oral cavity.  In this dataset, 
Actinomycineae, Capnocytophaga, Lactobacillus, Leptotrichia, Fusobacterium, 
Neisseria, Porphyromonas, Prevotella, Prevotella dentalis (formally Hallela), 
Streptococcus, Shuttleworthia, and Veillonella were all identified (Figure 3.1 and Table 
3.2).  These organisms have been routinely cultured and sequenced in oral samples 
(Downes et al., 2002; Jousimies-Somer & Summanen, 2002; Lazarevic et al., 2009; 
Williems & Collins, 1995). The oropharyngeal bacteria have also been sequenced in 
other CF studies (Bittar et al., 2008; Rogers et al., 2006).   
It is difficult to define the role of the organisms in the CF lung without identifying 
the species.  Each sequenced genus contains species that are part of the normal oral 
microbiota and organisms which cause infections in other areas of the body.  For example 
Neisseria contains two pathogenic species which cause gonorrhea and meningitis 
(Liljemark & Gibbons, 1971).  It is doubtful the organism is associated with lung disease 
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and the DNA from the oral strains were most likely present in the sputa.  Leptotrichia is 
another genus that contains both nonpathogenic species such as L. buccalis which is part 
of the healthy microbiota yet other species have been associated with bacteremia, 
neutropenia, and endocarditis (Bhally et al., 2005; Eribe & Olsen, 2008).  Some oral 
genera such as, Capnocytophaga, Porphyromonas, and Lactobacillus have species that 
are known to be pathogenic in the human oral cavity but an association with the lung has 
not been established (Bunyaratavej, 2003; Cannon et al., 2005; Geisler et al., 2001).   
Studies are beginning to make connections between oral flora and lung health.  
Certain oral bacteria are present more often in those suffering from asthma and chronic 
obstruction pulmonary disease (Arbes et al., 2006; Deo et al., 2009).  It is has been 
proposed that pneumonia or ventilator-associated pneumonia is partly attributed to oral 
bacteria and proper oral hygiene in nonambulatory patients will reduce the risk of 
infection (Bahrani-Mougeot et al., 2007; Paju & Scannapieco, 2007; Scannapieco, 2006).  
In addition, Capnocytophaga gingivalis, an oral microbe, was isolated from 
bronchoalveolar lavage (BAL) fluid of a patient with pneumonia (Geisler et al., 2001).  
Thus, it is possible for oral bacteria to reside in the lungs.   
Recently, oral microbes belonging to Streptococcus, Actinomyces, Veillonella, 
and Prevotella have been shown to colonize the oral cavity and the lungs (Hilty et al., 
2010; Lazarevic et al., 2009; Mabeza & Macfarlane, 2003; Shah et al., 2008; Sibley et 
al., 2008).  Prevotella and Veillonella have recently been isolated from the lower lungs of 
healthy individuals disproving the opinion that the lower lung is sterile (Hilty et al., 
2010).  Oral microbiota has also been attributed to lung infections.  Veillonella has been 
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associated with chronic anaerobic pneumonitis in a non-CF individual (Shah et al., 2008).  
Actinomyces also causes pulmonary actinomycosis (Mabeza & Macfarlane, 2003).   
It could be hypothesized that certain species within a genus are a part of the 
normal lung microbiota while others are pathogens.  In addition, it is also likely an 
organism can become pathogenic if certain conditions are present.  This has recently 
shown true for Streptococcus milleri.  The oral microbe has been cultured from the CF 
lung and shown to be pathogenic when present in high amounts (Sibley et al., 2008).  It is 
also possible the organism contributes to the disease through interactions with known 
pathogens.  For example, a strain of oral Streptococcus can induce a positive regulation 
of virulence factors in P. aeruginosa (Duan et al., 2003).  Virulence factors are known to 
help P. aeruginosa establish an acute infection in the CF lung (Goodman et al., 2004).  
Understanding the role of oropharyngeal bacteria in lung progression may lead to novel 
treatment methods. 
 
3.5.4  Rarely cultured bacteria are readily identified using molecular 
methods.  There were a number of sequence reads corresponding to organisms that are 
rarely cultured but identified in molecular studies.  In this study, two samples contained 
Campylobacter sequences at low abundances (1.03 and 1.22 %) (Figure 3.1 and Table 
3.2).  Though this genus is not associated with lung infections, it has been previously 
identified in a CF sample based on a band in a T-RFLP profile (Rogers et al., 2003).  
However, the organism was never sequenced from the sample (Rogers et al., 2003).  It 
has been sequenced from healthy oral samples (Keijser et al., 2008).   
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Eikenella, identified in this study in one sample, is a commensal bacterium in the 
mouth and upper respiratory system (Figure 3.1 and Table 3.2).  It can cause lung 
infections; although, to date it has not been associated with CF patients (Hoyler & 
Antony, 2000).   
Gemella, another anaerobic bacterium, was present in eight samples (Figure 3.1 
and Table 3.2).  Certain species are opportunistic pathogens and have been associated 
with endocarditis and isolated from lung abscesses  (da Costa et al., 1996; La Scola & 
Raoult, 1998; Valipour et al., 2005).  This organism has been sequenced from CF 
samples and cultured from BAL samples (Bittar et al., 2008; Harris et al., 2007; Tunney 
et al., 2008).  High concentration of Gemella in the CF lung can lead to exacerbations 
(Michael Surette; personal communication) 
Eikenella and Gemella may be more prevalent in oral and lung communities than 
previously thought.  Routine culturing methods for CF samples do not usually include the 
anaerobic growth conditions that are required to culture these organisms.  A recent study 
has shown that with proper culturing techniques numerous anaerobic bacteria in high 
numbers can be isolated from the CF lung (Tunney et al., 2008).  The significance of 
many anaerobes in the lung is unknown.  However, as that Gemella can lead to illness, 
other anaerobes may also contribute to lung disease. 
 
3.5.5  Unusual organisms present in CF sputa.  The most abundant genus in 14 
samples was Chryseomonas which is closely related to Pseudomonas (Figure 3.1 and 
Table 3.2).  Some species such as C. luteola have been reclassified as belonging to the 
Pseudomonas genus due to the high degree of similarity between their 16S rRNA gene 
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sequence (Anzai et al., 1997).  In addition, Ribosomal Database Project II (RDP; Release 
10) no longer includes the genus Chryseomonas and species were placed under 
Pseudomonas.  There is 100 % homology of the full length 16S rRNA gene between P. 
aeruginosa, P. flavescens, P. mendocina and Chryseomonas/Pseudomonas luteola.  The 
MTPS reads were analyzed with RDP II (Release 8) which may have had Chryseomonas 
separated from Pseudomonas.  Reanalysis with the newer release version is necessary to 
determine if the sequences belong to Pseudomonas or a closely related group.  If the 
sequences are indeed P. luteola then it may be the first report of this bacterium in the CF 
lung.  The organism is known to cause infections in the eye, brain, and around implanted 
devices such as prosthetic valves leading to bacteremia (Casalta et al., 2005; Gaschet et 
al., 2009; Uy et al., 2007).  Like P. aeruginosa, P. luteola expresses a beta-lactamase 
making it more resistant to antibiotics (Doublet et al., 2010).  Its ability to colonize 
humans and its resistant to antibiotics increases the need to confirm the presence of P. 
luteola.    
Flavimonas sequences were present in eight samples with a high abundance of 
23.1 % in CF2 (Figure 3.1 and Table 3.2).  However, the other seven samples were 
between one and two percent abundance.  This genus was reclassified as Pseudomonas in 
RDP II (Release 10)  (Anzai et al., 1997).  Formerly Flavimonas oryzihabitans, P. 
orzihabitans is a rare pathogen but has been implicated in catheter associated infections 
(Marin et al., 2000).  There is a high homology between the 16S rRNA sequence from 
strains of P. orzihabitans and various strains of P. aeruginosa, yet the V1_V2 region of 
the gene is not the same between all species which indicates a Flavimonas species was 
present.  Species-specific PCR could be used to confirm the presence of P. orzihabitans.  
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Some sequences were present in very low abundance.  Oribacterium was present 
in two samples with less than 2 % abundance (Figure 3.1 and Table 3.2).  This genus, 
discovered in 2004 from sinus pus obtained from a young boy, has not been cultured 
from any other source (Carlier et al., 2004).  However, it was sequenced from healthy 
oral samples (Keijser et al., 2008) 
Moryella, present in one sample (2.44 %), contains one species indoligenes which 
has only been isolated from three human abscesses (Figure 3.1 and Table 3.2) (Carlier et 
al., 2007).  This organism has not been well characterized and its relationship to human 
lungs and oral cavity is unknown.   
Megasphaera sequences were present in two samples in low abundances (Figure 
3.1 and Table 3.2).  The bacterium is normally associated with the rumens of animals.  
Phylogentic analysis of 16S rRNA sequences from uncultured bacteria have shown 
Megasphaera-like organisms present in the vaginal and oral cavity (subgingival plaque 
and endodontic infections) samples (Marchandin et al., 2003; Spear et al., 2008; Zozaya-
Hinchliffe et al., 2008).  In this study, the bacteria are most likely associated with the oral 
cavity.   
Two other taxa, Schlegellella and Shigella, were identified.  Schlegellella spp. 
were present in one sample at 7.37 %.  This genus contains aquatic bacteria some of 
which are associated with hot springs (Chou et al., 2006; Elbanna et al., 2003).  Two 
samples also had low abundances for Shigella which causes dysentery (Yang et al., 
2005).   
Oribacterium, Moryella, Megasphaera, Schlegellella and Shigella sequences were 
present in few samples and at low abundances.  Their role in the CF lung may be quite 
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minor.  It is possible that Oribacterium and Megasphaera are from the oral cavity as they 
have been sequenced from oral samples or are potentially colonizing the upper 
respiratory system.  Sequences from Moryella may be a rare member of the eubacteriome 
and attempts should be made to isolate the organisms from sputa. Schlegellella and 
Shigella sequences are perplexing to find in the CF sputa and could possibly be attributed 
to sequencing error.   Chryseomonas and Flavimonas are potentially novel bacteria in the 
CF lung.  These organisms were present in most samples at large abundances indicating 
that the organisms were metabolically active.  Due to the high 16S rRNA homology, it 
should be confirmed that these organisms are not in fact P. aeruginosa.   
 
3.5.6 Identifications above genus level are difficult to interpret.  Not all 
sequences obtained could be identified to the genus level.  Five taxa, Actinomycineae, 
Carnobacteriaceae, Coriobacterineae, Micrococcineae, and Propionibacterineae were 
identified at high taxonomic levels that contain many environmentally divergent 
organisms.  It is difficult to conjecture the significance of the taxon in the CF samples.   
Actinomycineae sequences may potentially be from common oral bacteria.  
Carnobacteriaceae sequences may indicate the presence of Carnobacterium, 
Dolosigranulum, and Granulicatella, organisms sequenced in other CF samples (Bittar et 
al., 2008; Harris et al., 2007; Rogers et al., 2009).  The suborder Coriobacterineae 
contains many organisms that have been isolated from the human oral cavity (Lazarevic 
et al., 2009).  Micrococcineae is a suborder of Gram-positive organisms mostly found in 
soil (Hennessee & Li, 2010).  Propionibacterineae is a suborder that contains a diverse 
group of bacteria living in dairy products to intestinal tracts of animals (Goldschmidt et 
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al., 2009) (Figure 3.1 and Table 3.2).  Sequencing the samples again with a different 
region of the 16S rRNA gene may provide better resolution of the community for these 
genera.   
 
3.5.7  Gender and ethnicity of the host may not affect the bacterial 
community.  Previous studies and this work has shown that the bacterial communities 
are not the same in CF individuals but rather unique (Bittar et al., 2008; Harris et al., 
2007; Rogers et al., 2003; Rogers et al., 2009).  It is not known why some CF patients 
have diverse communities while others may be dominated by one organism, such as P. 
aeruginosa.  This study attempted to determine if there was a correlation between the 
gender and ethnicity of the host and the bacterial community.  Using PCO and the Bray-
Curtis similarity matrix, it was determined that there was no correlation between the 
bacterial community (as a whole) and the host’s gender and ethnicity (separately or 
combined) (Figure 3.2).  Though this study did not find a link between these factors and 
the community, it does not necessarily indicate that gender and ethnicity do not play a 
role in the community.  A larger sample size is needed to increase the power of statistics.  
In addition, other races such as African-American should be added to the analysis. 
 
3.5.8  Healthy and CF bacterial communities are statistically different despite 
shared bacteria.  The Bray- Curtis similarity matrix calculated from the abundance of 
the identified taxa in each CF sputum sample and the healthy oral rinse were used to 
determine the similarity between the CF and healthy samples.  The PCO analysis of the 
CF sputa communities and the healthy oral rinse communities clearly indicates that the 
 146 
 
overall eubacteriomes between the two datasets were different (Figure 3.3).  The CF 
samples were not as tightly clustered indicating the dissimilarity between CF samples.   
The healthy samples were clustered together and away from the CF samples.  The 
separation of the two datasets show that the overall bacterial community in CF sputa is 
different from the community present in healthy oral rinses, yet there are organisms 
common to both groups.  Within the communities, 27 taxa were only present in healthy 
samples, 12 groups were associated with CF, and 22 taxa were present in both groups 
(Table 3.4).   
 
3.5.8.1  CF pathogens mostly absent in healthy eubacteriomes.  Twelve 
taxa were unique to the CF dataset.  It was not surprising to find Proteus, Pseudomonas, 
Staphylococcus, and Stenotrophomonas sequences in the CF dataset (Table 3.4).  Each 
genera contains pathogenic species that have been cultured from the lung (Patient-
registry, 2008; Whittier, 2001).  Sphingobacterium, an uncommon CF pathogen, was also 
unique to the CF samples (Reina et al., 1992).  Chryseomonas and Flavimonas, both of 
which have been reclassified as Pseudomonas, were not found in the healthy samples 
(Anzai et al., 1997).  This further supports the hypothesis that these two taxa are 
potentially pathogens.   
Shigella which is known to cause dysentery was present in two CF samples (Yang 
et al., 2005).  It is likely the bacteria were transient members of the oral community or 
identified incorrectly due to sequencing error. Lactobacillus, Shuttleworthia, and 
Eikenella were not found in any healthy samples which is surprising as they are known to 
be associated with the oral cavity (van houte et al., 1972).  These groups may have not 
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competed well with the rest of the communities in the healthy samples.  Moryella was not 
present in the healthy oral rinses.  This anaerobe may potentially be a rare bacterium in 
the lung.   
 
3.5.8.2  CF and healthy samples share bacteria.  Twenty-two taxa were 
present in both datasets (Table 3.4).  Achromobacter, Burkholderia, and Haemophilus are 
pathogens routinely cultured from CF patients.  Achromobacter sequences were present 
in one healthy individual (H22, 21.0 %) (Table 3.3).  This organism can cause infections 
in non-CF patients and it is possible the healthy individual was actually suffering from an 
infection.  Burkholderia in a healthy individual (H22, 1.18 %) was unexpected.  The 
Haemophilus sequences, present in all samples but H3, were most likely from species 
that live in the oral cavity (Keijser et al., 2008; Kraut et al., 1972; Sixou et al., 1991).  It 
is possible the six CF samples with Haemophilus DNA were not from H. influenzae but 
rather from the oral species.   
 The largest subset of shared taxa which included Actinomycineae, 
Campylobacter, Capnocytophaga, Gemella, Hallella, Fusobacterium, Lepotrichia, 
Megasphaera, Neisseria, Porphyomonas, Prevotella, Streptococcus, and Veillonella are 
known colonizers of the mouth (Table 3.4).  Species identification is needed to establish 
if the bacteria is unique to the normal oral sample or shared between the datasets.  
Oribacterium was present in both datasets (Table 3.4).  The organism is not well 
studied but it has been previously cultured from sinus pus and sequenced from healthy 
saliva (Carlier et al., 2004; Keijser et al., 2008).  Due to its low abundance in samples, it 
is doubtful the organism is a major player in the mouth or lung communities.  
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Schlegelella sequences were present and this group of bacteria is most often associated 
with aquatic environments (Chou et al., 2006).  It is likely the organism is not a resident 
of the mouth.  The taxonomic identification of Carnobacteriaceae 2, Coriobacterineae, 
Micrococcineae, and Propionibacterineae sequences are too broad to conjecture a 
hypothesis as to their role in the mouth.   
 
3.5.8.3  Bacterial diversity decreased in CF samples.  Twenty-seven taxa 
were identified in the healthy samples and not in the CF eubacteriomes (Table 3.4).  The 
diversity of the healthy eubacteriome was much greater than in the sputa.  It is not known 
if these taxa are a part of the core oral eubacteriome.  The significance of the organsisms 
may be revealed when the oral core biome is determined.  Perhaps in the future, the 
composition of the oral community could be used as an indicator of health.  
 
3.5.9  Fungi are prevalent in CF sputa.  Through the use of culturing and 
species specific PCR, multiple species of Aspergillus and Candida are known to culture 
the CF lung (Bakare et al., 2003).  There have also been reports of Scedosporium 
apiospermum, Exophilia sp., and Wangiella dermatitidis infections (Defontaine et al., 
2002; Dixon & Polak-Wyss, 1991; Horré et al., 2004).  Yet, the mycobiome in the CF 
lung has not been characterized.  This is the first study identifying fungi in CF sputa. 
From the 18 samples, 33 genera were identified (Figure 3.4 and Table 3.5).  
Sputum samples contained between 13 and 30 different taxa with an average of 26 ± 3 
(Table 3.5).  All but one sample (CF7) had more than 24 genera present.  These results 
highlight a complex mycobiome despite clinical results which report no fungal infections 
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in all patients.  The majority of the taxa were present in low abundances which may 
indicate low levels of growth at the time of sampling.  Shifts in the microbiome may 
promote growth of fungi which can lead to CF exhaberations.  Therefore, it is important 
to identify and understand the role of the mycobiome in the CF lung. 
 
3.5.10  Pathogenic fungi undetected by clinicians.  Though the average 
diversity of mycobiome appears as large as the eubacteriome, there were few fungi 
previously associated with the CF lung present.  Candida albicans sequences were 
present in eight samples (1.39 – 5.42 % abundance) (Supplemental Table 3.8).  This 
species is often ruled as a commensal organism in the mouth.  However, antibiotic 
treatment can shift the microbiome and cause rampant growth of Candida which leads to 
candidiasis.  If this was the case in the CF patients, the Candida sequences would most 
likely be more abundant. 
In addition, Aspergillus terreus (18/18), Aspergillus ustus (18/18), Cryptococcus 
neoformans (17/18), Exophilia (17/18) and Wangiella dermatitidis (1/18) sequences were 
present in the samples (Supplemental Table 3.8).  Though the abundances were low (< 
2%), their presence is still cause for concern.  These organisms are pathogenic and known 
to colonize CF patients.   
Pichia (P. anomala, P. membranaefaciens, and Pichia spp) sequences were the 
most abundant in all samples except for CF7 (15 - 22 %).  Many strains of Pichia are 
environmental and clinician would consider it a contaminate if cultured.  This reaction is 
beginning to change as P. anomala, P. membranefaciens and P. ohmeria have been 
shown to be causative agents of opportunistic mycoses.  Though other pathogenic species 
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were sequenced, the higher abundance of Pichia sequences indicated that this is the 
dominant colonizer in the mycobiome.   
3.5.11  Environmental fungi abundant in CF sputa.  Of the 33 genera present, 
the species from 24 genera are most likely environmental contaminates and unassociated 
with human mycobiomes (Supplemental Table 3.8).  Most of the species sequenced from 
the following genera are not associated with humans or known to be human pathogens: 
Amanita, Blastocladiella, Bulleromyces, Capronia, Cladosporium, Debaryomyces, 
Eutypella, Glomus, Geotrichum, Hortaea, Hypocrea, Metschnikowia, Mucor, 
Myrothecium, Olphidium, Penicillium, Phialophora, Rhinocladiella, Rhizoctonia, 
Rhodosporidium, Rhodotorula, Saccharomyces, Schizosaccharomyces, and Tricholoma.  
These fungi are either mushrooms, household mold, or associated with water, soil, and 
plants.   
Environmental fungi can cause chromoblastomycosis, which is a fungal infection 
of the skin and subcutaneous tissue.  The mycobiome contained four organisms, 
Cladophialophora arxii, Cladophialophora devriesii, Phialophora verrucosa, and 
Fonsecae pedrosoi which can occasionally cause chromoblastomycosis.     
In total, 27 genera identified from the sputa are most likely derived from 
consumed food and air. The sequences were present in low abundances which supports 
the conjecture that these fungi are transient members of the CF mycobiome. 
 
3.5.12  Gender and ethnicity may not effect fungal community composition.  
This study attempted to determine if there was a correlation between the gender and 
ethnicity of the host and the fungal community (Figure 3.5).  Using PCO, it was 
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determined that there was no correlation between the fungal community (as a whole) and 
the host’s gender and ethnicity (separately or combined).  As discussed with the bacterial 
community, these results do not necessarily indicate that gender and ethnicity do not play 
a role in the community.  A larger sample size and other races should be added to the 
analysis. 
 
3.5.13  Healthy oral cavity contains a diverse mycobiome.  Using MTPS, 
Ghannoum et al. identified 74 culturable and 11 non-culturable fungal genera 
representing a total of 101 species for all 20 participants (Table 3.6 and Supplemental 
Table 3.9) (Ghannoum et al., 2010).  Over 60 genera are commonly found in the 
environment and not associated with human infections.  The reoccurrence of the genera 
in multiple patients led the authors to state that the organisms were most likely in the oral 
cavity as a result from eating and breathing.   
The largest percentage of fungi identified in the mouth rinse samples was 
identified as non-culturable fungi.  Four pathogenic fungi were present in at least 20 % of 
the subjects.  Of these pathogens, Candida was present in 75 % of the samples.  The 
prevalence was much higher than other studies and the authors attributed it to better 
technology.  Aspergillus, Fusarium, and Cryptococcus sequences were surprising as that 
they have never been shown to colonize the mouth.  The authors conjectured that the 
organisms’ pathogenic behaviors were controlled by other fungi in the mycobiome. The 
study determined the mycobiome in the healthy mouth is diverse but the clinical 
relevance of the fungi are unknown (Ghannoum et al., 2010).  
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3.5.14  CF sputa and oral rinses contain unique mycobiomes.  Caution must be 
taken when comparing the CF and healthy mycobiome data sets.  The sequences from the 
two datasets were not analyzed together as one dataset.  The separate analyses may have 
led to different identifications for the sequences.  In addition, the CF analysis did not 
include uncultured fungi, rather if a sequenced was identified as uncultured the next 
closest aligned sequence from a cultured organism was used for the analysis.  The 
absence of this category in the CF samples skews any abundance-based statistical 
analysis.  Therefore, the two communities were compared with Sørenson similarity index 
based on presence/absence of the genera (Sorensen, 1948).  The results were shown on a 
dendograph (Figure 3.6).  Healthy mycobiomes were more similar to one another than 
with the CF communities.  This clustering pattern of the samples was attributed to 63 
genera only present in healthy samples and 22 genera unique to the CF dataset (Table 
3.7).  At the species level, C. albicans, an opportunistic pathogen, was the only shared 
organism between the two datasets.     
 
  3.5.14.1  Pathogenic fungi were present in healthy and CF subjects.  
Aspergillus, Candida, Cryptococcus, and Pichia sequences were associated with healthy 
and CF individuals.  Of the four species of Candida, C. albicans sequences were 
identified in the sputa samples.  In addition, Candida was much more prevalent in the 
healthy samples.  The oral samples contained six Aspergillus species, two Cryptococcus 
species and one Pichia species, none of which were present in the CF individuals 
(Supplemental Table 3.8 and 3.9).  It was unexpected to identify pathogenic fungi in the 
healthy mouth.  As mentioned by Ghannoum et al., these fungi may be controlled by 
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other members of the community preventing them from behaving as pathogens in the 
healthy individual.   
 
3.5.14.2 Environmental fungi abundant in both CF sputa and healthy 
oral samples but no species are in common. Twenty genera of environmentally 
associated fungi were present in the CF samples.  In addition, most if not all of the fungi 
unique to the mouth mycobiomes were from the environment.  No species were present 
in both datasets.  It is not surprising to find such a small overlap in genera between the 
two groups.  The participants were from south Florida or Cleveland, Ohio; two entirely 
different geographically locations.  The individuals were exposed to different fungi and 
that is reflected in their mycobiomes.  Moreover, subjects from the same environment do 
not share all the same fungi.  These differences could be attributed to where a person 
works or what they eat.   
 
3.5.15  Conclusion.  This study addressed the eubacteriome and mycobiome of 
the CF lung.  Through 454 sequencing, the polymicrobial nature of the CF lung was 
explored.  Pathogenic bacteria and microbes associated with the oral cavity were 
abundant.  Previous studies have shown that sputum is not contaminated by oral bacteria 
(Rogers et al., 2006).  Therefore, oral bacteria may play a role in the progression of lung 
disease.  Although the lung and mouth are different environments, the comparison is still 
noteworthy, demonstrating the overlap of oral bacteria present in the mouth and the 
sputa.  The results illustrate the need to understand the role of oral bacteria in the airways.   
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South Florida patients also have an extensive fungal community in their sputa.  
Although most of the fungi present were attributed to environmental sources, pathogenic 
species were present in patients negative for fungal infections.   
This sequencing study clearly demonstrates the complexity of the CF 
microbiome.  Future work should examine the significance of the members in the 
community.   
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Supplemental Table 3.8:  Frequency distribution (%) of fungal species present with at 
least 1 % abundance in the CF sputa mycobiome 
Samples CF1 CF2 CF3 CF4 CF5 CF6 CF7 CF8 CF9 CF11 CF12 CF13 CF14 CF15 CF16 CF17 CF18 CF19 #
Amanita phalloides 1.1 1
Aspergillus terreus 1.0 1.4 1.3 1.5 1.3 1.4 1.1 1.4 1.3 1.1 1.3 1.5 1.2 1.1 1.3 1.1 16
Aspergillus ustus 1.1 1.5 1.3 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Blastocladiella emersonii 1.0 1.4 1.3 1.6 1.3 1.4 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Bulleromyces albus 1.1 1.5 1.3 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Candida albicans 5.4 5.0 3.3 4.8 4.5 1.8 5.2 1.4 8
Candida dubliniensis 0
Capronia acutiseta 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Capronia coronata 1.4 1
Capronia epimyces 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Capronia pilosella 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Capronia pulcherrima 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Cladophialophora arxii 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Cladophialophora devriesii 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Cladophialophora sp. 1.4 1
Cladosporium cladosporioides 1.3 1
Cladosporium macrocarpum 1.3 1
Cladosporium sp. 2.8 1.0 2
Cladosporium tenuissimum 1.4 1
Cryptococcus neoformans 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Debaryomyces  hansenii 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Dipodascus albidus 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Eutypella vitis 1.0 1
Exophiala sp. 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Fonsecaea pedrosoi 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Geotrichum candidum 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Glomus mosseae 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Hortaea werneckii 2.8 1.3 2
Hypocrea koningii 1.1 2.2 1.1 1.1 1.2 1.0 6
Hypocrea muroiana 0
Hypocrea rufa 1.1 2.2 1.1 1.1 1.2 1.0 6
M etschnikowia bicuspidata 1.0 1.4 1.3 1.5 1.3 1.4 1.1 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
M ucor racemosus 1.0 1.4 1.3 1.6 1.3 1.4 1.1 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
M yrothecium atroviride 1.1 2.2 1.1 1.1 0.8 1.2 1.0 1.1 8
M yrothecium cinctum 2.3 1.5 4.6 2.3 2.3 1.7 2.0 0.3 2.3 2.0 1.8 2.1 12
M yrothecium inundatum 1.1 2.2 1.1 1.1 1.1 1.0 1.1 7
M yrothecium leucotrichum 1.1 2.3 1.2 1.1 1.2 1.0 1.1 7
M yrothecium roridum 4.3 1.7 2.8 9.0 4.5 4.4 3.2 3.9 4.6 4.1 3.6 3.9 1.1 13
M yrothecium verrucaria 2.2 1.4 4.5 2.3 2.2 1.6 2.0 2.3 2.1 1.8 2.2 11
Olpidium brassicae 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Paracentrotus lividus 1.1 1.5 1.3 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Penicillium argillaceum 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Penicillium freii 1.1 1.5 1.3 1.6 1.3 1.5 1.3 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.3 1.8 17
Phialophora sp. 3.2 1.7 2.2 1.7 2.7 1.9 5.4 3.5 1.9 3.5 2.9 3.3 1.8 3.5 3.2 3.1 3.2 1.9 18
Phialophora verrucosa 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Pichia anomala 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Pichia membranaefaciens 6.2 8.6 7.9 9.3 7.7 8.6 5.5 6.8 8.2 7.7 7.9 7.7 8.7 7.5 6.4 7.6 7.0 7.8 18
Pichia sp. 8.3 11.4 10.5 12.3 10.3 11.4 7.3 9.1 10.9 10.3 10.5 10.2 11.7 10.0 8.5 10.2 9.4 10.3 18
Rhinocladiella atrovirens 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Rhinocladiella phaeophora 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Rhizoctonia sp. 14.8 19.5 17.8 21.0 17.6 19.3 13.2 16.3 18.4 18.5 18.1 17.9 19.5 18.0 14.7 18.1 16.5 17.3 18
Rhodosporidium toruloides 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Rhodotorula glutinis 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Saccharomyces cerevisiae 8.2 1
Schizosaccharomyces fimicola 1.1 2.2 1.1 1.1 1.1 1.0 1.1 0.3 8
Schizosaccharomyces pombe 2.2 3.0 2.7 3.2 2.6 2.9 1.9 2.5 2.8 2.6 2.7 2.6 3.0 2.6 2.3 2.6 2.5 2.7 18
Schizosaccharomyces sclerotiorum 1.1 1.5 1.4 1.6 1.3 1.5 1.2 1.4 1.3 1.3 1.3 1.5 1.3 1.1 1.3 1.2 1.3 17
Tricholoma matsutake 2.2 3.0 2.7 3.2 2.6 2.9 1.9 2.5 2.8 2.6 2.7 2.6 3.0 2.6 2.3 2.6 2.5 2.7 18
Wangiella dermatitidis 1.38 1
Count* 54 37 38 36 40 37 15 45 38 45 41 39 38 45 48 40 43 37   
#  is the total samples that contained that specific taxon 
* is the total number of taxa present per sample 
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Supplemental Table 3.9:  Frequency distribution (%) of fungal species present with at 
least 1 % abundance in the healthy oral rinses mycobiome 
Organism H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14 H15 H16 H17 H18 H19 H20 #
Alternaria sp. 2.0 1
Alternaria tenuissima 1.1 1.0 2
Alternaria triticina 1.9 1
Amanita bisporigera 5.0 1
Ascomycete sp. 3.0 2.3 2
Aspergillus amstelodami 2.2 2.4 2
Aspergillus caesiellus 9.5 1
Aspergillus flavus 3.0 1
Aspergillus oryzae 1.0 1
Aspergillus penicillioides 1.0 1
Aspergillus ruber 1.1 2.3 2
Aspergillus sp. 3.3 2.6 3.0 29.0 2.0 4.0 6
Atractylodes macrocephala 6.0 7.2 2
Aureobasidium pullulans 6.3 4.6 2.3 1.9 10.9 11.8 2.8 6.0 4.5 6.4 10
Avena fatua 5.0 1
Bagnisiella examinans 8.0 1
Campylobacter concisus 2.5 1
Candida albicans 9.0 10.4 7.8 10.7 14.2 14.1 2.0 2.4 8
Candida khmerensis 1.3 1
Candida metapsilosis 2.7 1
Candida parapsilosis 2.4 3.2 1.0 3
Candida sp. 1.0 1
Candida tropicalis 4.7 2.5 2
Chaetomium globosum 1.2 1
Cladosporium cladosporioides 1.2 1.6 1.3 46.8 2.8 26.1 32.8 2.3 11.5 11.8 10
Cladosporium herbarum 1.8 1.1 2
Cladosporium sp. 4.5 1.3 1.1 8.3 5.7 8.4 1.3 2.4 3.6 9
Cladosporium sphaerospermum 1.1 1
Cladosporium tenuissimum 1.2 1
Claviceps purpurea 1.1 1
Clavispora lusitaniae 2.5 1
Conoplea fusca 3.4 1
Corynespora cassiicola 2.2 1
Cryptococcus cellulolyticus 3.8 1
Cryptococcus diffluens 3.3 1
Cryptococcus sp. 1.8 1
Cystofilobasidium lari-marini 3.6 1
Davidiella tassiana 1.1 1
Dothideomycete sp. 10.7 1.5 4.1 3
Dothioraceae sp. 3.0 1.7 1.9 5.3 4.2 1.6 2.8 1.3 2.3 9
Emericella rugulosa 1.2 1.0 2
Eurotium amstelodami 1.1 1.4 2
Eurotium sp. 9.6 1.3 4.0 1.1 15.5 5
Filobasidiales sp. 0
Flammulina velutipes 8.8 1
Fusarium culmorum 1.9 4.3 2
Fusarium oxysporum 3.1 1
Fusarium poae 1.1 1
Fusarium sp. 4.0 2.1 1.1 3
Gibberella sp. 1.7 1.6 3.8 16.9 4
Gigaspora margarita 1.2 1
Glomus fulvum 1.8 1
Glomus mosseae 5.4 13.1 2.0 3
Glomus sp. 7.1 1
Guignardia mangiferae 3.4 1
Guignardia sp. 1.7 1
Hormonema sp. 1.0 1.2 2
Hypocreales sp. 1.0 5.2 2
Issatchenkia orientalis 1.6 1  
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Organism H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14 H15 H16 H17 H18 H19 H20 #
Lasiodiplodia theobromae 2.8 1
Lecania gerlachei 4.4 1
Lewia infectoria 1.1 2.2 2
M acrophomina phaseolina 3.5 1
Nectria cinnabarina 1.0 1
Nigrospora oryzae 1.2 48.4 2
Ochroconis gamsii 3.2 7.6 2
Ophiostoma floccosum 40.0 1
Ophiostoma pulvinisporum 1.3 1
Orpinomyces sp. 2.1 1
Paecilomyces lilacinus 1.6 1
Penicillium brevicompactum 1.8 1
Penicillium glabrum 11.1 1
Penicillium sp. 1.8 1
Penicillium spinulosum 1.6 1
Peziza violacea 3.7 1
Phaeosphaeria nodorum 1.5 1
Phoma foveata 2.2 1
Phoma plurivora 1.7 1
Pichia guilliermondii 1.1 1
Pleosporaceae sp. 8.4 1.1 2
Pongo abelii 4.0 1
Pueraria montana 1.4 1
Pyrenophora tritici-repentis 2.1 1
Rhizopogon sp. 6.1 1
Saccharomyces bayanus 3.5 2.3 2
Saccharomyces cerevisiae 8.9 43.2 2.1 1.1 2.4 25.8 6
Saccharomyces ellipsoideus 2.4 1.3 2
Saccharomycetales sp. 5.6 13.7 1.1 12.4 6.0 8.0 1.8 18.1 0.0 0.0 1.4 7.3 0.0 13
Schizophyllum commune 14.7 2.6 2.2 3
Schizosaccharomyces japonicus 20.0 1
Schizosaccharomyces pombe 1.1 1
Sebacina incrustans 1.8 1
Sordariomycete sp. 1.7 1.3 2
Stachybotrys chartarum 6.2 1.3 1.2 3
Stemphylium solani 6.3 1
Subulispora britannica 2.5 1
Teratosphaeria sp. 1.2 1.9 17.1 1.1 17.7 16.8 1.1 10.9 5.3 9
Torulaspora delbrueckii 2.1 1
Tremellales sp. 1.9 1
Trichaptum abietinum 2.2 1
Trichocomaceae sp. 2.6 2.8 2.3 3
Trichosporon loubieri 4.1 1
Non-Cultivable ascomycete 4.1 2.1 25.5 37.2 25.0 1.2 3.5 28.5 5.5 48.2 1.9 5.6 21.3 13
Non-Cultivable basidiomycete 37.1 2.2 2.1 3.1 4
Non-Cultivable ectomycorrhizal 1.4 2.5 2
Non-Cultivable endophytic 1.1 2.5 1.1 1.2 2.9 1.2 1.3 1.1 8
Non-Cultivable eukaryote 2.4 3.1 2
Non-Cultivable fungus 5.1 3.1 2.3 1.6 3.3 3.2 3.2 1.2 11.7 1.9 3.4 6.1 29.0 17.6 9.7 3.2 16
Non-Cultivable glomeromycete 4.3 7.1 8.2 3
Non-Cultivable Glomus 6.2 5.4 2.2 1.4 3.0 8.0 1.8 7
Non-Cultivable Leptosphaeriaceae 9.6 1
Non-Cultivable soil 1.4 11.7 9.4 3.8 3.8 2.4 1.6 0.0 0.0 2.8 1.9 1.1 12
Non-Cultivable Unknown 4.4 1.5 3.1 6.3 11.3 14.3 18.2 5.4 4.0 0.0 4.7 20.8 2.2 16.3 14
Verticillium sp. 1.4 1
Wallemia sebi 7.3 1
Xylariales sp. 7.7 31.3 2
Zygosaccharomyces pseudorouxii 1.9 1
Zygosaccharomyces rouxii 2.1 1
Count* 19 21 17 17 14 27 22 19 21 25 10 15 15 12 10 22 13 20 23 19   
#  is the total samples that contained that specific taxon 
* is the total number of taxa present per sample 
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Chapter 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“SPR Detection of Bacteria Associated with the Cystic Fibrosis Lung”  
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4.1  Abstract 
 Traditional bacterial identification systems use phenotypic and biochemical 
analysis of the organism and/or antibody-based detection systems like ELISA.  Antibody-
antigen interactions can be observed on a nanoscale level using more sensitive techniques 
such as surface plasmon resonance (SPR).   This technique detects bacteria by indirectly 
monitoring the oscillations of electrons that exist at the surface of an antibody-coated 
gold sensor chip.  As a result of antibodies capturing bacteria, electron oscillations will 
change which is detectable by measuring the angle of light that is absorbed by the 
electrons.  This study proposed to detect the interactions of Pseudomonas aeruginosa and 
Staphylococcus aureus with their cognate antibodies using SPR.  The immunosensor 
detected P. aeruginosa and S. aureus at concentrations of 107 to 108 colony forming units 
per milliliter (cfu/mL).  The sensitivity of the P. aeruginosa immunosensor was increased 
by a factor of ten when bovine serum albumin (BSA) was not added to the sensor. The 
immunosensor was specific showing only a minimum reaction to Escherichia coli at 108 
cfu/mL.  Optimization of the immunosensor assembly will increase the sensitivity and 
accuracy of the biosensors.   
 
Keywords:  Surface plasmon resonance, Pseudomonas aeruginosa, Staphylococcus 
aureus 
 
 
Abbreviations:  SPR, Surface Plasmon Resonance; SAM, Self-Assembled Monolayer, 
BSA, Bovine Serum Albumin; cfu, colony forming units; cystic fibrosis (CF); phosphate 
buffer saline (PBS); overnight (ON) 
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4.2  Introduction 
 
 Per every million people, 2.4 people die in the United States as a result of a 
bacterial infection (World Health Organization, 2008).  Despite being an industrialized 
nation, the US is ranked 4th (for bacterial associated death) out of the 47 countries that 
give health statistics to the World Health Organization.  Many bacterial infections are 
treatable.  If not treated, an infection can lead to sepsis and ultimately death.  An accurate 
and timely diagnosis is key in eliminating the bacterial infection and preventing the 
spread of the organisms to uninfected people.    
Identification of the infecting organism is critical for successful treatment.  
Culturing for phenotypical and biochemical assays is the mainstay in most clinical 
laboratories.  Using various media, the sample from the infected person is inoculated 
onto plates or broth and then the organism is allowed to grow for a period of time 
(Murray & Baron, 2007).  Based on the phenotype of the organism and the media it is 
grown on, an identification of the bacteria is made.  Besides visual phenotypes, 
biochemical tests are performed.  Currently, multiple biochemical tests can be 
performed simultaneously using diagnostic kits such as the BioMérieux API system or 
the VITEK 2 by BioMérieux (Bosshard et al., 2006).  These products identify bacteria 
within two to 24 hours.  Both of these assays are not error-proof leading to 
misidentifications (Bosshard et al., 2006).  The accuracy of the VITEK2 ID-GNB card 
(BioMérieux, Marcy l'Etoile, France) has been examined (Bosshard et al., 2006; Brisse 
et al., 2002; O'Hara & Miller, 2003).  This system accurately identified 93.0 % of 414 
clinically relevant enteric bacteria strains and 95.1 % of the 103 glucose-fermenting and 
nonfermenting nonenteric strains (O'Hara & Miller, 2003).  Another study compared the 
 161 
 
VITEK2 ID-GNB card (BioMérieux) and API 20 NE (BioMérieux) with sequencing 
data from the same 107 isolates (Bosshard et al., 2006).  The API system was able to 
identify 54 % of the isolates to species level, 7 % to the genus level and failed to 
identify 39 % of the isolates.  Of the later, 26 % belonged to species that were not in the 
API database (Bosshard et al., 2006).  The VITEK 2 system had similar results whereas 
53 % of the isolates were identified to species level, one percent to genus level, and 46 
% (49 isolates) were unidentifiable.  Of the 49 isolates, 39 belonged to a species not 
represented in the VITEK 2 database (Bosshard et al., 2006).  The VITEK has also been 
compared with the BD Phoenix (BD Diagnostic System, Sparks, MD) to determine the 
accuracy in identifying isolates of the B. cenocepacia complex, a known CF pathogen 
(Brisse et al., 2002).  The study determined an overall identification rate of 50 % for 
both systems (Brisse et al., 2002).  The accuracy of commercial systems varies greatly 
but no system has a 100 % identification rate.  Misidentification can lead to improper 
treatment which can result in poor patient outcome and lead to a rise in antibiotic 
resistance (Levy, 2000).   
Pathogens can also be identified based on antibody – antigen interactions using an 
enzyme-linked immunosorbent assay (ELISA).  There are multiple ELISA protocols but 
the original method begins by attaching capture antibodies to a polystyrene plate.  Then, 
the sample is placed into the system and if present the bacteria will bind to the antibody.  
The antibody-antigen interaction is detected using either chromogenic or fluorogenic 
methods (Engvall & Perlmann, 1971).  The ELISA is not portable but still useful when 
analyzing clinical samples. 
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 Rapid and portable diagnostic systems have been developed based on the concept 
used in ELISA.  One category of antibody-based detection systems are referred to as 
immunochromatographic tests.  One of the most well known examples of this type is the 
at home pregnancy test (Vaiukaitis et al., 1972).  The dipstick is coated with mouse 
monoclonal antibodies that recognize the human chorionic gonadotrophin molecules that 
are present in urine when pregnant (Vaiukaitis et al., 1972).  The molecule binds to the 
antibody and the complex moves down the strip where it is ensnared by polyclonal 
antibodies which bind to the human chorionic gonadotropin.  At the location of the 
second reaction are dye molecules which undergo an enzymatic reaction to produce the 
colored line (Vaiukaitis et al., 1972).  Similar detection systems have been developed for 
diphtheria (Engler et al., 2002), HIV (Esfandiari et al., 2004), Mycobacterium 
tuberculosis (Esfandiari et al., 2004), vaginal Candida species (Matsui et al., 2009), and 
Escherichia coli O157:H7 (Park et al., 2008).  These systems can use various bodily 
fluids such as urine and sera as well as cultured bacteria in liquid solutions.   
The newest generation of immunochromatographic tests use nanotechnology.  
The secondary capture antibody in these tests have been conjugated with colloidal gold 
nanoparticles (Biagini et al., 2006; Chiao et al., 2008; Rong-Hwa et al., 2010; Shyu et 
al., 2002).  Using lateral flow, the analyte binds to the primary antibody and then moves 
towards the labeled secondary antibody forming another complex.  The sandwich 
complex flows to the capture pad on the test strip which will turn red when sufficient 
nanoparticles accumulate.  These tests have been developed to detect bacteria such as 
Staphylococcus aureus and numerous toxins such as ricin, botulism, and staphylococcal 
enterotoxin B (Biagini et al., 2006; Chiao et al., 2008; Rong-Hwa et al., 2010; Shyu et 
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al., 2002).  These tests may be the future of diagnostics as that they are rapid, portable, 
user-friendly, cost-efficient, and have a long shelf-life (Rong-Hwa et al., 2010). 
  Antibody-antigen interactions can also be observed with instruments that use 
surface plasmon resonance (SPR).  The SPR effect is a phenomenon where electrons that 
exist at the interface between any two materials oscillate and produce waves (Wood, 
1902, 1912).  This phenomenon can be used to determine if an antigen binds to an 
antibody (Kretschmann & Raether, 1968; Otto, 1968).  Using a SPR instrument, light is 
passed through a glass chip thinly coated with gold (Figure 4.1).  A specific frequency of 
light passes into the gold creating an evanescent wave.  The wave excites the plasmons 
causing them to resonate and form a plasmon wave which travels along the gold film 
interacting with the media in contact with the gold.   The remaining frequencies of light 
are reflected at a specific angle.  The angle of the light reflection, which can be measured, 
shifts as molecules adsorb onto the surface of the gold (Kretschmann & Raether, 1968; 
Schasfoort & McWhirter, 2008).  
One specific type of SPR biosensors is an immunosensor which detects 
interactions between antibodies and other molecules such as bacteria (Geddes et al., 
1994; Mayo & Hallock, 1989).  Essentially, SPR immunosensors detect antigens that 
bind to antibodies on the gold sensor by measuring the angle of light reflection 
(Kretschmann & Raether, 1968).  SPR immunosensors have been used to identify 
Escherchia coli O157:H7 (Fratamico et al., 1998; Meeusen et al., 2005; Oh et al., 2003; 
Su & Li, 2005; Subramanian et al., 2006a; Taylor et al., 2005), Vibrio cholera  
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(Jyoung et al., 2006), Salmonella enteritis (Bokken et al., 2003),  Salmonella 
typhimurium (Oh et al., 2004a), Salmonella paratyphi (Oh et al., 2004b), Listeria 
monocytogenes (Hearty et al., 2006; Koubova et al., 2001; Leonard et al., 2005), Yersinia 
enterocolitica (Oh et al., 2005),  and Campylobacter jejuni (Taylor et al., 2006).   
Immunosensors are designed using a layer-by-layer self-assembly method (Cui et 
al., 2003).  As that the design protocol can vary, the method used in this study is 
explained in depth.  The immunosensor self-assembly method starts with a glass chip that 
is thinly coated with gold on one side.  The chip is prepared by soaking it in 11-
mercaptoundecanoic acid (HSC10H20COOH) or similar alkanethiol solutions to allow a 
self-assembled monolayer (SAM) formation.  In this case, the gold molecule binds to the 
thiol group in 11-mercaptoundecanoic acid.  The carbon chain extends from the thiol and 
is terminated with a carboxcyclic acid group (Figure 4.2) (Stettner et al., 2009).    
Figure 4.1: Surface plasmon resonance phenomenon.  Incident light penetrates through a 
gold coated glass chip and a specific frequency of light will create an evanescent wave.  
This wave excites the plasmons and cause a plasmon wave to propagate along the surface 
of the gold.  The remaining light is reflected.  Adapted from www.icxt.com. 
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After the formation of SAM, chip is placed onto the SPR instrument for layer-by-
layer self assembly.  The gold sensor is set onto the window of the instrument using a 
matching liquid (refractive index = 1.515) to ensure that the refractive index of the sensor 
is the same as the glass window (Biosensing Instrument, 2006).  The instrument uses 
microfluidics which allows a carrier solution to constantly run over the sensor.  The 
carrier is a reference buffer which establishes the baseline angle of light reflection.  
Molecules such as antibodies are injected into a port and carried to the sensor by the 
carrier buffer.  After the injection is complete, the port closes and the carrier solution 
washes away unbound injected molecules.  Light is constantly beamed onto the sensor 
and reflected as the carrier solution and injected chemicals are delivered to the sensor 
(Figure 4.3) (Biosensing Instrument, 2006). The angle of reflection will change as  
Figure 4.2:  Self-assembled monolayer (SAM) formation on a gold coated chip.  A gold 
sensor chip is immersed in 11-mercaptoundecanoic acid.  The thiols bind to the gold 
leaving a chain of carbons ending with a carboxycyclic acid group  (Chang & Liao, 
2008). 
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To begin the layering process on the gold sensor, the SAM (COOH groups) are 
activated using N-hydroxysuccinimide (NHS) and N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC).  The EDC catalyzes the formation of amide 
molecules adsorb onto the gold sensor.  In between injections, the carrier/reference buffer 
flows over the sensor and the angle will stay constant forming a baseline measurement.  
bonds between carboxylic acids and amines.  EDC converts the carboxylic acid into a 
reactive intermediate (an ester) which can be attacked by amines.  The NHS is used to 
stabilize the intermediate for a longer period allowing an amide to be formed (Staros et 
al., 1986). A solution of Protein G is then injected, and the nitrogen groups on the protein 
attack the ester groups forming an amide bond between the carboxylic acid group on the 
SAM and the amines on the Protein.  Protein G molecules increase the layer of thickness 
on the gold sensor which affects the surface plasmons, thereby changing the angle of 
reflection.  Protein G is added to ensure the antibodies bind in the proper orientation 
(Figure 4.4) (Lee et al., 2007; Schmid et al., 2006). 
Figure 4.3.  Schematic diagram of SPR instrument.  The carrier buffer and/or injected 
chemicals flow into one port, across the gold sensor chip, and then the buffer with any 
unbound chemicals exits via the out port.  As the buffer flows, a light source is 
continuously beamed through a prism and into the gold chip.  The light is reflected and 
the angle of reflection is measured by a detector.  The angle of reflection is dependent 
on the molecules binding to the gold chip (Biosensing Instrument, 2006).  
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Any remaining unbound activated ester groups are deactivated by an 
ethanolamine solution.   The antibodies are injected and bind to the Protein G molecules 
in the proper orientation leaving the antigen binding sites on the antibodies exposed 
(Figure 4.3).  Antibodies may not have bound to all Protein G molecules leaving Protein 
G free to bind to non-selective antigens.  To prevent a false-positive reaction, the Protein 
G molecules are blocked by bovine serum albumin (BSA) which finishes the layer-by-
layer self assembly of the immunosensor.  Each addition increases the thickness of the 
layer adsorbed to the gold which directly affects the reflection of light.  The shifts in 
angle of reflection can be measured in real-time (Figure 4.5).   
To date, there are no SPR immunosensors for whole cell Staphylococcus aureus 
and Pseudomonas aeruginosa, two common opportunistic pathogens that are feared in  
Figure 4.4.  Antibody orientation. Panel A demonstrates antibodies binding to gold in 
multiple orientations.  Many antibodies bind in an orientation that compromises the 
ability of the antibodies to bind to antigens.  Panel B shows antibodies in the proper 
orientation as a result of the Protein G molecules attached to the gold layer.    
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Figure 4.5: The SPR response.  Panel A depicts a layer-by-layer self assembled gold 
sensor chip on the SPR window.  Incident light enters through a prism hitting the gold 
sensor.  The light is reflected.  Panel B is a close up view of the reflected beam of light.  
The incident light excited surface plasmons that were in contact with the layers above the 
gold film.  As a result of the electrons absorbing energy at a particular frequency of light, 
the reflected beam has a dark line within it.  The angle of the dark line within the beam is 
the SPR response and it shifts depending on surface layers above the gold sensor chip.  
Panel C is a sensograph.  The time and angular shift are measured throughout a SPR 
experiment. 
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hospitals.  S. aureus is a Gram-positive cocci that can be found in the skin flora of 
healthy humans (Hartmann, 1978).  The bacteria can also cause numerous infections due 
to its ability produce virulence factors and toxins (Freer & Arbuthnott, 1982; Jakubicz, 
1972; Kapral et al., 1965; Parker, 1924).  S. aureus has been associated with a range of 
infections from mild acne to life-threatening diseases such as pneumonia and septicemia 
(Corner, 1940; Noble, 1998; Olansky & McCormick, 1958; Schneck, 1957).  The 
bacteria can also cause respiratory infections in cystic fibrosis (CF) children and recent 
research has shown that the bacteria are still present in the lungs of adult CF patients 
(Beringer & Appleman, 2000; Kahl et al., 1998; Patient-registry, 2008).  In addition, S. 
aureus is one of the leading causes of nosocomial infections (Noskin et al., 2005; 
Wertheim et al., 2005).  These infectious could once be treated with penicillin, but now 
the bacteria are resistant to it and other beta-lactam antibiotics (Ashley & Brindle, 1960; 
Zetola et al., 2005).  The emerging resistant strains of S. aureus make it more of a 
challenge to treat a patient thus driving up the cost of treatment (Kim et al., 2001).  
P. aeruginosa is a Gram-negative rod-shaped bacterium that is known for its 
environmental versatility and ubiquity (lives in water, soil, and in animal tissues) (Ringen 
& Drake, 1952; Winslow et al., 1920).  The organism is capable of surviving in 
numerous environments due to its ability to metabolize a vast array of carbon sources 
(Conrad et al., 1979; Haynes, 1951; Niel, 1943; Ringen & Drake, 1952). P. aeruginosa 
produces numerous virulence factors and toxins which enable it to infect plants, animals, 
and humans that are either immunocompromised, have burn wounds or have CF 
(Caldwell et al., 2009; Doggett et al., 1964; Elrod & Braun, 1942; Finck-Barbançon et 
al., 1997; Griffith et al., 1989; Lowbury & Fox, 1954; Niilo, 1959; Wretlind & 
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Pavlovskis, 1981; Young, 1980).  Up to 80 % of all CF adults have a P. aeruginosa lung 
infection (Beringer & Appleman, 2000; Patient-registry, 2008).  It is also one of the 
leading pathogens in nosocomial infections (Aloush et al., 2006).  P. aeruginosa is 
intrinsically resistant to many antibiotics and is capable of acquire resistance to other 
drugs over the course of the infection  (Fullbrook et al., 1970; Li et al., 1994; Li et al., 
1998).   
Both S. aureus and P. aeruginosa cause infections which can be difficult and 
expensive to treat.  Identifying the agents of infection is the first step in treatment.  In this 
study, SPR biosensors will be developed using Staphylococcus-specific and P. 
aeruginosa-specific antibodies.  The corresponding bacteria will be detected based on the 
change of light refraction that is measured when the bacteria binds to the antibody that is 
fixed on the gold sensor.   
 
4.3  Materials and methods 
4.3.1  Bacterial isolates. Escherichia coli DH5α (New England Biolabs, Ipswich, 
MA), Pseudomonas aeruginosa PAO1 (Holloway & Morgan, 1986), and Staphylococcus 
aureus ATCC 17672 were grown overnight (ON) at 37 °C in Luria Bertani (LB) broth 
(10 g/L tryptone, 5g/L yeast extract, 5 g/L NaCL).  One milliliter of the ON was placed 
into 5 mL of fresh LB and grown until an optical density at 600 nm (OD600) was between 
0.4 and 0.5.  The cultures were pelleted by centrifugation at 16.6 X g for 10 minutes at 4 
°C.  The pellets were resuspended in 1X phosphate buffer saline (PBS) pH 7.0.  The 
samples were pelleted and washed two more times with 1X PBS.  The pellets were 
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resuspended in the PBS to achieve a final concentration of 108 colony forming units per 
milliliter (cfu/mL). 
 
4.3.2  Determination of bacterial concentration.  For each isolate, the washed 
pellet was resuspended in 10 mL of phosphate buffer saline (PBS).  Serial dilutions were 
made up till 106 dilution factor.  One hundred microliters for the 104, 105, and 106 
dilutions were plated on LB plates.  The plates were grown ON at 37 °C.  Colonies were 
counted the next day to determine the colony forming units per milliliter (cfu/mL) for 
each isolate at its particular OD600.  Based on the cfu/mL determination, a specific 
amount of 1X PBS was added to each pellet to make a 108 cfu/mL solution.  Bacteria for 
each experiment was then grown to the OD600 reading used in the cfu/mL calculation so 
that fresh bacteria could be used in the SPR experiments.   
 
4.3.3  Reagents and instrumentation.  The Biosensing Instrument 3000 and the 
associated Biosensing software and gold sensor chips (Biosensing Instrument, Tempe, 
AZ) were used for all experiments.  All chemicals were purchased from Sigma-Aldrich 
(St. Louis, MO) unless otherwise noted.  The antibody that was reactive with P. 
aeruginosa was rabbit polyclonal IgG anti-P. aeruginosa whole cell (ABCAM ab68538; 
Abcam, Cambridge, MA).  Anti-Staphylococcus enterotoxin B, polyclonal was used to 
detect S. aureus (Thermo Scientific PA17248; Thermo Fischer Scientific, Waltham, 
MA).   
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4.3.4  Preparation of gold sensor chip.  Gold sensor chips were immersed in 50 
mM 11-mercaptoudecanoic acid overnight at 4 °C to allow self-assembled monolayer 
(SAM) formation. The chips were washed with deionized water and dried.    
 
4.3.5  Immobilization of antibodies.  The SAM modified gold sensor was placed 
onto the window of the instrument using a matching liquid (refractive index = 1.515).  To 
allow for baseline stabilization, the reference solution which was 1X PBS (pH 7.0) was 
allowed to flow through the system at a flow rate of 0.150 mL/min.   The flow rate was 
decreased to 0.050 mL/min once a baseline was established.  The flow injection method 
was used throughout all experiments.  The SAM was activated by injecting 125 cc of a 
1:1100 mM N-hydroxysuccinimide (NHS) and 400 mM N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC).  The reference solution was allowed to run for 
60 sec between injections to flush out the system.  To increase the directional binding of 
the antibody, Protein G was coupled to the activated SAM by injecting 125 cc of 10 
µg/mL Protein G in 1X PBS (pH 7.0)  into the instrument.  Any remaining unbound 
activated ester groups were deactivated by 125 cc 1 M aqueous ethanolamine solution 
(pH 8.0).   Sixty seconds later, 125 cc of 1 mg/ml antibody was added.  The Protein G 
molecules that have no attached antibodies were blocked with 125 cc of 1 % BSA 
(depending on the experiment).  Excess BSA was removed from the sensor by running 
the reference buffer for 60 seconds.  All injection times were 10 µL/min except for the 
antibodies and bacteria which were set at 5 µL/min.   
The assembly process was monitored continuously by measuring the angle of 
light reflection (SPR response) in mDegrees.  The data was plotted on to a sensograph 
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with time in seconds on the x-axis versus resonance in mDegrees on the y-axis.  Peaks in 
the sensograph indicated changes in SPR response caused by the injected chemicals 
coming into contact with the functionalized gold surface.  Unbound molecules were 
washed away by carrier buffer causing the peak to decrease and a new baseline to form 
(Figure 4.6).  The difference between post-injection and pre-injection baselines 
(difference in angles) indicated the change in plasmon resonance caused by molecules 
adsorbing onto the gold layer (Figure 4.6).  The angle of light reflection shifted as each 
compound was added to the sensor.   
 
 
 
 
 
 
 
 
 
Figure 4.6:  A representative sensograph.  A theoretical SPR sensograph is depicted with 
time in seconds on the x-axis and angle reflection on the y-axis.  Baseline reflections are 
stable in between injections.  Injections cause a change in reflection.  The reference 
buffer washes away the excess injected chemical.  The adsorption of the chemical on to 
the gold layer is determined by subtracting the pre-injection baseline reference angle 
from the post-injection baseline reference angle i.e. Baseline Reference Buffer 2 – 
Baseline Reference Buffer 1. 
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Throughout the experiment, the carrier buffer of PBS continuously flowed past 
the sensor.  The SPR response to the reference buffer forms a baseline measurement 
which is recorded in a separate sensograph.  The sensograph produced from the injected 
compounds is subtracting from the reference sensograph, thereby removing background 
noise.  The resulting normalized data is plotted on another sensograph and analyzed using 
the Biosensing Real Time Data Analysis software (Biosensing Instrument, Tempe, AZ). 
 
4.3.6  Detection of S. aureus and P. aeruginosa.  The prepared immunosensors 
were tested using 125 cc of bacteria at difference concentrations. Bacterial concentrations 
ranged from 106 to 108 cfu/mL for S. aureus and 105 to 108 cfu/mL for P. aeruginosa.  
SPR was used to detect the interaction between S. aureus and anti-Staphylococcus 
antibodies, and P. aeruginosa and anti-P. aeruginosa antibodies.   
 
4.3.7  Determination of the sensitivity for the P. aeruginosa biosensor.   A 
second immunosensor was developed for P. aeruginosa.   In the previous experiments, 
BSA was used to decrease non-selective binding.  However, BSA is a large molecule that 
increases the thickness of the layers on top of the gold surface.  SPR is less sensitive 
when the layers above the gold surface becomes too thick.  In addition, the instrument 
cannot detect SPR when the distance between the bacteria and the gold becomes too 
great.  Thus to increase the sensitivity of the sensor, BSA was not added during the 
assembly process. The immunosensor was tested using P. aeruginosa concentrations 
from 105 to 108 cfu/mL.   
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4.3.8  Determination of the specificity for the P. aeruginosa sensor.  To 
determine if BSA was necessary to reduce non-selective binding, another P. aeruginosa 
biosensor was developed without BSA.  The sensor was first tested with 108 cfu/mL of E. 
coli.  After the reference buffer washed away any unbound bacteria, the sensor was tested 
using 107 and 108 cfu/mL of P. aeruginosa.     
 
4.4  Results  
In order to detect the presence of bacteria in a solution, immunosensors were 
manufactured using a layer-by-layer self assembly protocol.  The immersion of the chip 
in 50 mM 11-mercaptoudecanoic acid allowed self-assembled monolayer (SAM) 
formation of thiols which were activated using a 1:1 ratio of NHS:EDC. The generated 
reactive ester groups formed amide bonds with Protein G molecules.  The antibodies 
were then anchored to the chip via Protein G.  Free Protein G molecules were blocked 
with BSA to finish the assembly of the sensor.  The SPR instrument monitored each 
molecule absorbing on to the gold layer in real time.  The molecules absorbed onto the 
gold increased the thickness of the layer on top of the gold surface changing the plasmon 
resonance which affected the angle of light reflection.  After each chemical was injected 
into the carrier solution, the change in SPR angle (mDegrees) was determined. The 
baseline between peaks on the sensograph indicated the angle of incident for the 
reference or carrier buffer flowing pass the sensor which is dependent on the thickness of 
the layer above the gold chip.  The peaks represented the chemical injected into the 
carrier solution flowing over the sensor.  The angles of reflection within the peak area do 
not indicate molecules adsorbing onto the gold.  Rather, adsorption of molecules onto the 
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gold sensor is determined by the difference in baseline measurements before and after 
injection (Figure 4.6).   
 
4.4.1 Self assembly of S. aureus immunosensor.  In the S. aureus 
immunosensor, the reference buffer flowing past the sensor gave a baseline angle of light 
incident at 37.02 mDeg (Figure 4.7).  This angle shifts within a degree or two as the 
buffer flows above the sensor due to the limitation of the SPR instrument.  The injection 
of NHS:EDC caused the reflection to change 41.9 mDeg in comparison to the initial 
baseline (Figure 4.7).  The reference buffer washed away unbound molecules.  A solution 
of Protein G was injected and the reflection changed 47.523 mDeg (Figure 4.7).  The 
reference buffer continued to run as the solution of the anti-Staphylococcus antibodies 
was injected.  The SPR response was an angle 100.63 mDeg of light reflection (Figure 
4.7).  Unbound 1 % BSA was injected to block free Protein G molecules.  The angle of 
incidence was changed to 187.29 mDeg (Figure 4.7). 
 
4.4.2  Detection of S. aureus.  The layer-by-layer self assembled immunosensor 
was used to detect various concentration of S. aureus.  The sensor was first tested with 
106 cfu/mL of S. aureus in PBS (Figure 4.7).  The peak in the sensogram after the 
injection showed a 22.36 mDeg angle of reflection.  Baseline measurements before and 
after injection were not different; there was no change in light reflection (Figure 4.7).  
There was a slight change in the angle of light reflection for 107 cfu/mL at 16.73 mDeg.  
However, a more pronounced reflection was observed for 108 cfu/mL at 78.27 mDeg. 
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Figure 4.7: Detection of S. aureus using an immunosensor.  ∆y is the difference in angle of light reflection between post-injection 
and pre-injection.  The sensor was self assembled by injecting NHS:EDC which allowed the Protein G to bind to the SAM layer 
on the gold chip.  Ethanolamine deactivated any unbound ester groups.  The anti-Staphylococcus antibodies were injected at 1800 
seconds and a change in angle reflection was seen.  Injected BSA was used to block free Protein G.  Solutions of S. aureus at 106, 
107, and 108 cfu/mL were injected into the SPR instrument.  The angles of light reflection changed at 107 and 108 cfu/mL 
injections.  
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4.4.3 Detection of P. aeruginosa.  The 107 cfu/mL solution of P. aeruginosa 
increased the angle of reflection 16.15 mDeg from the pre-injection (Figure 4.8).  The 
first injection of the 108 cfu/mL solution contained an air bubble which flowed over the 
sensor changing the refractive index of the sensor interfering with the plasmon waves 
(Figure 4.8).  The next injection increased the angle by 36.34 mDeg as compared to the 
pre-injection measurement.  The same concentration was injected one more time showing 
a reflection difference of 80.77 mDeg (Figure 4.8). 
 
4.4.4 P. aeruginosa immunosensor used for sensitivity tests.  An 
immunosensor was developed to determine if sensitivity of the SPR response could be 
increased in the absence of BSA. The baseline of the thiol gold coated sensor was 
established.  The injection of NHS:EDC changed the angle of light reflection 150 mDeg 
(Figure 4.9).  Protein G injection caused a 131.70 mDeg change in angle (Figure 4.9).  
The ethanolamine injection decreased the incident angle below the pre-injection baseline 
by 131.46 mDeg (Figure 4.9).  The injection of anti-P. aeruginosa antibodies changed the 
light reflection 165.48 mDeg (Figure 4.9).  The 105 cfu/mL of P. aeruginosa in PBS was 
washed over the immunosensor causing a peak in the sensograph.  There was no 
difference in angle between the pre and post-injection.  Angles of reflection for 106, 107, 
and 108 cfu/mL were 13.14, 30.64, and 127.62 mDeg, respectively (Figure 4.9). 
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Figure 4.8: P. aeruginosa detection using an immunosensor.  ∆y is the difference in angle of light reflection between post-
injection and pre-injection.  The sensor was self assembled by injecting NHS:EDC which allowed the Protein G to bind to the 
SAM layer.  Ethanolamine deactivated any unbound ester groups.  The anti-P. aeruginosa antibodies were injected at 4300 
seconds which shifted the angle of reflection.  Injected BSA was used to block free Protein G.  Solutions of P. aeruginosa at 106, 
107, and 108 cfu/mL were injected into the SPR instrument.  The first 108 cfu/mL injection contained an air bubble which caused 
error in the SPR response.  The solution was injected two more times.  The 107 and both 108 cfu/mL solutions were detected. 
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Figure 4.9:   Sensitivity of the P. aeruginosa immunosensor.  ∆y is the difference in angle of light reflection between post-
injection and pre-injection.  The sensor was assembled by injecting NHS:EDC which allowed the Protein G to bind to the SAM 
layer on the gold chip.  Ethanolamine deactivated any unbound ester groups.  The anti-P. aeruginosa antibodies were injected at 
3300 seconds and a change in angle reflection was seen.  The carrier solution contained air and the bubble passed over the sensor 
at approximately 4100 seconds.  The 105 cfu/mL P. aeruginosa solution did not change the angle of light reflection.  Injections of 
P. aeruginosa solutions 106, 107, and 108 cfu/mL were followed by changes in angles of reflection.   
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4.4.5  The effect of BSA on non-selective binding using the P. aeruginosa 
immunosensor.  BSA is added to immunosensors to block free Protein G molecules to 
reduce non-selective binding (Dong et al., 2008; Jung et al., 2006; Jung et al., 2007; Lu 
et al., 2001).  The addition of BSA increases the thickness of the layers which can 
decrease the sensitivity of the SPR response.  In addition, not all published 
immunosensors use BSA (Fratamico et al., 1998; Waswa et al., 2006).  Therefore, an 
experiment was performed to determine if the P. aeruginosa immunosensor would give 
false positive results if BSA was not excluded (Figure 4.10).  An immunosensor was 
designed as described earlier to include the anti-P. aeruginosa antibody but exclude BSA.  
Briefly, the baseline of the thiol gold coated sensor was established at -10 mDeg.  The 
injection of NHS:EDC changed the angle of light reflection 139.01 mDeg (Figure 4.10).  
Protein G injection did not affect the light reflection.  The solution was injected again and 
the reflection changed 18.58 mDeg (Figure 4.10).  The ethanolamine injection decreased 
the incident angle below the pre-injection baseline by 41.81 mDeg (Figure 4.10).  The 
anti-P. aeruginosa antibodies injection changed the light reflection 357.73 mDeg (Figure 
4.10).  The reference buffer contained an air bubble which caused a spike in the 
reflection.  To test for non-selective binding, a solution of E. coli, which should not bind 
to anti-P. aeruginosa antibodies, was used.  A 108 cfu/mL solution of E. coli was injected 
and changed the light reflection by 7.32 mDeg.  The 107 and 108 cfu/mL P. aeruginosa 
solutions produced an angle of reflection of 103.96 and 74.26 mDeg, respectively (Figure 
4.10). 
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Figure 4.10: Specificity of P. aeruginosa immunosensor.  ∆y is the difference in angle of light reflection between post-injection 
and pre-injection.  The sensor was assembled by injecting NHS:EDC which allowed the Protein G to bind to the SAM layer on 
the gold chip.  Ethanolamine deactivated any unbound ester groups.  The anti-P. aeruginosa antibodies changed the  angle of 
reflection.  The carrier solution contained air and the bubble passed over the sensor at approximately 4800 seconds.  Once the 
baseline was stable, a 108cfu/mL E. coli solution was injected at 5700 seconds and no change in angle was seen.   Angular shifts 
occurred for 107, and 108 cfu/mL P. aeruginosa solutions.   
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4.5  Discussion 
 Bacteria can be identified using antibody-antigen interactions. SPR 
immunosensors have been shown to detect numerous bacteria based on antibody-antigen 
interaction.  This study attempted to develop two immunosensors to detect bacteria, 
specifically S. aureus and P. aeruginosa.  These bacteria cause infections in humans, are 
responsible for the bullk of nosocomial infections, and can be difficult to treat due to 
antibiotic resistance (Aloush et al., 2006; Ashley & Brindle, 1960; Fullbrook et al., 1970; 
Li et al., 1994; Li et al., 1998; Noskin et al., 2005; Wertheim et al., 2005; Zetola et al., 
2005).  The spread and the disease process of these organisms can be reduced by rapid 
detection in patients. 
 
4.5.1  SPR immunosensor detected S. aureus.  Using layer-by-layer self 
assembled, a Staphylococcus immunosensor was made.  At the beginning of the 
assembly, the sensor had layer of gold and a SAM of 11-mercaptoundecanoic acid 
molecules (Figure 4.7).  NHS:EDC chemically reacted with the 11-mercaptoumdecanoic 
allowing Protein G to bind thereby shifting the angle of reflection (Figure 4.7).  The anti-
Staphylococcus antibodies attached to the Protein G molecules fixed on the sensor 
causing the 100.63 mDeg change in angle (Figure 4.7).  Unbound 1 % BSA was injected 
to block free Protein G molecules and the angle of reflection changed 187.29 mDeg 
(Figure 4.7).   
Upon the completion of the sensor, solutions of S. aureus were used to determine 
if the sensor could detect bacteria.  A change in light reflection was observed while the 
106 cfu/mL solution flowed past the sensor as determined by the peak in the sensograph 
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(Figure 4.7).  Upon completion of the injection, the reference buffer carried away any 
unbound molecules.  The angle of reflection shifted and stabilized at the same angle of 
reflection that was observed before the injection.  Thus, no bacteria in the 106cfu/mL 
solutions were captured by the antibodies on the sensor.  Increasing the concentration of 
bacteria (107 and 108 cfu/mL) increased the angle of reflection proportionally (Figure 
4.7).  As that angular shift of light reflection indicates a change in the layer adsorbed on 
the gold sensor, it can be stated that the immunosensor assembled detected interactions 
between anti-Staphylococcus antibodies and S. aureus.   
The sensor was unable to detect cells less than 107 cfu/mL.  Sensitivity is a crucial 
characteristic of diagnostic assays.  Immunosensors for other bacteria and toxins have 
been developed with detection limits of 102 cfu/mL (Oh et al., 2004a; Oh et al., 2004b; 
Oh et al., 2005).  These sensors used SAM with various chemicals, Protein G/A, and no 
BSA (Oh et al., 2004a; Oh et al., 2004b; Oh et al., 2005).  Optimization of the self 
assembly protocol may increase the sensitivity of the sensor.  In addition, the effect of 
BSA on the sensitivity and specificity of the sensor should be examined.   
 
4.5.2  P. aeruginosa immunosensor detected solutions containing P. 
aeruginosa.  A P. aeruginosa immunosensor was assembled in the same manner as the 
Staphylococcus sensor (Figure 4.8).  The NHS:EDC chemically changed the SAM layer 
causing the angle of reflection to change by 41.07 mDeg (Figure 4.8).  There was no 
change in angle after the Protein G injection which indicted that no molecules were 
adsorbed on to the SAM layer.  To ensure that the sensor was properly designed, the 
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Protein G solution was injected again and the reflection changed 17.60 mDeg suggesting 
that molecules did bind to the ester group on the SAM layer (Figure 4.8).   
The ethanolamine injection deactivated any remaining ester groups.  The angle of 
light reflection shifted resulting in an angle that was less than the pre-injection angle 
(Figure 4.8).  The angular shift would indicate the molecules that were adsorbed onto the 
sensor before the ethanolamine injection were removed by the carrier solution containing 
the ethanolamine.  Removal of molecules decreased the thickness of the layer adsorbed 
onto the gold sensor and decreasing the angle of reflection.  This may be result of flow 
rate.  The carrier buffer ran for 60 seconds between each injection to ensure that any 
unbound molecules were carried away from the sensor.  This may have been too short of 
a time to ensure that unbound Protein G was removed from the surface of the sensor.  
Thus, the carrier buffer with ethanolamine continued to remove unbound Protein G 
decreasing the thickness of the layer on the gold and shifting the angle of reflection.  The 
decreased angle of reflection may have also resulted from the activity of ethanolamine.  If 
a portion of the SAM layer was free of Protein G and still reactive then the ethanolamine 
would deactivate the SAM layer, changing its shape and thus decreasing the thickness of 
the SAM layer.  The angle of reflection would decrease as more of the SAM layer was 
deactivated.  Both Protein G injections showed minimal changes in light reflection which 
suggests very few molecules attached and much of the SAM layer was left reactive which 
supports the ethanolamine explanation. 
The angle of reflection after the ethanolamine injection is still greater than initial 
baseline angle.  Continuing the assembly of the sensor, the anti-P. aeruginosa antibodies 
were injected.  The angle of light reflection shifted by 205.38 mDeg (Figure 4.8).  This 
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significant shift indicated that many antibodies attached to the sensor by coupling to 
Protein G molecules.  The angular shift of 275.80 mDeg was observed upon the addition 
of BSA indicating free Protein G was blocked by BSA (Figure 4.8). 
The self assembled immunosensor was tested using 106, 107, and 108 cfu/mL of P. 
aeruginosa (Figure 4.8).  There was no angular shift with the first injection which 
showed the sensor did not detect the specific bacteria in the 106 cfu/mL solution.  There 
was an angular shift for the other concentrations (Figure 4.8).  The change in angle was 
proportional to the increase in cell concentrations.  The second 108 injection caused the 
greatest change in angle indicating that the sensor had not reached saturation with the 
previous injections.   
Despite the unexpected angular shifts observed during the assembly process, the 
sensor clearly detected the presence of P. aeruginosa as shown by the angular shifts 
observed with the 107 and 108 cfu/mL injections.  As with the Staphylococcus 
immunosensor, the sensor should ideally be able to detect less concentrated solutions. 
 
4.5.3  BSA decreases the sensitivity of the P. aeruginosa sensor.  An 
immunosensor was developed to determine if sensitivity of the SPR response could be 
increased if BSA was excluded.  The angular shifts for the NHS:EDC, Protein G, 
ethanolamine, and anti-P. aeruginosa antibody injections were similar to the previous P. 
aeruginosa sensor (Figure 4.9).  The assembled sensor was tested with various 
concentrations of P. aeruginosa solutions.  The lowest limit of detection for an 
immunosensor was 106 cfu/mL for the P. aeruginosa sensor assembled without BSA.  
The presence of BSA lowered the threshold of detection to 107 cfu/mL for the other two 
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chips.  This suggests that BSA does influence the sensitivity of the P. aeruginosa 
biosensor.  Even without the BSA, the sensitivity of the sensor is much lower than 
published chips (Oh et al., 2004a; Oh et al., 2004b; Oh et al., 2005).   
 
4.5.4  Non-BSA chips shows selective binding of bacterial cells with cognate 
antibodies.  Accuracy and sensitivity are both important characteristics of a diagnostic 
tool.  Therefore, an experiment was performed to determine the selectivity of a sensor 
(Figure 4.10).  To test for non-selective binding, a solution of 108 cfu/mL E. coli was 
injected into the instrument.  The angle of light reflection shifted by 7.32 mDeg.  The 
shift indicated that high concentrations of E. coli non-specifically adsorbed to the sensor.  
The 107 and 108 cfu/mL P. aeruginosa solutions produced an angle of reflection of 
103.96 and 74.26 mDeg, respectively (Figure 4.10).  These results proved that the sensor 
was assembled correctly, functional, and specific.  The SPR response for the E. coli was 
insignificant in comparison to the response for the P. aeruginosa solution at the same 
concentration.  A similar insignificant angular shift was observed with E. coli on a  
Salmonella specific sensor (Waswa et al., 2006).  Future experiments need to be 
performed to determine if BSA is needed to prevent non-selective binding of other 
bacteria. 
 
4.5.5  Optimization of immunosensors.  In order to use SPR immunosensors as 
a diagnostic tool, the accuracy, specificity, and sensitivity of the sensors need to be 
improved.  SPR response can be affected by the instrumentation, environment and by the 
choice in chemicals used in the layer-by-layer self assembly process. 
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The instrument is very sensitive to the environment and should be placed in a 
temperature controlled area (Dudak & Boyaci, 2009).  Lack of temperature control causes 
an increase in standard deviation between readings (Dutra et al., 2007; He et al., 2007; 
Matsumoto et al., 2005; Naimushin et al., 2003).  Additionally, the instrument uses 
microfluidics to transfer chemicals to the gold sensor chip (Biosensing Instrument, 2006).  
The flow rate of the reference buffer and the injections can be modified to increase the 
adsorption of molecules to the sensor (Dudak & Boyaci, 2009).  Ideally, the flow rate will 
enable bacteria to bind to the antibodies before the reference buffer washes them away.  
Though if the rate is too slow, the antigens will form aggregates and not be able to bind 
to the antibodies.  On the other hand if the rate is too fast, then the mass transfer 
limitations will be minimized and antigens will flow past the antibodies unable to bind 
(Dudak & Boyaci, 2009; Skottrup et al., 2008).  The flow rate used in this study was an 
intermediate rate (10 µL/min for reagents and 5 µL/min for antibodies and bacteria); 
other published work used anywhere from 3 to 100 µL/min (Fratamico et al., 1998; Oh et 
al., 2004a; Oh et al., 2004b; Oh et al., 2005; Subramanian & Irudayaraj, 2006; Waswa et 
al., 2006).  In addition, the reference buffer must run in between injections.  Enough time 
needs to be allowed to ensure that excess or unbound molecules are washed away from 
the sensor.  Sixty seconds was used in this study which may have not been enough time 
to clean the sensor.  This factor is rarely detailed in published material.  Some of the 
published studies do not use microfluidics for assembly; rather the chip is immersed in 
Protein G or the antibody for hours to days and then rinsed off with a buffer (Oh et al., 
2004a; Oh et al., 2004b; Oh et al., 2005).  Longer incubation times with more effective 
rinses may increase the efficiency of the molecules binding to the sensor. 
 189 
 
Solutions used in the SPR sensor assembly also affect the SPR response.  First, 
the ionic solution and pH of the buffers may need to be optimized.  SPR sensitivity is 
affected by ionic strength as it directly affects the supramolecular interactions between 
antibody and the antigen (Srilatha & Murthy, 2006).  Besides PBS, HEPES buffer saline 
has been used (Fratamico et al., 1998; Waswa et al., 2006).  The composition of the PBS 
may have not provided the optimum ionic strength that would lead to the appropriate 
binding affinity constants.  The pH of the PBS solution also needs to be optimized for 
molecule interaction, especially the binding of antibodies to Protein G (Keeler et al., 
2007; Srilatha & Murthy, 2006; Waswa et al., 2006).  One study has shown that more 
antibodies bind to Protein G if a pH 5 is used while pH 7 is better for a sensor without 
Protein G (Fratamico et al., 1998).  In this work, pH 7 was used and that may have 
affected the angular shift of light reflection in response to the antibody (Fratamico et al., 
1998).   
The properties of the sensor can also be improved by using other methods to fix 
the antibodies to the sensor, such as coating the sensor with streptavidin and labeling the 
antibody with biotin (Dudak & Boyaci, 2007).  This method has been used to detect E. 
coli with a sensitivity  of 102 cfu/mL (Dudak & Boyaci, 2007).  This conjugation system 
may increase the detection limit for the P. aeruginosa and Staphylococcus 
immunosensors.  
The assembly process can also be optimized by changing the chemical used to 
form SAM.  There are some studies that conclude mixed SAMs (using two different 
alkanethiols) can increase the SPR response (Taylor et al., 2006; Tsai & Li, 2009).    
 190 
 
Once all these optimizations are determined, a sensor can be developed that is 
accurate, reproducible, and sensitive.  At this time, the SPR immunosensors developed in 
this study lack the sensitivity to be used to detect S. aureus and P. aeruginosa in a 
sample. 
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5.1  Overview 
 
 Cystic fibrosis is a genetic disorder that affects approximately 30,000 children and 
adults in the United States (Patient-registry, 2008).  In addition, one out of 31 people are 
have a mutation in one copy of the cftr gene encoding the cystic fibrosis transmembrane 
conductance regulator protein (Patient-registry, 2008).  If a person inherits two copies of 
the gene each carrying a mutation then the individual can aspect to have difficulties with 
their digestive, reproduction, and respiratory systems (Patient-registry, 2008).  During the 
1950’s few of these patients would live to attend elementary school.  Due to 
advancements in science and medicine, the median age of survival has risen to 37.4 years 
in 2008 (Patient-registry, 2008).  The leading cause of morbidity and mortality in CF 
patients is lung disease which stems from chronic microbial infection. 
 The CF lung contains a dehydrated layer of mucus which reduces the ability of 
the cilia to beat the microorganisms out of the lungs (Andersen, 1938).  The limited 
mucosal clearance, the inability of the host immune system to eradicate the infection, and 
development of antibiotic resistance leads to chronic infections that destroy the lungs 
leaving the patient in need of a lung transplant (Patient-registry, 2008).  In 2008, 158 
people received a transplant to extend their lives (Patient-registry, 2008).  Lung 
transplants are risky and the supply of lungs is limited (Adler et al., 2009).  The most 
likely way to increase CF life expectancy is to decrease bacterial and fungal lung load in 
the lungs.  In order to treat and reduce infections, one must identify the causative agent 
and understand the role the organism plays in the lung. 
 This dissertation served to further understand the CF lung infection.  First, the 
composition of the bacterial community in the CF lung and its dynamics over time were 
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determined using LH-PCR (Chapter 2).  Second, the members of the community both 
bacteria and fungi were identified using 454 sequencing (Chapter 3).  In addition, 
correlations between the diseased and healthy bacterial communities were identified 
(Chapter 3).  Thirdly, a bacterial diagnostic tool targeted towards CF pathogens was 
developed using SPR (Chapter 4).   
 
5.2  Bacterial community profiling of the CF lung 
 Based on culturing methods, it was thought only a few bacteria including  
Staphylococcus aureus, Haemophilus influenzae and Pseudomonas aeruginosa infected 
the CF lung (Whittier, 2001).  S. aureus, the predominant pathogen in children, is usually 
succeeded by H. influenzae later in childhood and P. aeruginosa becomes the 
predominant pathogen during adolescence, reaching a prevalence rate of 80% in adults 
(Beringer & Appleman, 2000; Patient-registry, 2008).  With the advent of molecular 
tools, it became known that the CF lung community is larger and more diverse than 
culturing results had show (Armougom et al., 2009; Bittar et al., 2008; Harris et al., 
2007; Rogers et al., 2003).  One of the earliest studies analyzed CF patient sputa and 
bronchoscopy samples with T-RFLP (Rogers et al., 2003).  The common pathogens, P. 
aeruginosa, Burkholderia cenocepacia, Staphylococcus aureus, and H. influenzae were 
identified in the CF samples (Rogers et al., 2003).  In addition, Achromobacter 
(Alcaligenes) xylosoxidans, Rhodotorula mucilaginosa, Abiotrophia spp, Bacteroides 
gracilis, Eubacterium brachy, Mycobacterium mucilaginosus, Mycoplasma salivarium, 
Porphyromonas salivae, Ralstonia spp, Staphylococcus hominis, Streptococcus 
anginosus, Treponema vincentii, Veillonella spp, Burkholderia gladioli, 
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Stenotrophomonas maltophilia and Pandoraea atypical were also shown to be members 
of this polymicrobial infection (Rogers et al., 2003).  Large scale Sanger sequencing 
projects continued to resolve the bacterial community and revealed the presence of 
organisms that were not previously associated with the CF lung.  Moxaxella cattharalis, 
Granulicatella elegans, Inquilinus limosus, Granulicatella adiacens, Rothia 
mucilaginosa, Dialister pneumosintes, Dolosigranulum pigrum, Lysobacter, Coxiellaceae 
were identified from either bronchoalveolar or sputum samples from CF patients (Bittar 
et al., 2008; Harris et al., 2007; Rogers et al., 2003).  These molecular studies indicate 
that the total ecology of the CF lung niche remains an open question.  This research 
continued to identify the bacterial community in the CF lung by examining snap shots of 
the overall bacterial community.   
Though the composition of the lung niche is being teased apart, a larger question 
still needs to be addressed.  The interactions between these organisms, the host, and the 
disease process are not well understood.  There are some correlations with patient age 
and infection.  As noted earlier, S. aureus is most often identified in children and P. 
aeruginosa is associated with adulthood (Beringer & Appleman, 2000; Patient-registry, 
2008).  Yet, the molecular studies have identified S. aureus in adults (Bittar et al., 2008).  
Culturing results also vary throughout a patient’s life indicating that some bacteria are 
transient while others are constantly present in the community regardless of antibiotic 
therapy (Beringer & Appleman, 2000; Patient-registry, 2008; Rogers et al., 2010; Smith 
et al., 2006).  Therefore it can be hypothesized that the bacterial community in the CF 
lung is dynamic.  This study used LH-PCR to obtain a snap shot image of the bacterial 
community in a CF sample at the time of collection.  The presumptive identities of the 
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organisms present in the sample were determined.  The bacterial profiles were also used 
in an attempt to understand how the community as a whole can be affected by the host 
and other community members over a period of time. 
 In this study, 19 CF sputa samples from adult patients in Miami, FL were 
analyzed for the presence of bacteria using LH-PCR (Chapter 2; (Doud et al., 2009)).  
The profiles generated demonstrate the complexity and uniqueness of the bacterial CF 
lung community (Chapter 2, Supplemental Figure 2.6 and 2.7).  Each peak in a profile 
represents at least one bacterium.   The V1_V2 profiles for 12 of the CF samples 
contained multiple peaks and were different from one another.  The most complex sample 
contained eight amplicons (Chapter 2, Figure 2.1A). Seven of the samples had identical 
V1_V2 profiles containing one peak at 342 bp (Chapter 2, Figure 2.1B).  In contrast, all 
V1 profiles contained multiple amplicons (10-30) and each profile was different 
demonstrating that lung communities are unique to a patient (Chapter 2, Figure 2.7 and 
Table 2.1).  The profiles from the V1_V2 region were more similar than the V1 LH 
profiles.  Thus, the V1 region had a higher power of discrimination than the V1_V2 
region.  The LH profiles provided snap shot pictures of the bacterial communities further 
highlighting the diversity and complexity of the CF lung infections.   
The drawback to LH-PCR is the lack of species identification.  It was first thought 
that organisms within in one genus would have the same length for a particular variable 
region.  A bioinformatic analysis using the newly designed AmpliQué highlighted the 
presence of extreme length variability in the V1_V2 region of the 16S rRNA gene 
(Gonzalez et al., 2009).  Not only do strains within a species vary in amplicon length, 
multiple genera can produce the same amplicon length.  Identification of bacteria in an 
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LH profile based on one amplicon length is nearly impossible.  Identification using LH-
PCR may be attainable if multiple regions of the 16S rRNA gene are used to profile the 
same sample.  Cloning and sequencing of the amplicons is the only way to identify an 
organism. 
Identification using other community profiling techniques can also be 
challenging.  T-RFLP has been used to analyze CF samples (Rogers et al., 2003; Rogers 
et al., 2004; Rogers et al., 2006; Rogers et al., 2009; Rogers et al., 2010).  This technique 
produces the same variable length fragments as LH-PCR and then the amplicons are cut 
with a restriction enzyme.  This additional step increases the discriminatory power of the 
technique (Rogers et al., 2003).  Bacteria identification is still presumptive as that the 
length of the amplicon generated from the restriction digestion can still be the same for 
multiple organisms.  Identification of bacteria is confirmed by cloning and sequencing 
(Rogers et al., 2003; Rogers et al., 2004). Identity of bacteria in a community is not 
easily determined with T-RFLP or LH-PCR but the techniques can easily provide an 
estimate of bacterial diversity associated with the sample (Doud et al., 2009; Rogers et 
al., 2003; Rogers et al., 2004).  However, community profiling can provide information 
on community dynamics.   
Microbial community dynamics have traditionally been studied in the field of 
ecology.  Many environmental factors such as nutrients, temperature, fertilization 
practices, and metal pollutants have been found to have an effect on the bacterial 
community in soil (Entry et al., 2008; Gunapala & Scow, 1998; Mills et al., 2003; 
Moreno et al., 2006; Vinas et al., 2005) and in marine and fresh water (Boer et al., 2009; 
Carrero-Colon et al., 2006; Crump et al., 2003; Simek et al., 2001).   
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LH-PCR and T-RFLP are quite commonly used in ecology to observe and 
understand the relationship between members of the community and external factors.  
The microbial ecology methodologies can be applied to microbial communities 
associated with infections.   
This study which used LH-PCR is the first to observe bacterial community 
dynamics in the CF lung.  One patient produced expectorated sputa multiple times in one 
day and then again one year and two years later.  Minor variations in the LH profile were 
seen in the samples taken from one day at all time points (Chapter 2, Figure 2.5).  In 
contrast, the bacterial profiles generated from samples at different time points (M1, M3, 
M16, and M17) were quite different from one another and from those samples given on 
the same day in M22.  Hence, there is a temporal variability in the CF lung bacterial 
community indicating the community is not static but rather dynamic (Chapter 2, Figure 
2.5).   
Other human associated bacterial communities have been found to be constant 
rather than dynamic.  Pyrosequencing was used to determine the composition of bacteria 
communities associated with various spots on the healthy human body (Costello et al., 
2009).  Samples were collected on two consecutive days and then a month later for two 
additional consecutive days.  The researchers concluded that each habitat has its own 
characteristic community and the communities were relatively stable over time (Costello 
et al., 2009).  The healthy human may contain a more stabilized microbiota because the 
human is not influenced by pathogenic microbes and therapeutic drugs (Hilty et al., 
2010) 
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The instability of the CF lung eubacteriome could be attributed to antimicrobial 
therapy.  To address this hypothesis, LH profiles were generated over a six month period 
from two individuals undergoing antibiotic treatment (Chapter, Table 2.2).  The variation 
in profiles from the medicated patients was much more dramatic than the changes in the 
communities from the stable patient.  In addition, the most dramatic changes (drastic 
changes in abundance and disappearance of peaks) correlated with changes in the 
patient’s antibiotic treatment (Chapter 2; Table 2.2).  Therefore, antibiotics are a potential 
driver of the CF bacterial community.  CF individuals from infancy are under periods of 
antibiotic treatment.  The continuous use of antibiotics has most likely disrupted the lung 
flora.  Antibiotic treatment has already been established as a driver of bacterial 
communities present in the mouse gastrointestinal track, the trachea of intubated people, 
and chronic wounds (Antonopoulos et al., 2009; Flanagan et al., 2007; Price et al., 2009).   
This study is the first to track the bacterial community in the CF lung over time.  
Although the study used a small sample size over a relatively short period of time, 
changes in the presence and abundance of amplicons in the LH profiles could be seen. To 
accurately identify the drivers of the community, a more comprehensive long term study 
needs to be performed.  Armed with the patient’s antibiotic information and long term 
sampling, it should be possible to determine the effectiveness of a drug against pathogens 
in the CF lung.  This could eventually lead to more effective treatments.  In addition, 
other drivers of the bacterial community need to be defined.  The composition of the 
bacterial community may be influenced by the patient’s age, ethnicity, cftr mutation or 
daily environment. 
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Future studies.  To understand the community dynamics of the CF lung, the core 
biome or baseline community of the healthy human mouth and nasopharyngeal regions 
must be determined.  Several recent studies have determined the microbiome in the oral 
cavity and lungs from healthy individuals (Ghannoum et al., 2010; Hilty et al., 2010; 
Keijser et al., 2008; Lazarevic et al., 2009; Zaura et al., 2009).  This information should 
be compared to CF data to discern the presence of unique organisms and their role in CF 
pulmonary failure.  Healthy samples, in addition to CF samples, can also be collected and 
analyzed as controls during a long term study.  It would be advantageous to use age, 
gender, and race matched samples.  Samples from healthy individuals that live with the 
CF patient could also be used to look at the role the environment has on the community.       
A much large sample size is needed to corroborate the preliminary results of this 
study.  Samples from CF patients from both genders, multiple races/ethnicities, different 
ages, and cftr mutations are needed.  In addition, the health of the patient (weight, lung 
function, disease progression) should be recorded.  Samples should be collected quite 
often, at least monthly though more often would be preferred for a long period of time (a 
year or more).   
Ideally, the analysis of sputa or BAL samples using a community profiling 
technique such as LH-PCR should be performed in conjunction with a sequencing 
technique, such as 454 pyrosequencing.  LH-PCR would provide bacterial profiles of the 
samples.  Sample profiles that show change from one time point to the next can then be 
further analyzed using sequencing.  The identity of the organisms and their relative 
abundance from each community would be compared with other time periods.  Using 
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multivariate statistics, changes in community can be identified and correlated with patient 
characteristics to identify the drivers of the CF community.   
 
5.3  High throughput 454 sequencing identifies bacteria and fungi associated with 
the CF lung 
Community profiling and Sanger sequencing projects have been used to study the 
polymicrobial nature of the CF lung (Armougom et al., 2009; Bittar et al., 2008; Harris et 
al., 2007).  These studies have shown that the bacterial communities are diverse and 
unique to each patient.  The list of bacteria associated with the CF lung as noted in the 
previous section is getting longer with every study. 
The CF lung can also be inhabited by fungi.  Species-specific PCR and culturing 
have identified a few fungi, such as Aspergillus and Candida (Bakare et al., 2003; Cimon 
et al., 2001; Mearns et al., 1967).  There have been reports of Scedosporium 
apiospermum, Exophilia sp., and Wangiella dermatitidis being cultured from CF sputa 
(Defontaine et al., 2002; Dixon & Polak-Wyss, 1991; Hennequin et al., 1997; Horré et 
al., 2004; Horré et al., 2009; Rogers et al., 2003; Williamson et al., 2001).  Recent 
statistics have shown that there is an increase in the prevalence of fungi being detected in 
the CF patient which may be a consequence of aggressive antibacterial therapy (Nagano 
et al., 2007).  Yet, the diversity of the fungal community has not been previously 
analyzed with community profiling techniques or sequencing.  A more comprehensive 
study is needed to determine if the fungal community is as diverse and unique as the 
bacterial community.   
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To resolve the microbiome, high throughput 454 sequencing was used to analyze 
the sputa from 19 south Floridian CF patients.  This study is the first to use this 
technology to analyze the bacterial and fungal communities simultaneously in the same 
samples. Multivariate statistics was used to identify similarities between the communities 
and the relationship of the host’s gender and ethnicity with the microbial community.  
The CF microbial communities were also compared to the communities sequenced from 
healthy oral rinses.   
The unique polymicrobial nature of the CF lung was shown by the data.   
Sequencing results identified numerous bacteria in the CF lung, some of which were not 
previously identified in other metagenomic studies (Armougom et al., 2009; Bittar et al., 
2008; Harris et al., 2007; Rogers et al., 2003; Tunney et al., 2008).  Thirty-four taxa were 
identified in the 18 samples.  All samples contained numerous organisms with the 
average of 9.6±3.3 taxa present.  Pseudomonas or Streptococcus were present in 16/18 
samples.  Chryseomonas was present in 15 samples and was the most abundant organism 
in 14 samples.  Fourteen samples contained sequences from Micrococcineae and 
Prevotella.  Chryseomonas, Flavimonas, and Moryella may potentially be novel bacteria 
in CF sputa. 
Many genera that contain common CF pathogens were sequenced including 
Pseudomonas, Haemophilus, Burkholderia, Staphylococcus, Achromobacter, and 
Stenotrophomonas (Chapter 3, Table 3.2).  In addition, many sequences corresponded to 
organisms that are known to be present in the oral cavity.  Some of these organisms are 
commensal while others are known to cause infections.  These oral sequences in the sputa 
may be contributed by oral bacteria that come in contact with the sputa during sampling 
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process or from bacteria that colonize the throat and lungs.  The role of oral associated 
organisms in the CF lung is unknown but it can be hypothesized that they play a role in 
lung disease progression (Bittar et al., 2008; Rogers et al., 2006).   
Some sequences were identified as organisms not cultured from CF samples but 
identified through sequencing (Bittar et al., 2008; Harris et al., 2007).  This analysis 
identified sequences belonging to three genera that that have never been cultured or 
sequenced from CF sputa or BAL (Chapter 3, Table 3.2).  Sequence hits for 
Chryseomonas and Flavimonas were obtained for some MTPS reads.  Both of these 
genera have been reclassified as Pseudomonas.  The species associated with those genera 
can be pathogenic and have not been associated with the CF lung.  Obtaining a full length 
16S rRNA sequence is needed to verify the identity of these sequences.  Sequences 
identified as Moryella were present.  Little is known about the anaerobe and this is the 
first time it has been sequenced from CF samples.  Overall, the 454 sequencing of the 
south Florida CF patients showed a more diverse eubacteriome in the CF sputa than other 
studies (Armougom et al., 2009; Bittar et al., 2008; Harris et al., 2007; Rogers et al., 
2003; Rogers et al., 2004; Rogers et al., 2006; Rogers et al., 2009; Rogers et al., 2010).   
 Many samples shared multiple taxa but statistically the communities were unique 
to each patient (Chapter 3, Figure 3.2).  Similarities between communities could not be 
attributed to patient’s gender or ethnicity (Chapter 3, Figure 3.2).  A much large sample 
size is needed to determine if gender and ethnicity affect the composition of the bacterial 
community. 
The bacterial communities in the CF sputa were compared to communities from 
healthy oral rinses.  PCO clustered healthy bacterial communities closely together and 
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separated from CF bacterial communities (Chapter 3, Figure 3.3).  Statistically, the 
overall bacterial community in the CF lung was quite different than the healthy oral 
samples.  Twelve taxa were present in both datasets most of which were associated with 
the oral cavity (Chapter 3, Table 3.4).  Achromobacter was present in one healthy sample 
which may indicate the person was not actually healthy.  Burkholderia was present in 
both groups; without the species, it cannot be determined if the pathogenic organism was 
present in the healthy sample.  Many of the common CF pathogens including 
Pseudomonas, Staphylococcus, and Stenotrophomonas were only sequenced in the CF 
samples.  The comparison of the communities indicated that some microbes sequenced in 
the CF samples may originate from the mouth.  
This study also used sequencing to identify the fungal taxa associated with the CF 
lung.  Previous to this research, the fungal community was thought to consist of a handful 
of fungi, mainly species of Aspergillus and Candida (Bakare et al., 2003; Cimon et al., 
2001; Mearns et al., 1967).  In contrast, 454 sequencing identified 33 taxa from 18 CF 
samples (Chapter 3, Figure 3.4 and Table 3.5 and Supplemental Table 3.8). The samples 
had an average of 26 ± 3 taxa.  Ten genera including Aspergillus were present in all 
samples. In regards to abundance, the most sequenced genus in 17 samples was Pichia 
with sequences from P. anomala, P. membranaefaciens, and Pichia sp.  The second most 
abundant genera in all 17 samples was Rhizoctonia (Chapter 3, Table 3.5).   
The opportunistic pathogen Candida albicans was present in eight samples.  In 
addition, the pathogens Aspergillus terreus, Aspergillus ustus, Cryptococcus neoformans, 
Exophilia, and Wangiella dermatitidis were present in many samples (Chapter 3, Table 
3.5 and Supplemental Table 3.8).  None of these patients were being treated for a fungal 
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infection yet the most abundant sequence in 17 samples was Pichia (P. sp., P. 
membranefaciens, and P. anomala).  Attempts should be made to corroborate the 
presence of the pathogenic fungi.   
Of the 33 genera present, 26 genera were environmentally associated fungi.  Their 
associated low abundances indicated the fungi were not colonizing the lung but rather 
transient members of the community originating from consumed food and inhaled air.   
Comparisons of the mycobiome established that each patient had a unique fungal 
community (Chapter 3, Table 3.5).  PCO statistically showed that gender and/or ethnicity 
did not contribute to the likelihood of organisms being shared between patients (Chapter 
3, Figure 3.5).  A correlation may be present when a larger sample size is analyzed.   
The mycobiomes in the CF sputa were compared to the fungal communities 
identified in healthy oral rinses (Chapter 3, Figure 3.6).  Based on the presence of genera, 
CF mycobiomes were clustered together and apart from healthy mycobiomes.  The two 
datasets shared 11 genera but at the species level only five organisms were in common.  
Four organisms were associated with the environment.  The remaining shared fungus was 
Candida albicans, an opportunistic pathogen that is commonly found in the mouth.  Both 
groups of samples contained numerous fungi present in the environment.  These fungi 
varied between the datasets which may be a result of the individuals living in two very 
different areas within the US. 
The CF sputa eubacteriome was established to be diverse containing pathogens, 
oral microbes, and environmental fungi.  The role of the organism in the progression of 
lung disease is unknown for the majority of the identified organisms.  The core biome of 
the oral cavity, nasal regions, throat, and bronchial tree should be determined to establish 
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which microbes are transient, beneficial to the host, or truly associated with the CF lung 
infection.  Deep sequencing may potentially determine the core biome but the 
significance of the other organisms not associated with the healthy community cannot be 
determined by sequencing alone. 
   
Future studies.  Patients who share the same cftr mutation can have different 
predominant pathogens in their microbiomes.  In addition, patients with the same 
pathogen can have completely different disease outcome.  These observations led 
researchers to study the CF microbiome.  In this study, the members of the microbiome 
were identified using deep sequencing.  These results have left more questions than 
answers.  First, is the assigned identity correct?  Secondly, are the sequences from 
metabolically active organisms?  Thirdly, what role does the community member play in 
the community?  All future CF community studies should address these three questions.   
To verify the identity of the organisms, the same CF samples can be sequenced 
using multiple genetic markers.  Using a bioinformatic program, the sequences can be 
joined to make longer contigs which are then used for identification.  Longer contigs will 
be more specific and thus organisms are more accurately identified.  If technology is 
improved, longer read lengths of one marker will be possible and multiple markers will 
not be necessary.  
Culturing the sequenced organism from the sample will also confirm its presence.  
For this method, it must be assumed that the identification obtained from a short 
sequencing read is correct.   Using selective media and growth conditions, the sequenced 
organism may be cultured.  The identities of the pure isolates can be verified by 
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sequencing the entire 16S rRNA gene for bacteria, 18S rRNA gene or the ITS regions 
located between the rRNA genes for fungi.  If the organism is cultured then it is 
obviously metabolically active in the lung. Using T-RFLP, and sequencing, 
Streptococcus milleri group was detected and subsequently cultured from CF samples 
(Sibley et al., 2008; Sibley et al., 2010).  This species is not readily identified using 
routine clinical culturing protocols (Sibley et al., 2010).  Creating growth media to isolate 
organisms identified by sequencing is laborious and will not always work for all 
microbes.   
A non-culturing molecular approach can also be used to determine if the sequence 
bacteria is metabolically active.  The active bacteria can be identified by analyzing the 
meta-transcriptome (Leininger et al., 2006; Urich et al., 2008).  In this method, the 
metagenomic RNA is isolated from the CF samples.  The total RNA is reversely 
transcribed into cDNA and then directly pyrosequenced.  The resulting output is large 
numbers of cDNA that are rRNA-tagged and mRNA-tagged sequences which provide the 
sequence-based transcriptome of the community.  Using bioinformatic programs like 
MEGAN, the sequences can be binned, aligned and identified (Leininger et al., 2006; 
Urich et al., 2008).  By analyzing the meta-transcriptome, the metabolically active 
bacteria in the CF lung can be identified.      
Determining the role of the organism in the community will be the most 
challenging issue to address.  Traditionally, Koch’s postulates must be fulfilled to state 
that an organism causes a disease (Koch, 1884).  Two requirements are that organism 
causing disease be isolated and grown in culture and that the pure isolated organism 
causes disease when introduced to a healthy person.  First, it will be difficult to 
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impossible to culture all microbes in the CF lung (Staley & Konopka, 1985).  In addition, 
it is more likely that a combination of microbes increases lung disease in CF rather than 
one specific organism.  Furthermore, CF lung disease progression is also affected by the 
host’s immune system (Makam et al., 2009).  The complexity of these relationships 
makes future studies on dynamics challenging. 
Bacterial interactions can be studied by growing combinations of organisms 
together in media or in artificial sputum (Sriramulu et al., 2005).  Competition studies 
can determine if bacteria can live in the same niche or if one bacteria flourishes in the 
community.  In addition, the growth media can be analyzed for bacterial secreted 
compounds that may be promote or decrease growth of another organism.  These 
experiments should start with only two organisms and then other CF organisms should be 
added in succession.  However, the bacterial interactions monitored in these conditions 
may not replicate the dynamics that occur in the complex CF lung.  
Recreating the microbial community in a model system will provide information 
on how the microbial community interacts with the host.  A porcine and mouse lung 
models have been developed that can be used to study lung infections (Hoffmann et al., 
2005; Rogers et al., 2008).  These animal models can be infected with various 
combinations of microbes and the affect on the lung can be studied.  In addition, BAL 
samples from the lungs can be analyzed to determine the persistency of a microbe that 
was colonized in the lung at the beginning of the infection.  These studies will provide a 
glimpse into the human CF lung. 
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5.4  SPR as a bacterial detection tool 
 During a routine or a sick visit, a clinician will take a sputum sample from a CF 
patient and send it to the lab for analysis.  The sample is cultured on various media and 
based on a phenotypic and biochemical assays, identification is made (Murray & Baron, 
2007).  Empirical treatment is initiated before microbial identification, based on the site 
of infection and if the isolate is Gram positive or Gram negative.  Within a day or two, 
the clinician is notified of the laboratory result and adjusts treatment.  For limited 
microbes, identifications can also be obtained using methods based on antibody-antigen 
interactions, such as the ELISA (Engvall & Perlmann, 1971; Pedersen et al., 1987; Voller 
et al., 1978).  Molecular tools are favored for rapid detection of organisms.  Many of 
these methods were discussed in Chapter 1.  Diagnostic tools for microbial identification 
are constantly being upgraded or developed anew to achieve faster, cheaper, and more 
accurate identifications.  This study looked at the feasibility of using surface plasmon 
resonance (SPR) as a bacterial diagnostic tool.   
SPR is a phenomenon in which molecules between the interface of two media 
vibrate (Wood, 1902, 1912).  This phenomenon can be used to determine if an antigen 
binds to an antibody (Kretschmann & Raether, 1968; Otto, 1968).  Using a SPR 
instrument, light is passed through a glass chip thinly coated with gold (Chapter 4, Figure 
4.1).  A specific frequency of light passes into the gold creating an evanescent wave.  The 
wave excites the plasmons causing them to resonate and form a plasmon wave which 
travels along the gold film interacting with the media in contact with the gold.   The 
remaining frequencies of light are reflected at a specific angle.  The angle of the light 
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reflection, which can be measured, shifts as molecules adsorb onto the surface of the gold 
(Kretschmann & Raether, 1968; Schasfoort & McWhirter, 2008).  
SPR immunosensor detects interactions between antibodies and other molecules 
such as bacteria (Geddes et al., 1994; Mayo & Hallock, 1989).  Essentially, SPR 
immunosensors detect antigens that bind to antibodies on the gold sensor by measuring 
the angle of light reflection (Kretschmann & Raether, 1968).  SPR immunosensors have 
been used to identify Escherchia coli O157:H7 (Fratamico et al., 1998; Meeusen et al., 
2005; Oh et al., 2003; Su & Li, 2005; Subramanian et al., 2006a; Taylor et al., 2005), 
Vibrio cholera (Jyoung et al., 2006), Salmonella enteritis (Bokken et al., 2003),  
Salmonella typhimurium (Oh et al., 2004a), Salmonella paratyphi (Oh et al., 2004b), 
Listeria monocytogenes (Hearty et al., 2006; Koubova et al., 2001; Leonard et al., 2005), 
Yersinia enterocolitica (Oh et al., 2005),  and Campylobacter jejuni (Taylor et al., 2006).   
This research study developed SPR immunosensors to detect Staphylococccus and 
Pseudomonas aeruginosa using the self assembled layer-by-layer approach.  The gold 
sensor chip was functionalized with SAM and then activated to allow binding of Protein 
G molecules which enables either Pseudomonas aeruginosa or Staphylococcus antibodies 
to bind to the sensor in the proper orientation (Chapter, 4, Figure 4.7).  The sensitivity 
and specificity of the sensors were determined using various bacterial solutions. 
 The Staphylococcus sensor was able to detect 107 and 108 cfu/mL of 
Staphylococcus aureus (Chapter 4, Figure 4.7). A P. aeruginosa immunosensor detected 
107 and 108 cfu/mL of P. aeruginosa (Chapter 4, Figure 4.8).   
SPR immunosensors have been capable of detecting bacteria down to the 102 
cfu/mL (Oh et al., 2004a; Oh et al., 2004b; Oh et al., 2005).  Attempts were made to 
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improve the sensitivity of the P. aeruginosa sensor by excluding BSA in the assembly 
process (Chapter 4, Figure 4.9).  This modification enabled the sensor to detect 106 
cfu/mL.  Therefore, the sensor without BSA was more sensitive.  BSA has been shown to 
decrease the sensitivity of other immunosensors (Dong et al., 2008; Jung et al., 2006; 
Jung et al., 2007; Lu et al., 2001).    
The absence of BSA may increase false positives for the sensor.  Therefore, an 
experiment was performed to determine the selectivity of a P. aeruginosa sensor made 
without BSA (Chapter 4, Figure 4.10).  The sensor detected a minimal angular shift for a 
108 cfu/mL E. coli solution demonstrating the specificity of the sensor.   
 In summary, four immunosensors were successful assembled.  These sensors 
could detect either Staphylococcus or P. aeruginosa cells in a solution.  The sensitivity 
and specificity of the sensors were not ideal and not as good as other published sensors.  
Optimization of the self assembling process may lead to sensors that could be used for 
bacterial detection in a clinical setting. 
  
Future studies.  The qualifications for any detection system are reproducibility 
and accuracy.  In addition, for marketing reasons, systems should be sensitive, cost 
efficient, easy to use, portable, and provide diagnosis in a short period of time.  At this 
time, SPR immunosensors lack the vast majority of these characteristics.   
The immunosensors developed in this work do not meet many of the criteria 
needed for clinical use.  The assembly and detection protocols need to be optimized.  A 
detailed description of potential optimization steps was discussed in Chapter 4 (Chapter 
4.5.5).  Briefly, all future work should be performed in a temperature control setting 
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(Dudak & Boyaci, 2009; Dutra et al., 2007; He et al., 2007; Matsumoto et al., 2005; 
Naimushin et al., 2003).  Flow rates of both the reference buffer and the injections should 
be determined so that enough time is allowed for molecules to interact on the gold 
surface without causing unbound molecule aggregates to form on the surface (Dudak & 
Boyaci, 2009; Skottrup et al., 2008).  Different methods can be used to ensure proper 
orientation of the antibodies onto the sensor without decreasing the sensitivity of the 
sensor (Dudak & Boyaci, 2007).  In addition, the ionic composition and pH of buffers 
should be adjusted to maximize the detection limit (Srilatha & Murthy, 2006).  Choice of 
antibodies also plays a role in adjusting the sensitivity and accuracy of the detection 
system.   
In general, SPR immunosensors are more cost efficient then using sequencing for 
bacterial detection but more expensive than the commonly used phenotypic detection 
systems (Dalvie et al., 2005; Rantakokko-Jalava et al., 2006).  The largest part of the 
SPR cost is the gold chip that costs around $30.  It is possible to reuse the chip after the 
first detection experiment by injecting a harsh chemical that removes all material 
adsorbed onto the gold (Waswa et al., 2006).  This method does affect the gold on the 
glass chip which will decrease the sensitivity of the next detection experiment.  
Validation studies would have to be performed to determine how significant the decrease 
is.  The loss of sensitivity may outweigh the need to reduce cost.  Low labor costs also 
makes the system more cost efficient.  No additional training would be required for the 
technician to use SPR. The instrument is relatively easy to use with the only labor being 
manual injections into the instrument.   
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The time required for results is on par with ELISA and commercial identification 
systems (Funke & Funke-Kissling, 2005; Janyapoon et al., 2000; Rantakokko-Jalava et 
al., 2006).  The lengthiest part of the analysis for all these methods is isolating and 
culturing a bacterium from a sample.  Once the sensor has been assembled and the 
bacteria have grown, the antibody-antigen interaction can be observed within three to ten 
minutes depending on the injection flow rate.  Changes in SPR response are observed in 
real time and no additional wait is needed for the results.  With optimization of buffers, 
chips, antibodies, and assembly protocols it may be possible to create an immunosensor 
that can use human fluids and is faster and cheaper than current identification tools.   
 Currently developed SPR immunosensors could only be marketed to test for one 
type of bacteria in a pure culture or with samples containing two or three isolates that do 
not cross react with the antibodies on the sensor chip.  As discussed earlier, a CF sputum 
sample contains a multitude of bacteria.  A multiplex SPR immunosensor could be 
developed to analyze complex samples like CF sputa.  This sensor must be made with 
multiple species-specific polyclonal antibodies affixed to the chip.  In addition, the SPR 
response for each type of antibody on the chip would have to be distinguishable from 
each other.  Advances in nanotechnology may allow SPR instruments to detect multiple 
antibody – antigen detections at faster rates and better detection limits.    
 
5.5  Conclusions    
 This work further proved the CF lung contains numerous bacteria and fungi and 
the lung community is dynamic affected by multiple drivers.  By understanding the 
members in the community, one can begin to learn the role of the organisms within the 
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community and how they affect the host.  These relationships are the key to decreasing 
lung damage and increasing the median age of survival for the patient, which is 37.7 
years of age (Patient-registry, 2008).  In the future, antibiotics may be prescribed to shift 
the community dynamic to a healthier state instead of killing one bacterium which leaves 
the door open for other pathogens.   
The research projects in this study used two groups of CF patients, with 18-19 
participants.  These patients were all adults and mostly Caucasians.  Future studies should 
use a larger population size that includes various races, ethnicity, ages, and cftr 
mutations.  These factors as well as diet, health, and antibiotic use should be used to 
statistically determine if there is a correlation between the factors and the microbiome.  In 
addition, healthy samples need to be analyzed to determine the organisms associated with 
the normal oral/lung core biome.  Through the use of 454 sequencing and LH-PCR, the 
organisms in the lung can be identified, tracked and then related to host factors.  Then, it 
can be determined if the presence of some organisms are necessary for good lung 
function.  Contrary to common belief, the bronchial tree of the healthy person is not 
sterile and these microbes may play a role in maintaining lung health (Hilty et al., 2010).  
Certain personal factors may also increase the likelihood of a particular microbe 
colonizing the lung.  Determining how a microbial community causes pathogenicity is 
the next step to understanding the CF lung biome. 
 The studies addressed in this work can also be implemented with infants and 
children.  By using LH profiling and 454 sequencing, the transition from a sterile 
newborn lower lung to the complex adult lung infection can be observed.  Determining 
the organism that first cultures the lung and how the infection progresses throughout 
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childhood may change how the United States treats CF children.  In Europe, CF patients 
are treated early and aggressively with antibiotics with the goal being eradication 
(Hansen et al., 2008).  In the US, treatment is only post infection (Flume et al., 2009).  
Understanding the community in the neonate may lend one course of treatment better 
than the other and perhaps extend the life span considerably. 
 CF lung infections will need to be diagnosed, understood, and treated until cftr 
mutations are no longer being passed on to new generations.  Continuing this research 
using 454 sequencing and community profiling with a large population of CF and healthy 
individuals may provide the knowledge needed to stabilize the lung community and 
reduce the pathogens that cause lung deterioration which ultimately kills the CF 
individual. 
The advances of sequencing technology has made it cheaper, faster, and easier to 
identify microbial DNA in a CF sample.  The name of the organism is but the first step in 
understanding the microscopic community living in the CF lung.  Understanding how 
bacteria interact with each other and with the host is the next step in the puzzle. 
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